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Vector-Mediated RNA Interference in Zebrafish: A Feasibility Study 
Amanda Kelly, 10th September 2010 
 
Abstract 
Zebrafish are becoming an increasingly popular model organism in which to 
model diseases with a genetic component.  Their use is hindered however, 
by the lack of an efficient, reliable, stable and cost-effective method to carry 
out reverse genetics and model diseases which arise from a loss of function 
of a gene.  RNAi is a method of post-transcriptional gene regulation and has 
been widely manipulated in other systems to knockdown genes at will.  This 
thesis therefore looks at the feasibility of vector-mediated RNAi in zebrafish 
by attempting to knockdown green fluorescent protein (GFP) and the 
Parkinson‟s disease-associated gene PTEN Induced Kinase 1 (PINK1).   
Initial results in HEK 293 cells and in G0 animals were encouraging, 
however low expression of the self-reporting vector made the identification of 
transgenic animals difficult.  To improve expression levels the vector was 
modified to contain a Gal4-VP16/UAS amplification cassette.  Inclusion of 
this cassette led to increased expression and knockdown capabilities of the 
vector in HEK 293 cells and led to the successful identification of transgenic 
zebrafish.  Despite high level expression however, no knockdown of GFP or 
PINK1 was detected in transgenic zebrafish larvae expressing the RNAi 
vectors out to 5 dpf. This lack of knockdown was shown to be despite the 
expression of the main components of the RNAi pathway and the production 
of customised miRNAs throughout development and across tissues.  
Interestingly however, in adult transgenic zebrafish 50% knockdown of 
PINK1 was detected in brains expressing two independent PINK1 miRNAs 
compared to the control miRNA and wild type zebrafish brains.  This 
knockdown coincided with increased transcript expression of the RNAi 
components and increased production of customised mature miRNA in the 
brain compared to embryos.   
In an attempt to improve vector-mediated RNAi in zebrafish, the effect 
of over-expression of components of the RNAi machinery, including 
Argonaute 2, Dicer, Drosha and Exportin 5 was assessed in zebrafish cells. 
Of these, only over-expression of Argonaute 2 improved knockdown in HEK 
293 cells and resulted in moderate knockdown in two independent zebrafish 
cell lines, PAC.2 and ZFL cells.  This improvement in knockdown was shown 
to be a result of the RNase activity of Argonaute 2 as mutation of this domain 
abrogated the effect of Argonaute 2 over-expression.  Despite the 
encouraging results in zebrafish cell lines, injection of Argonaute 2 mRNA 
into transgenic zebrafish failed to produce knockdown, suggesting perhaps, 
that in zebrafish embryos other factors apart from Argonaute 2 are also 
limiting  
Given the difficulties of vector-mediated RNAi in zebrafish, this 
technology is at present not a feasible approach to knocking down genes in 
zebrafish, at least not to an extent as to model complete loss of gene 
function.
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TAE tris acetate EDTA 
TBS tris buffered saline 
TBS-T TBS-Tween 
TE tris EDTA 
u units 
UAS upstream activating sequence 
UPS ubiquitin-proteasome system 
wks weeks 
Xpo5 Exportin5 
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1 Introduction 
 
Animal models have been extremely important in understanding biological 
processes involved in both normal homeostasis and disease states. The 
zebrafish in particular, has proved extremely valuable due to its many 
advantages over other model organisms such as the mouse and flies.  One 
such advantage is the amenability of zebrafish for phenotype-guided drug 
discovery in high-throughput screens to identify novel therapeutic agents.  A 
major limitation in this drug discovery process is the lack of zebrafish disease 
models, caused not least by an inability to effectively model diseases which 
result from a loss of function of a particular gene.  This research therefore 
explores the possibility for the use of vector-mediated RNA Interference 
(RNAi) in zebrafish in order to stably, reliably and cost-effectively knockdown 
genes.  It is hoped that the development of this technology will enable the 
generation of new disease models, and in particular I am interested in 
developing a Parkinson‟s disease (PD) model.  PD is a debilitating disease 
which affects the dopaminergic neurons of the substantia nigra and for which 
there are currently no effective treatments.  Importantly, several forms of PD 
are caused by loss of function of gene products including PARK6, which 
results from the loss of function of the kinase, P-TEN induced kinase 
1(PINK1).  The following therefore reviews gene knockdown in zebrafish and 
the potential use of RNAi and discusses the aetiology and genetic basis of 
PD with the view to developing an RNAi-induced model. 
1.1 Use of the Zebrafish as a Model Organism 
The zebrafish is a rapidly emerging model organism in which to study 
embryonic development and disease.  The popularity of this organism is due 
to the ease of production and manipulation.  The high fecundity of the 
zebrafish means that a mating pair can produce hundreds of embryos per 
breeding (Amatruda et al., 2002).  This is accompanied by the rapid and ex 
utero development of optically transparent embryos, which makes it possible 
to study embryogenesis and organogenesis and to detect functional and 
morphological changes in internal organs without having to kill or dissect the 
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organism (Eisen, 1996). Furthermore, easy and affordable husbandry, 
together with a relatively rapid generation time of just 3 months (Amatruda et 
al., 2002), makes the zebrafish an economically viable option.  Sequencing 
and annotation of the zebrafish and human genomes has revealed a high 
degree of genetic conservation.  In addition, in contrast to other invertebrate 
models being used zebrafish and humans also have a lot of physiological 
similarities; both develop extensive and complex cardiovascular, nervous, 
digestive, immune, endocrine and excretory systems, thus allowing the use 
of zebrafish to study vertebrate specific processes (Eisen, 1996). Genetic 
and physiological conservation between humans and zebrafish, along with 
their small size and high fecundity also make them ideal for use in high-
throughput screening to identify potential therapeutic and/or toxic compounds 
for a vast array of diseases (Zon and Peterson, 2005).  Perhaps most 
importantly however, in relation to the aims of this research, is the ease with 
which the zebrafish can be genetically modified to generate transgenic 
animals. 
1.1.1 Transgenesis in Zebrafish 
The production of transgenic zebrafish used to be carried out simply by the 
injection of plasmid or linear DNA into early embryos.  This was a highly 
inefficient means of transgenesis and often resulted in the genome insertion 
of concatemers of DNA which were eventually silenced through DNA 
methylation.  In 2002, the field of transgenesis was revolutionised when the 
Wittbrodt lab demonstrated that flanking transgenes with a meganuclease 
restriction site and co-injecting into embryos along with the appropriate 
meganuclease significantly improved rates of transgenesis and prevented 
the formation of concatemers (Thermes et al., 2002).  Further advancements 
came with the discovery of an autonomous transposon in medaka (Oryzias 
latipes) called Tol2 (Koga et al., 1996).  Functional dissection of the 
transposable and transposase elements of Tol2 meant that it was now 
possible to flank transgenes with the arms of the transposable element.  
Upon co-injection of the transposon-flanked transgene and transposase 
messenger RNA (mRNA) into the host, the transgene is transposed into the 
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host genome.  This method has substantially improved rates of transgenesis 
in a host of organisms including, zebrafish (Kawakami and Shima, 1999; 
Kawakami et al., 2000), Drosophila (Urasaki et al., 2008), xenopus 
(Kawakami et al., 2000), chicken (Sato et al., 2007) and mouse (Kawakami 
and Noda, 2004). 
As well as the technology to efficiently produce transgenics, numerous 
promoter elements have been identified in the zebrafish allowing tissue-
specific expression of transgenes.  Furthermore, numerous conditional 
systems have been shown to function in zebrafish, including the heat-
inducible system using the heat-shock promoter, (HSP70) (Adam et al., 
2000), a doxycycline-inducible system using Tet repressors and tet operators 
(Huang et al., 2005), a Cre/lox recombinase system (Langenau et al., 2005), 
and the Gal4/UAS system (Scheer and Campos-Ortega, 1999).  Indeed the 
Gal4/UAS system combined with Tol2 has been used as an enhancer trap 
and has provided the zebrafish community with a wealth of driver lines 
(Asakawa and Kawakami, 2008; Davison et al., 2007; Scott et al., 2007).      
1.2 Gene knockdown 
Despite the wide-spread uptake of zebrafish as a versatile and tractable 
model organism, there is currently no reliable and affordable technology for 
stable gene knockout/ knockdown in zebrafish.  The section evaluates 
possible techniques ranging from homologous recombination and 
mutagenesis to transient morpholino technologies and the possibility of 
RNAi. 
1.2.1 Homologous Recombination 
Homologous recombination is the knockout method of choice in mice. It 
relies on the endogenous recombination machinery of cells to replace genes 
with modified versions of themselves.  These modified versions can be 
engineered to alter or eliminate gene function, for example through the 
introduction of a premature stop codon, or changes in the sequence 
encoding the active site of a protein.  In mice, homologous recombination is 
carried out in embryonic stem cells (Doetschman et al., 1987; Doetschman et 
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al., 1988) which are then transplanted into embryos and result in the 
development of chimeras (Thompson et al., 1989).  Assuming the modified 
ES cells contribute to the germ line, a proportion of the offspring of these 
mice will carry the modified gene.  Alternatively, in animals where ES cells 
have not been identified, fibroblast donor cells can be modified and then their 
nuclei transferred to enucleated oocytes (Lai et al., 2002; McCreath et al., 
2000).    
In zebrafish, ES-like cells have been isolated (Sun et al., 1995), 
transplanted and shown to contribute to the germ line (Ma et al., 2001).  
However, the rate of transmission, at 2-4%, is extremely low.  Nuclear 
transfer of modified nuclei has also been achieved, however with similar 
transmission rates (Lee et al., 2002).  Despite these achievements gene 
inactivation in zebrafish via homologous recombination is still yet to be 
achieved and progress in this area has been very slow. 
1.2.2 Random Mutagenesis 
An alternative method of knocking out gene function is to randomly induce 
mutations in genomes and then screen for these mutations.  Mutagenesis 
can be brought about using chemical mutagens such as the alkylating agents 
ethyl methanosulfonate (EMS) or ethyl-N-nitrosourea (ENU) or insertional 
mutagens such as transposons (Sivasubbu et al., 2006) or pseudotyped 
retroviruses (Amsterdam and Hopkins, 2004; Golling et al., 2002).  Where 
chemical mutagens are used, mutations can be identified by a method called 
Targeting Induced Local Lesions in Genomes (TILLING).  In this method, 
mutations in genes of interest are identified by amplification and direct 
sequencing of that gene from individual fish DNA samples (Wienholds and 
Plasterk, 2004; Wienholds et al., 2002).  Where transposons or retroviruses 
are involved mutations can be somewhat more easily identified.  A restriction 
enzyme which cuts near the 5‟ end of the vector is used to cut up the 
genome, linkers are then added to the ends of fragments and linker-
mediated PCR performed, where one primer is specific for the vector and the 
other is specific for the linker.  Amplified products can then be sequenced to 
identify where the insertion is (Ellingsen et al., 2005).   
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A major disadvantage to the use of random mutagenesis is the huge 
amount of time, space and hence money required in the generation and 
breeding of mutagenised zebrafish. Indeed, Amsterdam and Hopkins 
estimated that given the size of the zebrafish genome (1.6 x109 bp), 500,000 
randomly placed retroviral insertions would have to be screened to reach 
saturation of the genome (Amsterdam and Hopkins, 2004). Furthermore, 
chemical and insertional mutations can often be silent or result in incomplete 
loss of function. 
1.2.3 Zinc Finger Nucleases: Targeted Mutagenesis 
Zinc Fingers are protein domains which recognise and bind specifically to 3 
base pairs (bp) of DNA or RNA.  The specific binding capacity of zinc fingers 
can be exploited and numerous zinc fingers can be arrayed together to 
recognise longer lengths of DNA.  In addition, nuclease domains can be 
fused to the zinc finger arrays which enable engineered zinc fingers to act 
like restriction enzymes and induce double strand breaks at sequence-
specific locations in the genome. Double strand breaks are then repaired by 
the cell‟s endogenous non-homologous end joining machinery. This process 
is highly mutagenic, often resulting in random insertions or deletions at the 
break site, which can result in loss of function of the targeted gene.  Using 
this method, targeted knockout mutations have been introduced in human 
cells (Zou et al., 2009) and in in vivo animal models, including Drosophila 
(Beumer et al., 2006) and zebrafish (Doyon et al., 2008; Foley et al., 2009; 
Meng et al., 2008).   
Despite the promise of zinc fingers, there are several limitations to this 
technology.  Firstly, there is the potential for off-target effects which may 
cause detrimental developmental defects preventing the use of some zinc 
finger combinations.  Secondly, there are as yet a limited number of 
validated zinc fingers, so identifying unique zinc finger target sites in the 
target regions of zebrafish genes may limit the use of this technology.  
Finally, the type of mutation introduced is random and may not have the 
desired effect. 
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1.2.4 Morpholinos 
Morpholinos are antisense oligonucleotides with a modified backbone, which 
makes them resistant to nucleases and therefore extremely stable.  
Morpholinos can be designed to function in one of two ways.  Firstly, they 
can be designed against the translation initiation site, in which case they 
prevent the translation of mRNA by preventing ribosome entry through steric 
hindrance.  Alternatively, they can be designed to target splice acceptor or 
splice donor sites, this either results in incorrect splicing of the mRNA or in 
loss of the transcript via nonsense mediated decay.  Morpholinos were 
initially used in zebrafish to phenocopy known mutants such as no tail, nacre 
and sparse (Nasevicius and Ekker, 2000) and since then have become a 
widely used tool to elucidate gene function and embryogenesis in zebrafish.  
The use of morpholinos  is limited however, as there have been numerous 
reports of sequence-specific and non-specific „off-target‟ effects, which often 
lead to phenotypes such as neuronal cell death, small eyes and heads and 
disrupted somites and notochord (Ekker and Larson, 2001).  This makes 
deciphering what are on-target and off-target effects difficult.   Another major 
limitation is the transient nature of morpholinos, which means that they 
cannot be used to study development and gene function past the first few 
days of embryogenesis.  
1.2.5 RNA Interference (RNAi) 
The recent discovery of RNAi as an innate and potent method of sequence-
specific gene knockdown in organisms ranging from plants and fungi to 
worms, flies, mice and humans, combined with the ease in which it can be 
manipulated to target genes of interest, has lead to the rapid uptake of RNAi 
as a general lab technique to knockdown genes.  The presence of functional 
RNAi machinery in zebrafish combined with the possibilities of vector-
mediated delivery of RNAi, means that this technique may hold the key to 
achieving efficient, stable and cost-effective gene knockdown in zebrafish.  
The following section discusses the RNAi pathway in detail and how it might 
be used in zebrafish to successfully target genes for knockdown. 
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1.3 Gene Knockdown by RNAi 
RNAi is an evolutionary conserved pathway of post-transcriptional gene 
regulation, in which small RNA effector molecules sequence-specifically 
regulate gene expression. The small RNA effector molecules can either be 
endogenously expressed microRNAs (miRNAs) or exogenous small 
interfering RNAs (siRNAs).   
1.3.1 Micro RNAs (miRNAs) and Small Interfering RNAs (siRNAs) 
miRNAs are small non-coding RNA molecules which post-transcriptionally 
regulate gene expression by base-pairing to mRNAs and either blocking the 
translation of the mRNA or causing its destabilisation and  degradation.  The 
first miRNA gene to be identified was lin-4 in Caenorhabditis elegans  (Lee et 
al., 1993).  lin-4 encodes a miRNA which  was identified as a translational 
suppressor of the lin-14 gene, whose down regulation is required for 
progression of C. elegans from the first to second larval stage, and later lin-
28, a protein which initiates the transition between the second and third larval 
stage (Moss et al., 1997).  lin-4 regulation of lin-14 and lin-28 was shown to 
be dependent on the imperfect base pairing between the lin-4 miRNA and 
the 3‟ Un-Translated Regions (UTRs) of lin-14 and lin-28 which blocked the 
translation of the mRNAs (Ha et al., 1996; Lee et al., 1993; Moss et al., 1997; 
Olsen and Ambros, 1999; Wightman et al., 1993).  Initially, this type of post- 
transcriptional gene regulation was believed to be an oddity of C. elegans 
until a second miRNA was identified.  This second miRNA was let-7 which 
regulates in the same way the translation of lin-41 mRNA (Reinhart et al., 
2000; Vella et al., 2004).  The importance of this discovery was the 
realisation of the evolutionary conservation of both let-7 and lin-41 among 
metazoans, raising the possibility that this method of gene regulation may be 
more far reaching than previously thought (Pasquinelli et al., 2000).  Today 
over 14,000 validated miRNA precursors have been identified across 133 
distinct species ranging from fungi to mammals (Griffiths-Jones, 2004; 
Griffiths-Jones et al., 2006; Griffiths-Jones et al., 2008).  The human genome 
itself has been shown to contain over 900 miRNA precursors and miRNAs 
are believed to regulate up to 30% of the genome (Lewis et al., 2005).   
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Concurrently with the identification of miRNAs, it was realised by 
chance through knockdown experiments using sense and antisense RNAs,  
that the exposure of C. elegans to double-stranded (ds)RNA caused potent 
and sequence-specific gene silencing through binding to mRNA (Fire et al., 
1998) and inducing its cleavage (Montgomery et al., 1998).  In 2001, it was 
realised that dsRNA was being processed in vivo to form small dsRNA of 
between 21-25 nucleotides (nt) in length which closely resemble endogenous 
miRNAs and that these siRNAs were the mediators of silencing (Elbashir et 
al., 2001b).  Furthermore, the mechanism is  also conserved, as this form of 
silencing is common to plants, fungi, worms and flies, and might be an 
endogenous defence mechanism against viral infection or parasitic nucleic 
acids (Hannon, 2002).   
Although not appreciated at first, analysis of the mechanisms of these 
two methods of gene silencing proved that they both make use of the same 
pathway, which is described below. 
1.3.2 The miRNA/RNAi Pathway: An Overview 
The effector molecules of both siRNA- and miRNA-induced silencing are 
~21-25 nt dsRNA with 5‟ phosphate groups, 3‟ hydroxyl groups and 
asymmetrical 3‟ 2 nt overhangs (Elbashir et al., 2001b), however they differ 
in their modes of biogenesis. 
miRNAs are transcribed in the nucleus either as genes in their own 
right, or embedded within protein-coding and non-coding host genes, in 
which case their expression is regulated by the promoter elements of the 
host. Often, they are found clustered together in polycistronic transcripts 
transcribed from the same promoter region and may contain representatives 
of distinct miRNA families, indicating the coordinated regulation of 
expression of numerous miRNAs (Griffiths-Jones et al., 2008; Thatcher et al., 
2008a). During transcription, the primary or pri-miRNA transcript, which 
consists of a double stranded stem, a terminal loop and flanking ssRNA is 
cleaved by a microprocessor complex.  This microprocessor complex 
consists of the RNaseIII-like enzyme Drosha and cofactors, including 
DGCR8 (DiGeorge Syndrome Critical Region 8, also known as Pasha in flies 
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and worms).  Cleavage of  pri-miRNAs by the microprocessor creates ~70 nt 
stem-loop structures termed precursor, or pre-miRNAs which have 5‟ 
phosphate groups, 3‟ hydroxyl groups and 2 nt overhangs at their 3‟ ends 
(Figure 1.1) (Denli et al., 2004; Gregory et al., 2004; Han et al., 2004; 
Landthaler et al., 2004; Lee et al., 2003).  Pre-miRNA is then transported out 
of the nucleus into the cytoplasm by a nuclear transport receptor complex, 
Exportin 5 (Xpo5)-RanGTP (Bohnsack et al., 2004; Lund et al., 2004; Yi et 
al., 2003). The loop structure is then removed via cleavage by the 
cytoplasmic RNaseIII-like endonuclease, Dicer to form a ~ 22 nt miRNA 
duplex with 5‟ phosphate groups and asymmetrical 2 nt 3‟ overhangs.  This 
processing also occurs within a microprocessor complex which also contains 
the human immunodeficiency virus transactivating response RNA-binding 
protein (TRBP) which stabilises the interaction of Dicer with pre-miRNA 
through its three dsRNA binding domains.  Processing by Dicer is coupled 
with the preferential assembly of one strand, the guide strand, into the 
effector complex, known as the RNA-induced silencing complex (RISC) or 
the micro ribonucleoprotein (miRNP), while the other strand, the passenger 
strand, is degraded (Bartel, 2004).   
   Once loaded into the silencing complex, the miRNA acts on its 
target either by binding through a seed region (usually nucleotides 2-8)  to its  
3‟ UTR and causing translational repression or mRNA destabilisation or by 
binding with complete complementarity to the mRNA and inducing cleavage 
of the mRNA (Figure 1.1). In the majority of cases, endogenous miRNAs 
function by binding through a seed region to the 3‟ UTRs of their targets.  
The exception to this is the miRNA miR-196 which has been shown to bind 
with almost complete complementarity to the Hoxb8 mRNA and cause its  
cleavage in mouse embryos and in cell culture (Yekta et al., 2004).   
Small interfering RNAs (siRNAs) can either be chemically synthesised 
or are generated from an exogenous source of dsRNA (e.g. from viral 
infection).  In the case of the latter, Dicer cuts the dsRNA up randomly into 
small double-stranded 21-25 nt siRNAs.  These siRNA duplexes then enter 
into the same pathway as described above (Figure 1.1).  However, in 
contrast to miRNAs the majority of siRNAs induce gene silencing by binding 
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to a target with complete complementarity, resulting in the cleavage of the 
mRNA.  Despite this distinction, endogenous miRNAs have been shown to 
be able to induce cleavage of mRNA containing completely complementary 
target sequences (Zeng et al., 2003) and conversely, when siRNAs 
imperfectly complement the 3‟ UTR of their target, translational repression or 
mRNA destabilisation may ensue (Doench et al., 2003; Zeng et al., 2003).   
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Figure 1.1: Biogenesis of and Post-transcriptional Suppression by microRNAs and 
small interfering (si)RNAs.  The nascent primary miRNA (pri-miRNA) transcripts are first 
processed into ~70-nucleotide precursor miRNAs (pre-miRNAs) by Drosha inside the 
nucleus. Pre-miRNAs are transported to the cytoplasm by Xpo5-Ran-GTP and are 
processed into mature miRNA duplexes by Dicer. Dicer also processes long dsRNA 
molecules into siRNA duplexes. One strand of the miRNA or siRNA duplex is preferentially 
assembled into the RNA-induced silencing complex (RISC) or microribonucleoprotein 
(miRNP), which subsequently acts on its target by binding through a seed region in the 
3‟UTR and causing translational repression or mRNA destabilisation or, by binding with 
complete complementarity and cleaving the mRNA. 
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1.3.3 RNAi Processes in Depth 
1.3.3.1 Drosha Processing 
Drosha is a class II RNase III-like enzyme which consists of two tandem 
endonuclease domains (endoND), and a double stranded RNA binding 
domain (dsRBD) (Figure 1.2).  The two tandem endonuclease domains fold 
back on each other and create a pseudo-dimer catalytic core in which the 
first and second endonuclease domains independently cut the dsRNA in a 
staggered manner and produce 3‟ 2-nt overhangs (Han et al., 2004).  In 
order for this to happen in the correct place, Drosha needs to recognise and 
orientate itself properly along the stem loop structure.  Originally, it was 
proposed that Drosha itself may recognise the terminal loop structure and 
unstructured ssRNA flanking the stem loop (Zeng et al., 2005b).  However, 
more recent evidence suggests that recognition of primary miRNA transcripts 
is dependent on binding of the co-factor DGCR8, a protein containing two 
dsRBDs, to the ssRNA/dsRNA junction at the base of the stem loop.  Once 
DGCR8 is bound to the ssRNA/dsRNA junction Drosha then orientates itself 
along the stem loop so that the catalytic domain cleaves ~ 11bp from the 
flanking ssRNA (Han et al., 2006).    Indeed, both Drosha and DGCR8 are 
essential (Denli et al., 2004; Gregory et al., 2004; Han et al., 2004) and 
sufficient for processing of primary miRNA transcripts (Han et al., 2004).    
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Figure 1.2: Domain Composition of Components of Animal RNAi.  Double stranded 
RNA binding domains (dsRBDs) bind to pri- and pre- miRNAs.  Endonuclease domains 
(endoND) form intermolecular dimers which cleave pri- and pre- miRNAs.  PAZ domains 
bind to 3‟ overhangs of mature miRNAs.  DExD helicase modifies the catalytic activity of 
Dicer.  PIWI domains contain an RNase H-like fold which in the case of Ago2 cleaves target 
mRNA in a sequence-specific manner.  MID domain binds to the 5‟ phosphorylated ends of 
guide strand miRNAs.   Modified from Nowotny and Yang (2009). 
 
1.3.3.2 Export from the Nucleus 
After processing by Drosha, pre-miRNA is exported from the nucleus.  Export 
from the nucleus is carried out by the karyopherin β transporter, Exportin 5 
(Xpo5) in a RanGTP dependent manner (Bohnsack et al., 2004; Lund et al., 
2004; Yi et al., 2003).  Binding of the RanGTP•Xpo5 complex to pre-miRNA 
is sequence independent, but requires a terminal double stranded „minihelix‟ 
of ≥ 14 bp, a based paired 5‟ end and 3‟ overhang of ≤ 3 nt (Gwizdek et al., 
2003).  Once bound the RanGTP•Xpo5•pre-miRNA complex is translocated 
through the nuclear pore complex (NPC) into the cytoplasm.  In the 
cytoplasm RanGTP is hydrolysed to RanGDP, which in turn causes the 
release of the pre-miRNA.  Once the pre-miRNA is released exportin 5 is 
transported back into the nucleus and the process begins again.   
1.3.3.3 Dicing and Loading 
Once transported to the cytoplasm pre-miRNA is further processed by Dicer 
to form mature miRNA duplexes.  Dicer is a class III RNaseIII-like 
endonuclease which contains two endoND domains, a dsRBD, a PAZ 
domain and two DExD helicase domains (Figure 1.2).  Dicer binds pre-
miRNAs through its dsRBD and the PAZ domain.  The dsRBD recognises 
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dsRNA without sequence-specificity, whereas the PAZ domain specifically 
binds to the 3‟ ends of ssRNA or to the protruding 3‟ 2 nt overhang generated 
by Drosha processing.  RNA cleavage takes place in a mechanism similar to 
Drosha cleavage, in which the two tandem endonucleolytic domains fold 
back on themselves to create a catalytic core.  The site of Dicer cleavage is 
determined by the distance between the PAZ domain, bound to the 3‟ end of 
the stem loop, and the active endonucleolytic site (Zhang et al., 2004). Like 
Drosha processing, Dicer processing also results in 3‟ 2 nt overhangs.    The 
DExD helicase domain has a dual role.  Firstly, it acts as an autonomous 
inhibitor of catalytic Dicer activity, as removal of the DExD helicase domain 
enhances catalytic activity.  Secondly, it is required for the association 
between Dicer and co-factors such as TRBP.  Notably, increasing availability 
of TRBP also enhances the catalytic activity of full-length Dicer, but not of 
Dicer with the DExD helicase domain removed.  This suggests that the 
binding of the DExD helicase domain to Dicer co-factors acts as a molecular 
switch between low and high catalytic activity (Deddouche et al., 2008).   
After Dicer cleavage one strand of the miRNA/siRNA duplex is 
preferentially loaded into RISC.   Guide strand selection is believed to be 
dependent on the thermodynamic stability at the ends of the dsRNA duplex, 
with the strand with the lower stability at the 5‟ end being preferentially 
selected for loading into RISC (Khvorova et al., 2003; Schwarz et al., 2003).  
In Drosophila,  guide strand selection was shown to be dependent on the 
orientation of the Dicer-2 RNA binding partner R2D2 which binds to the 5‟ 
end of the most thermodynamically stable strand and prevents its assembly 
into RISC (Tomari et al., 2004).  Recently, TRBP, which had already been 
shown to recruit Argonaute 2 to siRNAs (Chendrimada et al., 2005), has 
been shown to be the possible human equivalent of R2D2 (Gredell et al., 
2010).  However, detection of 5‟-thermodynamically stable miRNA strands in 
some tissues and tissue-specific differences in strand selection, suggests 
that strand selection may be more complex and be dependent on further 
signals outside of the miRNA duplex sequence and perhaps also on 
expression of other factors (Hu et al., 2009; Ro et al., 2007).  
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1.3.3.4 RNA Induced Silencing Complexes: translational repression, mRNA 
destabilisation or mRNA degradation 
The major component of RISC is a member of the argonaute (Ago) family of 
proteins.  Ago proteins are defined by the presence of PAZ, Mid and PIWI 
domains (Figure 1.2).  PAZ domains recognise and bind to the single 
stranded 3‟ ends of miRNAs/siRNAs (Song et al., 2003) while the Mid 
domain recognises the phosphate at the 5‟ end of the miRNA/siRNA 
(Nowotny and Yang, 2009).  The PIWI domain encodes the endonuclease 
activity of argonaute and is structurally similar to the RNase H family of 
proteins, which cleave RNA in RNA/DNA hybrids (Liu et al., 2004; Song et 
al., 2004).  In mammals there are four argonaute proteins Ago1-Ago4 and 
four argonaute-related proteins, called PIWIs which are restricted in 
expression to the germ cells.  Although, Ago proteins are the only component 
to be continuously found  in RISC, numerous accessory proteins have been 
shown to associate, including RNA helicases such as RNA helicase A (Robb 
and Rana, 2007), MOV10 (Meister et al., 2005) gemin 3 and gemin 4 
(Mourelatos et al., 2002), nucleases such as the staphyloccal nuclease 
Tudor-SN (Caudy et al., 2003) and RNA-binding proteins such as fragile X-
related protein (dFXR) (Caudy et al., 2002), VIG (Caudy et al., 2002), 
TNRC6B/KIAA1093 (Meister et al., 2005), TRBP (Chendrimada et al., 
2005), PACT (Lee et al., 2006) and GW182 (Liu et al., 2005a).  The vast 
array of accessory proteins means that there may be a huge number of 
combinatorial RISC complexes with distinct functions. 
1.3.3.4.1 Translation Repression and mRNA Destabilisation 
The majority of endogenous silencing complexes loaded with miRNA carry 
out gene regulation through translational repression or destabilisation of the 
target mRNA.  All four mammalian Ago proteins have been shown to induce 
translation repression/mRNA destabilisation by binding of single or multiple 
miRNAs through a seed region (usually bases 2-8) to the 3‟ UTR of the 
target.  As yet the precise mechanisms by which this takes place are not fully 
understood, but may be down to one or a combination of the following 
mechanisms:   
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 Prevention of competent ribosome assembly and hence translation.  
This prevention is possibly mediated through association of RISC with 
EIF6, which has been shown to prevent the association between 40S 
and 60S ribosomal subunits and hence prevent the assembly of the 
80S competent ribosome (Chendrimada et al., 2007; Thermann and 
Hentze, 2007).  
 Repression of the formation and binding of translation initiation 
complexes to the m7G cap of mRNAs (Humphreys et al., 2005; 
Mathonnet et al., 2007).   Indeed, Ago2 was found to bind to m7G cap 
and competes with the translation initiation factor eIF4E for binding to 
the cap (Kiriakidou et al., 2007).  
 Interaction of RISC with active ribosomes, rendering them prone to 
premature termination (Petersen et al., 2006).  
 Induction of deadenylation of target mRNA, which subsequently leads 
to mRNA destabilisation (Bagga et al., 2005; Behm-Ansmant et al., 
2006; Giraldez et al., 2006; Wu et al., 2006).  Consistent with this is 
the finding that miRISCs have been shown to co-localise with 
Processing bodies (P-bodies), granules which contain the enzymes 
necessary for mRNA degradation, such as deadenylases, decapases 
and exonucleases (Liu et al., 2005b; Sen and Blau, 2005).   
Methods of miRNA mediated repression of target genes are reviewed in 
Filipowicz (2008). 
1.3.3.4.2 mRNA Cleavage 
mRNA cleavage is dependent on complete (or almost complete) 
complementarity between the miRNA/siRNA and the target mRNA.  Unlike in 
translational repression or mRNA destabilisation only one mammalian Ago 
protein, Ago2 is able to induce silencing via mRNA cleavage. Cleavage is 
mediated through the PIWI domain of Ago2.  The PIWI domain in Ago2 
contains a unique RNase catalytic domain consisting of two aspartates (D) 
and a Histidine (H) (DDH) at positions 597, 669 and 807 (relative to human 
Ago2) respectively (Rivas et al., 2005).  These three active sites are 
conserved in Ago2 proteins (or equivalents) in all species including 
Drosophila, zebrafish, mice and humans.  The DDH motif however is also 
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found in the mammalian Ago3 protein, however other residues around the 
active site are not conserved and mutation of the non-conserved residues of 
Ago2 to those residues found in Ago3 have been shown to inactivate the 
RNase activity of Ago2 (Liu et al., 2004).  That Ago2 is the protein 
responsible for RNAi mediated knockdown by siRNAs targeted to the open-
reading frame  (ORF) has been confirmed by the finding that knockout of 
Ago2 renders mouse embryo fibroblasts (MEFs) incapable of gene 
knockdown in response to siRNAs (Liu et al., 2004). As stated previously, 
cleavage of the mRNA is dependent on sequence complementarity, but 
especially important is complementarity at position 10 and 11 where mRNA 
cleavage takes place.  A single mismatch at either of these two positions 
completely disrupts mRNA cleavage. 
1.3.4 Delivering Targeted Gene Knockdown using RNAi 
The discovery of RNAi in C. elegans meant that it was now possible to 
knockdown target genes in a sequence-specific manner.  The next major 
hurdle was how to deliver the siRNA effector molecules of RNAi.   While 
organisms such as C. elegans and Drosophila melanogaster (Kennerdell and 
Carthew, 1998) responded as expected to injection or ingestion of dsRNA, its 
use in mammalian systems was hampered by the fact that long dsRNAs elicit 
an immune response.  During this immune response, interferon activates 
RNaseL and Protein Kinase R (PKR).  Activation of RNaseL causes 
degradation of several RNA species including ribosomal RNA, while  Protein 
Kinase R (PKR)  is a dsRNA-dependent protein kinase which blocks protein 
synthesis through the phosphorylation of the translation initiation factor eIF2α 
(Stark et al., 1998; Williams, 1997).  Fortunately, it was soon realised that 
delivery of short, chemically synthesised dsRNAs which resemble Dicer-
processed siRNAs do not elicit such an immune response and are able to 
effectively knockdown targets via mRNA cleavage in both invertebrate and 
vertebrate systems, including human cells (Caplen et al., 2001; Elbashir et 
al., 2001a).  Since then, the use of chemically synthesised siRNAs to 
knockdown genes in mammalian cells and animals has been a wide-spread 
reverse genetic tool in elucidating and manipulating gene function.  Despite 
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the wide-spread use of chemically synthesised siRNAs there are major 
limitations to their use.  Unlike in plants (Dalmay et al., 2000; Mourrain et al., 
2000), fungi (Cogoni and Macino, 1999) and worms (Sijen et al., 2001; 
Smardon et al., 2000) where RNAi is long lived due to the amplification of 
siRNAs by RNA-dependent RNA polymerases, mammals, flies and fish have 
no such polymerase, and so siRNA mediated gene knockdown is only 
transient.  This makes the use of siRNAs at best expensive and at worst 
impossible in situations where gene knockdown should be maintained.  To 
overcome this, vector–mediated mechanisms for stably producing siRNAs 
have been developed.  These vectors fall into two major categories.  The first 
are polymerase III- (pol III-) responsive vectors, and the second are pol II-
responsive vectors. 
1.3.4.1 Pol III-responsive Vectors 
Pol III-responsive vectors utilise polymerase III promoters, usually U6 or H1 
promoters to drive expression of short hairpin (sh)RNAs. Pol III-responsive 
promoters are short, well defined enhancers which drive expression of short 
RNAs which lack polyA tails and instead transcription is terminated by a run 
of four or more Thymidine (T) residues.  Importantly, cleavage of the 
transcribed RNA occurs after the second in a run of uridines.  By inserting 
the sense and antisense sequence of the target mRNA separated by a 
spacer downstream of a pol III promoter a transcript which folds back on 
itself to form a short hairpin with 3‟ 2 nt overhangs is produced.  These 
shRNAs resemble the short stem-loop structures of pre-miRNA, and so enter 
into the miRNA processing pathway and are cut by Dicer to release a ~ 21nt 
siRNA.  This system was first successfully used by Brummelkamp et al. 
(2002) to silence E-cadherin and p53 in the breast cancer cell line MCF-7.  
Since then, they have been widely and successfully used by many 
laboratories.  Despite their ability to successfully induce silencing of targeted 
genes, there are limitations in the use of pol III-responsive promoters.  
Firstly, it is not possible to identify when and where the shRNA is being 
expressed by means of a tandem-expressed marker protein such as green 
fluorescent protein (GFP).  Secondly, spatial and temporal specificity of 
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shRNA expression, which may be required when using vector-mediated 
RNAi in organisms, cannot be easily controlled using pol III-responsive 
vectors.  Despite this, conditional pol III-based RNAi systems have been 
described.  One such system is created through the insertion of a tet 
operator (tetO) just upstream of the transcription start site. TetO interferes 
with the TATA box through the recruitment of the exogenously expressed 
tetracycline repressor (tetR).  Upon addition of doxycycline the tetR is 
sequestered and transcription of the shRNA is enabled.  This system was 
used by Hoeflich et al., (2006) to conditionally knockdown BRAF in a mouse 
tumour xenograft model.  However, this system does not guarantee complete 
suppression of the shRNA.  In an improvement upon this system fusion of 
the tetR to the Krüppel-associated box (KRAB) protein has been shown to 
result in stringent silencing of the gene downstream of the tetO through the 
formation of heterochromatin (Wiznerowicz and Trono, 2003).  Finally, 
conditional knockdown systems have been created through the insertion of 
loxP sites within the shRNA vector.  In this system, tissue-specific or 
temporal expression of Cre results in the excision of DNA between the IoxP 
sites.  In this way vectors have been designed so that shRNA can be 
expressed either in the presence or absence of Cre (Garcia-Otin and Guillou, 
2006). 
1.3.4.2 Pol II-responsive Vectors 
Pol II-responsive vectors utilise polymerase II promoters to deliver miRNAs.  
An effective method of pol II-responsive expression of customised miRNAs 
has been described Cullen and colleagues (Zeng et al., 2005a; Zeng et al., 
2002).  In this system, pol II promoters are used to transcribe a naturally 
occurring human primary miRNA transcript, in this case hsa-miR-30a, but 
with the target sequence modified to target a gene of interest.  Use of an 
endogenous primary miRNA backbone ensures the correct Drosha and Dicer 
processing of the customised miRNA.   It also means that by embedding the 
primary miRNA sequence within an intron, miRNA and a reporter gene can 
be co-expressed from the same promoter.  The vast array of pol II promoters 
also means that the expression of the miRNA could be controlled in a tissue-
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specific and/or temporal manner.  Finally, multiple customised miRNAs, 
targeting the same or distinct genes can be embedded within one 
polycistronic transcript (Zeng et al., 2005a) 
1.3.5 RNAi in Zebrafish 
Zebrafish have been shown to have fully functional RNAi machinery.  
Homologs of both mammalian Dicer and Drosha have been identified in 
zebrafish and a putative exportin 5 and 4 putative argonaute genes have 
been found with a high degree of conservation to their mammalian 
counterparts. The most recent count of cloned and validated miRNAs in 
zebrafish puts the total number of miRNAs expressed at 217 (Soares et al., 
2009), and inclusion of bioinformatically predicted miRNAs takes the total 
number of miRNAs to over 400 (Thatcher et al., 2008a).  They have been 
shown to be involved in numerous biological processes (Dore et al., 2008; 
Pase et al., 2009; Thatcher et al., 2008b; Woltering and Durston, 2008; Yin 
et al., 2008), expressed in a wide range of tissues (Flynt et al., 2007; 
Giraldez et al., 2005; Kapsimali et al., 2007; Kloosterman et al., 2007; 
Mishima et al., 2009; Zeng et al., 2009) and are present at a variety of 
developmental time points (Begemann, 2008; Kloosterman and Plasterk, 
2006).  Indeed the role of miRNAs has been shown to be extremely 
important in zebrafish development.  Disruption of Dicer by TILLING leads to 
growth arrest at 8 dpf and lethality between 14 and 15 days.  Morpholinos 
targeting Dicer induce a more severe phenotype and growth arrest occurs at 
about 4 dpf.  The difference in severity here is down to the contribution of 
maternal mRNA in the mutant fish which is inhibited in the morpholino 
knockdown studies (Wienholds et al., 2003).  In a further study, maternal-
zygotic (MZ) Dicer mutants were generated by a germ line replacement 
technique to ensure no maternal contribution of Dicer mRNA or protein.  
These fish all underwent axis formation and differentiation of multiple cell 
types, however they all displayed abnormal morphogenesis during 
gastrulation, brain formation, somitogenesis and heart development 
(Giraldez et al., 2005).  Thus miRNAs play an essential role in the normal 
development of zebrafish.  In particular the miRNA miR-430 was shown to be 
essential in normal zebrafish development, as injection of Dicer processed 
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miR-430, a miRNA which promotes mRNA deadenylation and clearance of 
maternal mRNAs, into MZDicer mutants rescued many of the associated 
brain and gastrulation defects (Giraldez et al., 2005; Giraldez et al., 2006).  
Furthermore, endogenous miRNAs were shown to be able to silence 
exogenous GFP with specific miRNA target sites in its 3‟ UTR (Giraldez et 
al., 2005; Kloosterman et al., 2004) and in the ORF and 5‟ UTR 
(Kloosterman et al., 2004).  However, despite the importance of miRNAs 
during zebrafish development, the production of MZDicer mutant embryos 
demonstrates that miRNAs and functional RNAi machinery are not required 
for germ line formation. 
The first targeted RNAi-mediated gene knockdown in zebrafish was 
demonstrated through injection of dsRNA into embryos.  This technique was 
successfully used by Wargelius et al., (1999) to knockdown the zebrafish 
gene no tail (ntl), flathead (flh) and pax2.1/no isthmus (noi), by Li et al., 
(2000) to knockdown ntl, pax.6.1 and exogenous GFP, and by Acosta et al., 
(2005) to knockdown myostatin (mstn).  Li et al., (2000) and Acosta et al., 
(2005) both reported highly efficient levels of knockdown, with little or no off-
target effects.  In contrast, Wargelius et al., (1999) despite achieving good 
knockdown also reported a high level of off-target defects, that were present 
in all injected fish regardless of the dsRNA sequence injected.  Studies by 
Oates et al.,(2000),  Zhao et al., (2001) and Mangos et al., (2001) went 
further, suggesting that they found no evidence of specific gene silencing, 
but a more global knockdown of mRNA most likely attributable to an 
interferon response.  As a result the use of dsRNA as a technique to study 
gene knockdown in zebrafish has not been widely adopted. 
 Chemically synthesised siRNAs were first used in zebrafish by Dodd 
et al., (2004) to knockdown the zebrafish Duchenne muscular dystrophy 
(dmd) gene.  Efficient knockdown of dystrophin was detected via qPCR 
analysis and injected embryos exhibited delayed development of the 
myotubules resulting in a disruption to the somites, characteristic of muscular 
dystrophy.  In agreement with Dodd et al., (2004), Kloosterman et al., 
(2004)Liu et al., (2005c), Chang and Nie, (2008)  and Blidner et al., (2008) 
have also reported specific knockdown of target genes using siRNAs in 
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zebrafish.  However, work by Gruber et al., (2005) suggested that although 
siRNAs could induce specific gene silencing in zebrafish cell lines when 
injected into zebrafish embryos they resulted in morphological defects, 
abnormal development and early death, similar to the morphological defects 
seen with the injection of dsRNA.  This may suggest that siRNAs like 
dsRNAs are able to induce an interferon response resulting in non-
sequence-specific defects. Alternatively, it is possible that high levels of 
exogenous siRNA compete with endogenous miRNAs for components of the 
RNAi machinery, thus titering out the activity of essential endogenous 
miRNAs.  This hypothesis is supported by Zhao et al., (2008), who 
demonstrated that injection of siRNAs leads to  a reduction in levels of 
processed miRNAs.  In particular, they showed reduced levels of miR-430.  
Co-injection of pre-processed miR-430 with siRNAs was shown to 
significantly reduce the off-targets effects, suggesting that injection of siRNA 
results in non-specific defects in zebrafish embryos due to a titering out of 
the miR-430. 
As well as concerns over off-target and toxic effects of siRNAs, a 
major limitation to the use of siRNA in zebrafish embryos is the brief 
temporal manner in which they can be used.  Clearly, if RNAi is to be used 
as an effective tool to target genes in zebrafish, a more permanent means of 
targeted gene knockdown is required.  To this end I propose the use of a pol 
II vector-mediated delivery strategy of RNAi, based on the hsa-miR-30a 
system established by Zeng et al. (2005a).  It is hoped that such a delivery 
strategy which more closely mimics the natural production of miRNAs will 
effectively knockdown target genes without producing the unwanted off-
target effects.  Expression of the RNAi transgene will only occur with the 
onset of zygotic transcription and hence it is hoped that detrimental defects 
shown to result from reduced early processing of miR-430 due to competition 
with siRNAs will be eliminated.  Indeed, since embarking on this project it 
has been demonstrated that single-cell injection of constructs expressing 
shRNAs under the control of both pol III (Wang et al., 2007) and pol II (Su et 
al., 2008) promoters are capable of silencing exogenous GFP and zebrafish 
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ntl in zebrafish embryos. Importantly however, neither paper demonstrated 
heritable transmission of targeted gene knockdown. 
This research therefore aims to demonstrate heritable vector- 
mediated targeted gene knockdown in zebrafish.  Proof of principle will be 
sought by knocking down GFP in zebrafish embryos.  The kinase, P-TEN 
Induced Kinase 1 (PINK1), a gene whose loss of function is associated with 
Parkinson‟s disease, will then be targeted in the hope of generating a novel 
Parkinson‟s disease model. 
1.4 Parkinson‟s Disease 
Parkinson‟s disease (PD) is the second most prevalent neurodegenerative 
disease after Alzheimer‟s in the western world.  The pathological hallmark of 
the disease is the progressive loss of dopaminergic neurons from a region of 
the midbrain called the substantia nigra pars compacta (SNpc), commonly 
accompanied by the development of proteinacious neuronal inclusions called 
Lewy bodies.   
Normal motor function is dependent on the regulated synthesis and 
release of dopamine (DA) by the neurons projecting from the SNpc to the 
striatum (Chase et al., 1998).  Damage and loss of these neurons leads to a 
reduction in dopamine present in the striatum and ensuing motor impairment.  
Motor impairments associated with PD, including bradykinesia, tremor, 
rigidity and postural impairments, become apparent when about 70% of the 
striatal DA and 50% of the nigral dopaminergic neurons are lost (Dunnett and 
Bjorklund, 1999). In addition, patients also suffer from non-motor symptoms 
including, olfactory impairments, gastrointestinal dysfunction, depression, 
sleep disturbances, and cognitive impairment.  These non-motor symptoms 
however, are likely related to alterations in brain regions other than the SNpc 
and usually occur at later stages of disease progression.   
Currently the treatments for PD focus on relieving the motor 
symptoms, most commonly by administering Levadopa (L-dopa), a metabolic 
precursor of dopamine, to replace that lost through the death of the 
dopaminergic neurons.  The beneficial effects of this therapy are limited, as 
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side-effects such as the onset of L-dopa-induced dyskinesias become 
apparent after 3-5 years treatment (Nutt, 2001).  No treatments to date 
however, can stop or slow the disease progression by preventing the loss of 
dopaminergic neurons.  In order to identify possible therapeutic compounds 
animal models which adequately mimic the complex nature of the disease 
are of great urgency.   
1.4.1 The Aetiology of Parkinson’s Disease 
Current understanding of the mechanistic basis for the loss of dopaminergic 
neurons in Parkinson‟s disease centres around three distinct but interrelated 
mechanisms. These are oxidative stress, mitochondrial dysfunction and 
dysfunction of the ubiquitin-proteasome system (UPS).  
1.4.1.1 Oxidative Stress 
Oxidative stress is caused by the unregulated production of reactive oxygen 
species (ROS), such as hydrogen peroxide, nitric oxide and highly reactive 
hydroxyl radicals.  Excessive generation of ROS leads to deregulation of 
intracellular calcium signalling and eventually cell death.  The brain has a 
very high oxygen consumption and therefore propensity to generate these 
ROS, but a relatively low level of antioxidants and so is susceptible to 
oxidative damage.  Dopamine production and transport by the dopaminergic 
neurons of the SNpc can result in the production of vast quantities of ROS, 
making these cells even more susceptible and eventually leading to selective 
dopaminergic cell death (Barnham et al., 2004).  The SNpc of sporadic PD 
patients‟ brain post-mortems shows evidence of substantial oxidative 
damage to lipids, proteins and DNA and a depletion of endogenous anti-
oxidants (Jenner, 2003).  
1.4.1.2 Mitochondrial Dysfunction 
The mitochondria are the primary site for the generation of cellular energy.  
Mitochondrial dysfunction can therefore lead to energy failure and eventually 
cell death.  Indeed neurotoxins known to induce parkinsonism, such as 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and rotenone function by 
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inhibiting mitochondrial complex 1, resulting in energy failure and cell death 
(von Bohlen und Halbach et al., 2004).   
1.4.1.3 The Ubiquitin-Proteasome System 
The ubiquitin-proteasome system is the major way in which misfolded and 
unwanted proteins are removed.  The presence of Lewy bodies in PD 
patients‟ brains which stain heavily for α-synuclein, a protein usually 
degraded by the proteasome, suggests deregulation of the ubiquitin-
proteasome system may be involved in Parkinson‟s disease.  Indeed, 
proteasomal inhibition in PC12 cells leads to the formation of ubiquitin- α-
synuclein immunoreactive inclusions (Biasini et al., 2004) and biochemical 
studies have demonstrated reduced proteasome function in the substantia 
nigra of patients with sporadic PD (McNaught and Jenner, 2001).   
1.4.2 The Genetics of Parkinson’s disease 
In the majority of cases PD is a late-onset sporadic disease usually caused 
by the interaction between multiple genetic susceptibilities and environmental 
factors, the most important of which being age.  However, monogenic forms 
of the disease have also been identified and so far mutations in seven genes 
have been identified as causal factors in development of PD, often giving rise 
to early onset forms.  The genes involved include, three autosomal dominant 
genes, α-synuclein (SNCA) (Chartier-Harlin et al., 2004; Kruger et al., 1998) 
and leucine-rich repeat kinase 2 (LRRK2) (Paisan-Ruiz et al., 2004) and 
ubiquitin C-terminal hydrolase L1 (UCHL1) (Leroy et al., 1998) and four 
autosomal recessive genes including parkin (PRKN) (Kitada et al., 1998), 
DJ-1(Bonifati et al., 2003), PTEN-induced putative kinase 1 (PINK1) (Valente 
et al., 2004b) and  ATPase type 13A2 (ATP13A2) (Ramirez et al., 2006).  In 
line with current thinking about the mechanistic basis of sporadic PD, all of 
the genes so far identified as causative genes are in some way associated 
with UPS, responding to oxidative stress and mitochondrial function. 
In the case of the autosomal recessive genetic factors, Parkin, DJ-1, 
PINK1 and ATP13A2, PD is caused by loss of function mutations in the 
gene.  PINK1 mutations are the second most common cause of autosomal 
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recessive PD, the first being Parkin.  Furthermore, it is believed that parkin 
may act downstream of PINK1 so understanding PINK1 function in the 
disease may shed light on Parkin forms of PD.     
1.4.2.1 PINK1  
The PINK1 gene encodes a serine threonine kinase, which localises to the 
mitochondria (Valente et al., 2004a).  Most of the mutations in the PINK1 
gene are missense mutations, particularly in the kinase domain and result in 
loss of function of the gene, however whole gene deletions have also been 
described.   PINK1 has been shown to be involved in several mitochondrial 
functions including protecting cells from oxidative stress-induced apoptosis, 
facilitating normal respiration, aiding the ubiquitin-proteasome system (UPS) 
and enabling calcium signalling. It also plays a possible role in mitochondrial 
fusion and fission events and facilitates mitochondrial trafficking.  For a 
review see  Deas et al., (2009)  
The first evidence that PINK1 protected cells from stress-induced 
apoptosis came when cells deficient in PINK1 were shown to be more 
susceptible to mitochondrial toxins (Deng et al., 2005; Valente et al., 2004a; 
Wood-Kaczmar et al., 2008) and conversely over-expression of PINK1 was 
shown to protect cells (Deng et al., 2005; Valente et al., 2004a).  
Subsequently, it was shown that cells deficient in PINK1 had increased 
cytoplasmic and mitochondrial reactive oxygen species (ROS) (Gandhi et al., 
2009; Wood-Kaczmar et al., 2008). ROS are a natural by-product of oxygen 
metabolism, but their accumulation causes oxidative stress by damaging 
DNA, proteins and lipids and makes cells more vulnerable to stress-induced 
apoptosis.   PINK1 is believed to protect cells from oxidative stress by 
phosphorylating the mitochondrial chaperone tumour necrosis factor 
receptor-associated protein 1 (TRAP1).  Once phosphorylated TRAP1 
prevents the release of cytochrome c from the mitochondria and H2O2 
induced apoptosis.  Mutation of the kinase domain of PINK1 impairs the 
phosphorylation of TRAP1 and makes cells more prone to oxidative-stress 
induced cell death.  Conversely the protective effect of PINK1 over-
expression is abolished in cells lacking TRAP1 (Pridgeon et al., 2007).   
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PINK1 has also been shown to be involved in mitochondrial 
respiration as PD mutations in PINK1 result in reduced oxygen consumption 
and ATP production (Liu et al., 2009).  One explanation may be that PINK1 
has a direct effect on either the expression or activity of the electron 
transport chain.  Alternatively, an accumulation of ROS in response to loss of 
PINK1 may possibly inhibit glucose transport and so result in a lack of 
metabolic substrate delivery to the mitochondria (Deas et al., 2009).    
PINK1 has also been linked to the UPS.   In particular, PINK1 has 
been shown to be an upstream activator of the ubiquitin ligase parkin (Yang 
et al., 2006).  Ubiquitination is required for removal of proteins by the UPS 
and so reduced parkin activity may lead to an increase in unwanted proteins. 
The importance of this pathway in loss of PINK1 neurotoxicity is confirmed 
by the fact that loss of dopaminergic neurons in the PINK1 deficient 
Drosophila is alleviated by over-expression of parkin.  Protein ubiquitination 
is also an ATP dependent process, so reduced ATP production due to 
mitochondrial dysfunction may be another way in which PINK1 mutations 
affect the UPS (Deas et al., 2009).  In agreement with UPS impairment in the 
absence of PINK1, increased, compensatory autophagic vacuoles and 
lysosomes have been detected in PINK1 deficient cells (Deas et al., 2009).  
PINK1 has also been shown to interact with the protease HrtA2 (Plun-
Favreau et al., 2007).  Little is known about the function of HtrA2; however it 
has been proposed to be involved in the mitochondrial protein quality control 
system (Spiess et al., 1999; Walsh et al., 2003).  
Finally, PINK1 has been shown to regulate mitochondrial calcium flux 
through the Na+/Ca2+ exchanger, and PINK1 deficiency results in the 
accumulation of calcium in mitochondria (Marongiu et al., 2009).  This in turn 
stimulates ROS production, and leads to ensuing toxic effects and reduced 
respiration.  Interestingly, dopaminergic neurons rely on calcium channels 
instead of sodium channels to maintain their action potential, and so are 
commonly exposed to high calcium levels.  The reduced capacity to buffer 
calcium in the absence of PINK1 may therefore be one explanation why 
dopaminergic neurons in particular are affected in Parkinson‟s disease (Deas 
et al., 2009).  
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1.4.3 Animal models of Parkinson’s disease 
To date most of the in vivo data about PINK1 has been collected from loss of 
function mutations in Drosophila.  Drosophila lacking PINK1 display a wide 
range of phenotypes including, male sterility, disorganised mitochondrial, 
reduced mitochondrial mass, lowered concentrations of ATP, muscle 
degeneration, minor loss of dopamine neurons and increased sensitivity to 
oxidative stressors such as paraquat and rotenone (Clark et al., 2006; Park 
et al., 2006; Yang et al., 2006).  
 PINK1 knockout mice also show evidence of impaired mitochondrial 
respiration in the striatum and reduce striatal plasticity and hence reduced 
DA release.  However, no impairments were found in overall DA levels or the 
number of dopaminergic neurons (Kitada et al., 2007).  Thus, it has been 
suggested that mouse models recapitulate the early stages of Parkinson‟s 
disease (Gautier et al., 2008; Kitada et al., 2007).  
Although the Drosophila has proved invaluable in dissecting out 
PINK1 signalling pathways, their use as invertebrates for therapeutic 
research is limited. Meanwhile, mice as vertebrates are perhaps more similar 
to humans in terms of aetiology and how they respond to therapeutics, but 
are limited by the fact that they cannot be easily used in high-throughput 
screens.  Therefore, zebrafish may be a good intermediate.  As vertebrates 
they have a similar neuronal complexity to mice and humans, but their small 
size and high fecundity make them a viable option for use in high-throughput 
screens.  
1.4.4 Zebrafish: Suitability to Modelling PD 
The feasibility of using zebrafish to model complex neurological diseases 
relies on there being some degree of anatomical and functional similarity 
between the zebrafish and human brain, and in particular dopaminergic 
neurons equivalent to those of the SNpc must be present.  Recently, a 
catecholaminergic system similar to that present in mammals has been 
described by immunohistochemical experiments.  In light of these 
experiments, a zebrafish dopaminergic system has been identified. In 
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contrast to mammals, zebrafish dopaminergic neurons are in the 
diencephalon and telencephalon, but not in the midbrain, the location of the 
mammalian SNpc (Ma, 2003; Rink and Wullimann, 2001).  However, a group 
of dopaminergic neurons in the ventral diencephalon were shown to project 
into the striatum in the zebrafish brain, and thus this region in the forebrain is 
believed to be the anatomical equivalent of the SNpc (Rink and Wullimann, 
2001).  Figure 1.3 shows the position of zebrafish dopaminergic neurons and 
the ventral diencephalon. 
 
Figure 1.3: Dopaminergic Neurons in the Zebrafish Larvae. Whole mount in situ 
hybridisation with a riboprobe against the dopamine transporter (DAT) on 4 dpf zebrafish 
larvae. Neurons of the ventral diencephalon the anatomical equivalent of the human SNpc 
are circled in white.  Arrows point to dopaminergic neurons in the bilateral pretectal clusters 
of the telencephalon (Adapted from (McKinley et al., 2005)). 
 
Furthermore, PD models created by the application of MPTP have 
already been produced in zebrafish (Bretaud et al., 2004; McKinley et al., 
2005). McKinley et al. (2005) showed significant neurodegeneration of 
dopaminergic neurons particularly in the pretectal clusters and in the ventral 
diencephalon. They also showed that this neurodegeneration could be 
prevented by co-incubation with either the monoamine oxidase (MAO-B) 
inhibitor L-deprenyl or the dopamine transporter (DAT) inhibitor nomifensine, 
thus indicating that the mechanism of dopamine neuron toxicity in mammals 
is conserved in fish.    
Taken together the evidence provided here suggests that zebrafish would 
make an appropriate model organism in which to model Parkinson‟s disease.  
The importance of PINK1 in both sporadic and familial forms of PD makes it 
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an interesting target for knockdown to further elucidate its involvement in PD 
and potentially to generate a PD model.  Moreover, the PINK1 gene has 
recently been successfully targeted by RNAi in mice and so PINK1 has been 
shown to be an accessible target for RNAi induced knockdown (Zhou et al., 
2007). 
1.5 Aim 
The aim of this PhD is to develop a method and investigate the viability of 
stable and heritable vector-mediated RNAi in zebrafish.  This will be done 
through targeted knockdown of stably expressed GFP and endogenous 
PINK1. 
It is hoped that knockdown of PINK1 will lead to the generation of a 
Parkinson‟s disease model which could be used in high-throughput 
therapeutic screens and in further elucidation of how loss of PINK1 leads to 
the development of Parkinson‟s disease.  
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2 Materials and Methods 
2.1 Buffers and Solutions 
Solution Procedure Components 
Chorion water + 
methylene blue 
(optional) 
Embryo culture 60 mg Instant Ocean 
salts ((Tropic Marin ®), 
10-5% methylene blue, 
1L dH2O 
MS222 Anesthetising/ killing 
fish 
7.7mM MS222, 1mM 
tris, pH 8.5 in dH20 
Alkaline Lysis  
Solution I 
Plasmid miniprep 100 mM Tris pH 8.0, 50 
μg/ml RNase A 
Alkaline Lysis  
Solution II 
Plasmid miniprep 0.2 N NaOH in 1% SDS 
Alkaline Lysis  
Solution III 
Plasmid miniprep 4 M KAc,  11.5% glacial 
acetic acid 
TAE buffer DNA electrophoresis 40 mM Tris base, 1 mM 
EDTA, 0.1% glacial 
acetic acid 
DNA Lysis Buffer DNA Extraction 50 mM Tris (pH 8), 100 
mM EDTA, 0.5% SDS 
(w/v), pH 7.2 
TE Buffer Reconstituting DNA 10 mM Tris (pH 7.5), 1 
mM EDTA 
Annealing buffer annealing shRNAs 10 mM tris pH 8.0, 50 
mM NaCl, 1 mM EDTA 
IP Lysis Buffer Protein Extraction 
(cells) 
1mM HEPES pH 7.4, 1 
mM EDTA, 15 mM 
NaCl, 0.5% Triton X-
100 
½ Ginzburg  
Fish Ringers 
 
Deyolking embryos 55 mM NaCl, 1.8 mM 
KCl, 1.25 mM NaHCO3 
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Solution Procedure Components 
SDS Lysis Buffer Protein extraction 
(embryos) 
20mM HEPES pH 7.4, 
0.1 M NaCl, 1 mM DTT, 
1%  SDS (w/v) 
4% Triton-X 100 Lysis 
Buffer 
Protein extraction 
(embryos 
20 mM HEPES pH 7.4, 
0.1 M NaCl, 1 mM DTT, 
1% SDS (w/v) 
RIPA Lysis buffer Protein Extraction 
(zebrafish tissues) 
25 mM Tris (pH 7.6), 
150 mM NaCl, 1% NP-
40 (v/v), 1 % sodium 
deoxycholate (w/v), 
0.1% SDS (w/v) 
Running Buffer SDS-PAGE 25 mM tris, 192 mM 
glycine, 1% SDS (w/v) 
Transfer Buffer Western Blot Transfer 25 mM Tris, 192 mM 
glycine, 1%  SDS (w/v), 
20% methanol 
Table 2.1: Solutions used in this theis. 
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2.2 Zebrafish husbandry 
Zebrafish were housed at the BSU (Biological Services Unit), the University 
of Manchester and maintained according to standard conditions described in 
the zebrafish handbook (Westerfield, 2000).  Tap water, used for housing 
zebrafish, was first passed through activated carbon, mechanical and 
biological filters. Water temperature was maintained at 28-26ºC, while 
light/dark cycles of 14hrs light and 10hrs dark were used.  Embryos up to 5 
dpf were cultured at 28.5°C in chorion water (Table 2.1).  Larvae were 
transferred to the BSU at 5 dpf from which point they were fed daily on 
commercial powdered fish flakes. At one month old adult fish were fed daily 
on both dried fish food and live Artemia nauplia.  Animals were sacrificed 
using schedule I methods.  This entailed overdosing the fish with 4% MS222 
(Table 2.1) for 30 minutes and the pithing the brain with a needle.  
2.2.1 Breeding and Embryo Collection 
Zebrafish were placed in thoron boxes (Aquatics, Inc.) with males and 
females separated with a plastic divide the night before breeding.  After the 
switching on of lights in the morning, divides were removed, initiating 
spawning.  Embryos fell through the mesh of the inside tank of the thoron 
boxes into the outer tank and could be easily collected.    
2.3 Microinjecting Embryos 
DNA and RNA were injected into the cytoplasm of single-cell embryos. 
Morpholinos were injected into embryos up until the 4 cell stage. An injection 
volume of 1 nl (around 1/100th of the egg volume) was injected using a PLI-
90 Pico-Injector microinjection station.  Injected embryos were incubated at 
28.5°C.  Embryos were either transferred to the BSU at 5 dpf or destroyed. 
2.3.1 Injection Solutions 
2.3.1.1 I-SceI-mediated Transgenesis 
Injection mixes comprised of 300 ng of plasmid DNA, 1 x I-SceI buffer, 5 u of 
meganuclease enzyme (NEB), 0.05% (w/v) phenol red in a final volume of 15 
μl ddH2O.  
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2.3.1.2 Tol2-mediated Transgenesis 
Injection mixes comprised of 125 ng of plasmid DNA, 125 ng Tol2 
transposase RNA and 0.05% phenol red in a final volume of 10 μl ddH2O. 
2.3.2 Screening and Imaging Transgenic Zebrafish 
Embryos were monitored on a daily basis up to 4 dpf for fluorescent protein 
expression and phenotype development using Leica MZFLIII microscope.  
Multidimension acquisition images were taken using a Stereo Lumar.V12 
microscope (Zeiss) attached to a monochrome Axiocam and using 
AxioVision 4 software.  Z-stack images were taken using an Axioplan 2 
microscope (Zeiss) equipped with an apoptome and compiled to generate 
extended focus images.  In order to take images embryos were first 
anaesthetized with a 1 in 20 dilution of MS222 (Table 2.1).   
2.4 General Cloning Methods 
2.4.1 PCR 
The following basic protocol was used for all DNA amplification.  1 μl of 
template genomic DNA (approximately 5ng), 100 ng plasmid DNA or 1 μg 
cDNA was added to a PCR mastermix containing 1 x GoTaq PCR buffer 
(Promega), 0.5 mM MgCl2 (Promega), 0.1 µM dNTPs (Bioline), 0.15 µM of 
both forward and reverse primers, 1 u GoTaq DNA polymerase (Promega) 
made up to 20 µl using DEPC H20.  Cycling conditions consisted of: 95°C for 
5 mins and then 28 cylces of 95°C for 30 secs, specific annealing 
temperature (usually 55°C) for 40 secs, and 72°C for 1 min.  This was 
followed by a 10 mins extension at 72°C.  Specific changes to cycle number, 
annealing temperature and elongation time can be viewed in the methods 
section of each results chapter. 
2.4.2 p-GEM T Cloning 
PCR products were cloned into the p-GEM T vector (Promega) following 
manufacturer‟s guidelines. 
2.4.3 DNA Digestion 
DNA digestion was carried out  using approximately 10 g of plasmid DNA, 1 
x appropriate restriction enzyme buffer (Roche or NEB) and 5 u of the 
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appropriate restriction enzyme (Roche or NEB).  The digestion mixtures were 
made up to 20 l with DEPC H2O, and 100 μg/ml BSA (Bovine Serum 
Albumin) added where necessary.  The mixtures were then incubated for 
between 2 and 16 hrs depending on the restriction enzyme used at 37C.  
Digest mixtures were run on an appropriate percentage agarose gel and the 
desired fragment purified using a GFX purification kit (Amersham 
Biosciences) and following manufacturer‟s guidelines. 
2.4.4 DNA Blunting Reaction 
To blunt unwanted overhangs created by restriction enzyme digestion, 
reactions were set up as follows: 40 μl purified DNA, 2 mM DNTPs, 100 
μg/ml BSA, 1 x T4 DNA polymerase buffer (Roche), 5 u T4 DNA polymerase 
(Roche) made up to a final volume of 60 μl with DEPC water. The reaction 
was then incubated at 12°C for 15 mins.  DNA was then purified using a GFX 
purification kit (Amersham Biosciences) and following manufacturer‟s 
guidelines. 
2.4.5 Ligation Reactions 
Ligations used 1 u T4 DNA ligase enzyme (Invitrogen) and 1 x ligase buffer 
(Invitrogen). Reactions were set up with a 3:1 molar ratio of insert to vector 
(approximately 200ng of vector was used in each reaction), made up to 20 μl 
with DEPC H20 and incubated at 16°C overnight or room temperature (RT) 
for 2 hrs. 
2.4.6 Transformations 
Ligation mixtures were added to pre-thawed One Shot® competent E. coli 
cells (Invitrogen) and incubated on ice for 20 mins.  Cells were then heat-
shocked at 42°C for 45 secs, placed immediately back on ice for 5 mins and 
then incubated at RT for 5 mins.  After incubation the cells were plated onto 
pre-warmed LB agar plates containing 50 μg/ml of the appropriate antibiotic 
(ampicillin or kanamycin).  The plate was incubated at 37°C overnight. 
2.4.7 Isolation of Plasmid DNA (mini prep) 
Bacterial colonies were inoculated into 2 ml LB broth containing 50 μg/ml of 
the appropriate antibiotic (ampicillin or kanamycin).  Following overnight 
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incubation in a shaking incubator (250 rpm, 37°C), plasmid isolation was 
performed via alkaline lysis.  1 ml of culture was decanted into a 1.5 ml 
microcentrifuge tube and centrifuged for 60 seconds at 13 000 rpm.  After 
discarding the supernatant the bacterial pellet was resuspended in 100 μl of 
ice cold Alkaline Lysis Solution I (Table 2.1).  200 μl of Solution II (Table 2.1) 
was added and the contents mixed by inverting the tube 5-6 times. 160 μl of 
Solution III (Table 2.1) was then added and the mixture mixed again by 
inverting 5-6 times.  After addition of 200 μl of chlorophorm the contents of 
the tube was mixed vigorously and was then centrifuged for 15 minutes at 13 
000 rpm, producing three layers.  400 μl from the upper aqueous layer was 
then transferred to a fresh tube and an equal volume of propan-2-ol added.  
This mixture was centrifuged for a further 10 minutes at 13 000 rpm, and the 
supernatant removed and discarded, leaving a DNA pellet.  The DNA pellet 
was washed with 1 ml 70% ethanol and centrifuged at 13 000 rpm for 10 
mins.  The supernatant was discarded and the pellet allowed to air dry.  
Once dry, the DNA was re-suspended in 50 μl ddH20. 
2.4.8 PCR Colony Screening 
Single colonies from transformation plates were screened for the presence of 
the correct construct by inoculating a PCR reaction of 1 x GoTaq PCR buffer 
(Promega), 0.5 mM MgCl2, 0.1 µM dNTPs, 0.15 µM fwd primer, 0.15 µM rev 
primer, 1 u GoTaq DNA polymerase (Promega) made up to 20 µl using 
DEPC.  Cycling conditions consisted of: 95˚C for 5 mins and then 28 cylces 
95˚C for 30 secs, 55˚C for 40 secs, and 72˚C for 1 min.  This was followed by 
a 10 minute extension at 72˚C. The PCR products were then run on an 
appropriate agarose gel. 
2.4.9 DNA Sequencing 
Sequencing reactions contained 400 ng plasmid DNA or 100 ng PCR 
product, 3.3 pmol primer, 2 μl Terminator Ready reaction mix (Big dye 
version 1.1, ABI) and 3 μl sequencing buffer made up to a final volume of 20 
μl.  The cycling conditions consisted of a denaturation step at 94°C for 5 
mins, 35 cycles of 96°C for 30 secs, 50°C for 10 secs, 60°C for 5 mins, and 
an extension at 72°C for 10 mins.  Amplified DNA was transferred to a 1.5 ml 
microcentrifuge tube and precipitated by adding 2 μl NaAc (pH5.2) and 50 μl 
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96% ethanol, and incubating at rt for 20 mins.  Precipitated DNA was 
pelleted by centrifugation at 13 000 rpm for 30 mins and washed in 250 μl 
70% ethanol, before air drying at room temperature.  Samples were sent to 
the University of Manchester Sequencing Facility, where the reaction 
products were separated by polyacrylamide gel electrophoresis.  Analysis of 
sequence data was performed using BioEdit software.  
2.4.10 Maxi Prep 
Large scale plasmid isolation of cloned constructs was carried out using 
QIAfilterTM Plasmid Maxi kit (Qiagen) according to the manufacturer‟s 
instructions. 
2.4.11 Site Directed Mutagenesis (SDM) 
Site-directed Mutagenesis was performed using a Quikchange® site directed 
mutagenesis kit (Stratagene) and following manufacturer‟s instructions.  
Primer sequences are given in the relevant chapters. 
2.4.12 In vitro Transcription 
mRNAs were transcribed using a T7 message machine (Ambion) and 
following manufacturer‟s instructions.  Once synthesised mRNA was purified 
using an RNeasy Mini kit (Qiagen) and a test sample was run on a 2100 Bio-
analyser (Agilent Technologies). 
2.5 Generating miRNA Vectors  
2.5.1 Cloning miRNAs into pGEM-T 
Appropriate miRNA target sequences were identified for each gene to be 
knocked down using BLOCK-IT™ RNAi Designer (Invitrogen) and blasting 
sequences against the zebrafish genome to check they do not share high 
sequence homology with other genes, with particular attention paid to the 
seed region of the miRNA.  Forward and reverse primers which incorporate 
the hsa-miR-30a backbone, the sense and antisense target sequence, and 
KpnI and EcoRI restriction sites were designed (primer sequences for 
miRNAs are given in the appropriate results chapter).  miRNA primers were 
annealed and extended in PCR reaction conditions consisting of 1 μg 
forward and reverse primers, 1 x GoTaq Buffer (Promega), 2.5 mM MgCl2, 
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100 μM dNTPs and 1 u GoTaq polymerase (Promega), made up to 20 μl 
with deionised water.  Cycling conditions consisted of 95°C for 5 mins, 
followed by 10 cycles of 95°C for 20 secs, 37°C for 20 secs, 68°C for 10 
secs, and a final extension of 68°C for 5 mins. Annealed PCR products were 
separated from un-annealed single stranded DNA by electrophoresis on a 
2.5% agarose gel made up with 1 x TAE buffer containing 0.5 μg/ml ethidium 
bromide.  The annealed PCR product was excised from the gel and the DNA 
extracted using a GFX purification kit (GE Healthcare) following the 
manufacturer‟s instructions. All miRNAs were first cloned into the pGEM-T 
vector (Promega) following manufacturer‟s guidelines.  Positive clones were 
identified by KpnI/EcoRI restriction digest of mini preps. 
2.5.2 Cloning miRNAs into Silencing Vectors 
miRNAs were liberated from pGEM-T vector (Promega) with EcoRI/KpnI 
restriction digest (see 2.4.3) and ligated (see 2.4.5) into the appropriate 
silencing vector which had also been linearised with EcoRI/KpnI restriction 
digest.  Ligations were then transformed (see 2.4.6) and positive colonies 
were identified by PCR colony screening (see 2.4.8) using miRNA forward (5‟ 
- TGCTGTTGACAGTGAGCGA - 3‟) and mcherry 5‟ reverse (5‟ – 
TGGCCATGTTATCCTCCTCG - 3‟) primers. 
2.6 Genotyping Zebrafish 
2.6.1 Genomic DNA Extraction from Fish Larvae/Tissues for 
Genotyping 
To check the identity of miRNAs present in transgenic zebrafish, transgenic 
offspring or tail clippings from transgenic fish were lysed in 380 μl of DNA 
Lysis buffer (Table 2.1) supplemented with 0.5 mg/ml Proteinase K (Sigma-
Aldrich).  Samples were incubated at 55˚C overnight with gentle agitation, 
after which 400 μl isopropanol was added and samples were mixed by 
shaking.  Samples were then centrifuged at 13 000 rpm for 15 mins to pellet 
the DNA.  The supernatant was then discarded and the pellet was washed in 
70% ethanol and centrifuged for a further 10 mins at 13000 rpm.  The 
supernatant was discarded and samples left to air dry for 10 mins.  DNA was 
then resuspended in 50 μl TE buffer (Table 2.1).   
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2.6.1.1 Nested PCR and Sequencing 
2.6.1.1.1 1st PCR 
I μl genomic DNA was used in a general PCR mix (see 2.4.1) along with the 
first set of genotyping primers listed in Table 2.2. Cycling conditions 
consisted of: 95˚C for 5 mins and then 24 cycles of 95˚C for 30 secs, 55˚C 
for 40 secs and 72˚C for 1 min, followed by a final extension of 72˚C for 10 
mins.   
2.6.1.1.2 2nd/Nested PCR 
PCR products from the first round PCR were diluted 2.5-fold and 1 µl 
transferred to a second PCR reaction (see 2.4.1) along with the second set 
of genotyping primers (Table 2.2) which contain binding sites for M13 fwd 
and rev primers. Cycling conditions were as above (see 2.6.1.1.1).  The 
resulting PCR product was again diluted 2.5-fold and 1 µl was used in 
sequencing reactions (see 2.4.9) using M13 fwd and rev primers (Invitrogen).  
Sequences were analysed using BioEdit to check for the presence of the 
correct miRNA. 
Primer Name Sequence 
Genotyping Fwd 1 CAGCAGCTGAGGAGTGATC 
Genotyping Rev 1 TTACTTGTACAGCTCGTCCATG 
Genotyping Fwd 2 
(M13 fwd) 
TGTAAAACGACGGCCAGTCTTGGTGAGTACTATAGGCT 
Genotyping Rev 2 
(M13 rev) 
CAGGAAACAGCTATGACCTCCTTGATGATGGCCATG 
Table 2.2: Primers Used to Genotype Transgenic Zebrafish.  Sequences are given in a 
5‟ to 3‟ format.  M13 fwd and rev binding sites are underlined. 
2.7 Tissue Culture 
2.7.1 Cell Maintenance and Passage 
2.7.1.1 HEK 293 Cells 
HEK 293 (Human Embryonic Kidney) cells were cultured in DMEM 
(Dulbecco‟s Modified Eagle Medium): F12 (1:1) + GlutaMAXTM (Invitrogen) 
supplemented with 10% FCS (Fetal Calf Serum) and 1% 
penicillin/streptomycin and grown at 37°C in 5% CO2.  
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2.7.1.2  AB.9 Cells 
Zebrafish AB.9 cells originating from the adult caudal fin (ATCC® Number: 
CRL-2298TM) were cultured in DMEM (Dulbecco‟s Modified Eagle Medium): 
F12 (1:1) + GlutaMAXTM (Invitrogen) supplemented with 10% FCS and 1% 
penicillin/streptomycin and grown at 28°C in 5% CO2.  
2.7.1.3 PAC.2 Cells 
PAC2 cells, a fibroblast cell line derived from 24 hpf embryos (Lin et al., 
1994) were cultured in Leibovitz‟s L-15  medium (Invitrogen) supplemented 
with 15% FCS and 1% penicillin/streptomycin and grown at 28°C without 
CO2. 
2.7.1.4 ZFL Cells 
ZFL cells, an adult zebrafish liver epithelial cell line (ATCC® Number: CRL-
2643TM) were cultured in DMEM (Dulbecco‟s Modified Eagle Medium): F12 
(1:1) + GlutaMAXTM (Invitrogen) supplemented with 10% FCS, 1% 
pen/strep, 0.1 ug/ml epithelial growth factor (EGF, Sigma-Aldrich) , 0.01 
mg/ml insulin (diluted in HCL, Sigma-Aldrich), 0.1% Lipid mixture (v/v, 
Sigma-Aldrich) and grown at 28°C in 5% CO2.  
 
All cells were passaged upon confluency by washing twice in Dulbecco‟s 
Phosphate Buffered Saline (DPBS) without calcium and magnesium chloride 
(Sigma) and detaching in TrypLE (Invitrogen).  HEK 293 cells were seeded 
into new flasks/wells at a 1:10 ratio.  Zebrafish cells were seeded at a ratio of 
1:3. 
2.7.2 Transfections 
24 hours prior to transfection cells were detached using TrypLE (Invitrogen) 
and then passaged into 6 well culture plates (Costar).  30 mins prior to 
transfection cells were washed in PBS and the appropriate fresh medium 
was added.  For zebrafish cell transfection fresh medium lacked antibiotics.  
Per well to be transfected 87 μl of antibiotic free media and 3 μl FuGENE HD 
(Roche) were mixed together and incubated at room temperature for 5 mins.  
1 μg (10 μl) plasmid DNA was added to the DMEM/FuGENE HD mix and 
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incubated at room temperature for a further 45 mins.  100 μl transfection mix 
was then added to each well of cells.  Transfections were carried out in 
triplicate.   24 hrs post transfection zebrafish cells had the medium containing 
FuGENE HD removed and fresh medium containing antibiotics replenished. 
2.8 Fluorescent Flow Cytometric Analysis 
2.8.1 Transfected Cells 
Transfected cells were harvested 3 days post transfection by first washing in 
DPBS and then detaching form the culture plate by incubating for 5 mins in 
TrypLE.  Once detached cells were transferred to a 1.5 ml centrifuge tube 
and spun for a few secs at <5500 rpm.  The supernatant was then removed 
and cells were resuspended in DPBS, before analysing on a FACS Aria (BD 
Biosciences) equipped with a 488 nm and 594 nm laser for analysis of GFP 
and mcherry fluorescent levels respectively.  Forward and side scatter 
measurements enabled the removal of aggregated and dead cells/debris 
from the analysis.  In HEK 293 and AB.9 cells where GFP and the RNAi 
vector (mcherry) were co-transfected the ratio of GFP:mcherry in mcherry 
positive cells was calculated.  In PAC.2 YFP and ZFL GFP cells the 
YFP/GFP content of mcherry positive cells was calculated. 
2.8.2 Zebrafish 
Between 10-15 transgenic zebrafish were transferred to a 1.5 ml 
microcentrifuge tube and incubated in 1x trypsin (Sigma-Aldrich) with 
agitation for approx. 15 mins.  Once trypsinised, samples were spun down at 
< 5500 pm for a few secs.  Supernatant was then removed and cells were 
resuspended in PBS before passing through a 50 micron filter, to remove 
debris.  Trypsinised zebrafish cells were then analysed on FACS Aria (BD 
Biosciences) equipped with a 488 nm and 594 nm laser for analysis of GFP 
and mcherry fluorescent levels respectively.  Forward and side scatter 
measurements enabled the removal of aggregated and dead cells/debris 
from the analysis.  The GFP content of mcherry positive cells was compared 
to GFP levels in non-transgenic sibs (NTS) with regard to RNAi vector.  
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2.9 Quantitative PCR (qPCR) 
2.9.1 RNA Extraction  
Total RNA was extracted from cells grown in a well of a six well plate, 
zebrafish embryos/larvae and adult zebrafish organs using the RNeasy® 
Lipid Tissue Mini Kit (Qiagen) and following manufacturer‟s instructions.  An 
RNase-Free DNase Set (Qiagen) was also used following manufacturer‟s 
instructions to perform on the column DNase digestion. Extracted RNA was 
quantified using a Nanodrop spectrophotometer (Thermo Scientific) aliquoted 
into 1 μl aliquots and stored at -80˚C.   
2.9.1.1 Time Course and Tissue Bank mRNA Extraction 
To make each time course cDNA, RNA was exacted using the above method 
from 30 embryos and larvae at the 1 cell stage, 4 hpf, 12 hpf, 1 dpf, 2dpf, 3 
dpf, 4 dpf, 5 dpf, 6 dpf, 7 dpf and 3 weeks post fertilisation.   For each tissue 
bank, organs were extracted from 6, 6 month old adult zebrafish (3 male and 
3 female).  
2.9.2 Reverse Transcription 
First strand cDNA was reversed transcribed from RNA using Omniscript® RT 
Kit (Qiagen).  Reaction mixtures consisted of 1 μg RNA, 1 x reverse 
transcription buffer, 0.5 mM of each dNTP, 1 μl oligo (dT) 15 (Promega), 10 u 
RNase inhibitor (Roche), 4 u Omniscript reverse transcriptase and made up 
to 20 μl with DEPC H20. After assembly reaction mixtures were incubated at 
37°C for 1 hr.  Synthesised cDNA was quantified on a Nanodrop 
spectrophotometer (Thermo scientific) and diluted to 100 ng/μl 
2.9.3 Real Time- qPCR (sybr-green) 
Sybr-green-based qPCR reactions consisted of 1 x SYBR Green Jumpstart 
TM Taq Ready MixTM  (Sigma-Aldrich),  0.2 μM forward and reverse primers, 
200 ng cDNA made up to 20 μl with DEPC H2O.  Samples were analysed on 
a Peltier Thermal Cycler (PTC-200) connected to a Chromo4 Continuous 
Fluorescence Detector (MJ Research).  Cycling conditions were as follows: 
94oC for 2 mins followed by 40 cycles of 94oC for 15 secs and 60oC for 1 
min.  Melting curve analysis was performed from 45oC to 95oC.  
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2.9.4 Validation of qPCR Primers 
Primers were validated by determining the CT values from a serial dilution of 
cDNA and plotting those values against the log quantity of cDNA used in 
each reaction to produce a straight line.  A slope with a gradient of -3.32 
indicates that the primers are 100% efficient.   -3.1 is equivalent to 90% 
efficiency and -3.58 is equivalent to 110% efficiency.  Only primers which fell 
between these ranges and gave rise to a correlation coefficient (R2) of at 
least 0.97 were accepted for use in cDNA quantification.  Validated primer 
pairs are listed in the appropriate results chapters. 
2.9.5 Analysis of qPCR Data: Comparative CT (ΔΔCT) Method 
The cycle threshold (CT) level was set manually at the linear part of the 
curve at a point in which doubling the cDNA concentration leads to a 
doubling in signal intensity.   The ΔΔCT is then calculated using the following 
formula: 
ΔΔCT = ΔCT Test Sample – ΔCT Calibrator Sample 
where, 
ΔCT = CT Target – CT Housekeepers 
To convert the ΔΔCT into a fold change on calibrator levels the ΔΔCT is 
reversed using the formula: 
2^(-ΔΔCT). 
2.10 Immunoblotting 
2.10.1 Protein Extraction from Cultured Cells 
To extract protein from confluent cells, media was removed via aspiration 
and cells were washed twice in DPBS.  100 µl of chilled IP buffer (Table 2.1), 
supplemented with 1% protease inhibitor cocktail (Amersham Biosciences) 
and 1 % phosphatase inhibitor cocktail (Set II; Calbiochem)   inhibitors, was 
added to each well of a 6-well cell culture plate and cells were detached 
using a cell scraper. The lysate was transferred into a microcentrifuge tube 
and was incubated on ice for 5 mins. Samples were then centrifuged at 12 
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000 x g at 4C for 15 mins, and the supernatant containing protein extract 
was transferred to a fresh tube.  Protein was quantified in mg/ml using 
Advanced Protein Assay reagent (Cytoskeleton Inc.) and following 
manufacturer‟s instructions. Absorption was measured at 595 nm on a 
Jenway 6305 spectrophotometer (Jencons-PLS) and proteins were aliquoted 
before being snap frozen in liquid nitrogen and then transferred to a -80°C 
freezer.  
2.10.2 Protein Extraction from Embryos and Larvae 
Embryos were dechorionated either manually or by soaking for 10 mins in  a 
2 mM Pronase solution (Sigma-Aldrich) and deyoked by transferring 
embryos (up to 20) into a tube containing 1 ml ½ Ginzburg buffer (Table 2.1) 
supplemented with 1% protease inhibitor cocktail, 0.75 mM EDTA 
(ethylenediaminetetraacetic acid), 0.3 mM PMSF 
(phenylmethanesulfonylfluoride) dissolved in isopropanol (stock 
concentration 100 mM).  Embryos/larvae were dissociated from the yolk sac 
by pipeting up and down and then shaking at 11 000 rpm at 4oC for 5 mins.  
Embryos were then spun down at 2 000 rpm for 1 min and the supernatant 
removed and discarded.  150 μl chilled SDS Lysis Buffer (Table 2.1) 
supplemented with 1% protease inhibitor cocktail, 1% phosphatase inhibitor 
cocktail, 0.75 mM EDTA and 0.3 mM PMSF was added to the embryos, and 
embryos were disaggregated using a pestle for 1 min on ice.  Samples were 
then heated to 95oC for 3 mins and  a further 150 μl chilled Triton X-100 
Lysis Buffer (Table 2.1) supplemented with 1% protease inhibitor cocktail 
and 1% phosphatase inhibitor cocktail  was added to each tube. Samples 
were incubated for a further 2 mins on ice and then spun at 13 000 rpm for 1 
min.  Supernatants were transferred to a new tube and protein quantified 
using the Bicinchoninic Acid (BCA) kit for protein determination (Sigma-
Aldrich) and following manufacturer‟s instructions.  The remaining sample 
was aliquoted and snap frozen in liquid nitrogen before transferring to a -
80°C freezer. 
2.10.3 Protein Extraction from Adult Brain Samples 
Dissected brains were homogenised on ice using a pestle in RIPA Buffer 
(Table 2.1) supplemented with 1 % protease inhibitor cocktail and 1% 
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phosphatise inhibitor cocktail.  Samples were incubated for 5 mins on ice 
before centrifuging at 13 000 rpm for 15 mins at 4oC.  Supernatant was the 
transferred to a fresh tube and protein quantification was performed using 
Advanced Protein Assay reagent (Cytoskeleton Inc.) and following 
manufacturer‟s instructions, before aliquoting protein, snap freezing in liquid 
nitrogen and storing at -80oC. 
2.10.4 Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
(SDS-PAGE)  
Protein lysates were thawed on ice and equal amounts of protein (~30 μg) 
were mixed with 2 x NUPAGE® LDS sample buffer (Invitrogen). After 
thorough mixing, samples were boiled at 95C for 10 mins. A 4-15% gradient 
SDS-polyacrylamide ready gel (Bio-Rad) was immersed in Running Buffer 
(Table 2.1) and protein samples and Precision Plus ProteinTM Dual Colour 
Standards (Bio-Rad) were loaded.  The gel was run at 100-130 V until the 
proteins were well separated. 
2.10.5 Electrophoretic Transfer  
Proteins were transferred from SDS-PAGE gel to an Immobilon-P transfer 
membrane (Millipore). First the membrane was activated by soaking in 
methanol for 15 secs, followed by a wash in ddH2O for 2 mins. The gel and 
membrane were assembled into a transfer cassette and immersed in chilled 
Transfer Buffer (Table 2.1).  Protein transfer was performed at 100 V for 45 
mins.  
2.10.6 Blocking, Primary Antibody and Secondary Antibody 
Following transfer, membranes were washed briefly in Tris-buffered saline 
(TBS) (Table 2.1), and were then blocked in 5% milk (marvel) made up with 
TBS/Tween (TBS, 0.05% (v/v) Tween (Sigma-Aldrich)) for 1 hr at rt with 
gentle agitation. After washing in TBS/T, membranes were incubated with 
the appropriate primary antibody, diluted as required in 1% milk TBS/T at 
4ºC overnight with gentle agitation. The following day, membranes were 
washed three times for 5 mins in TBS/T and then incubated with a 1:10 000 
dilution of the appropriate horseradish peroxidase (HRP)-conjugated 
secondary antibody (GE Healthcare) in 5% milk/TBS/T for 1 hr at rt.  
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2.10.7 Detection: Enhanced Chemiluminescence (ECL) 
After incubation with the secondary antibody, membranes were washed 3 
times for 5 mins in TBS/T and proteins were incubated for 1 min in ECL plus 
detection reagent (Amersham Biosciences) at rt and then exposed on Kodak 
Biomax MR film and developed using an Optimax film processor. To quantify 
western blots, blots were scanned and analysed by densitometry using 
ImageJ. 
2.11 Statistics 
All quantitative data was analysed with the appropriate statistical test 
indicated in each figure and using the 5% significance threshold.  Where a 
significant difference was found, this is indicated using the * system (* = p < 
0.05, ** = p < 0.01, *** = p < 0.001).  All graphical data is depicted with bars 
indicating standard error of the mean. 
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3 Development and Validation of Vector-Mediated RNAi in 
Zebrafish Embryos 
3.1 Introduction 
The use of zebrafish to model disease and in reverse genetics has been 
limited by an inability to effectively and reliably knockdown genes.  The 
discovery of RNAi as an evolutionary conserved mechanism of gene 
regulation offers a new avenue to explore in knocking down genes in 
zebrafish.   Indeed siRNAs have already been used by various groups to 
knockdown zebrafish genes with varying degrees of success (Blidner et al., 
2008; Chang and Nie, 2008; Dodd et al., 2004; Gruber et al., 2005; 
Kloosterman et al., 2004; Liu et al., 2005c).  However, a major limitation in 
the use of siRNAs was a high level of general toxicity (Gruber et al., 2005; 
Zhao et al., 2008) due to the delivery of large quantities of siRNA into early 
stage embryos, which seems to saturate the RNAi machinery to the point at 
which essential endogenous miRNAs, such as miR-430, are not successfully 
processed (Zhao et al., 2008).  Development of a vector-mediated system of 
RNAi in which primary miRNAs transcripts encoding customised miRNAs are 
only produced after the initiation of transcription and at more physiological 
levels may therefore avoid these problems as well as providing a more stable 
and heritable form of knockdown.     
A vector suitable for RNA polymerase II (pol II)-driven expression of 
customised miRNAs has been developed by Dr. Paul Walker, the Hurlstone 
Laboratory, and is depicted in Figure 3.1.  In this system a promoter of 
choice is cloned upstream of a non-coding first exon and first intron of 
Elongation Factor 1 alpha (ef1α), downstream of which is the reporter gene, 
mcherry.  Within the intron is a stuffer fragment surrounded by KpnI and 
EcoRI restriction sites which enables miRNAs to be easily cloned in.  
Activation of the promoter results in expression of both miRNA and the 
reporter gene.  Pol II promoters can be easily cloned in and out using ApaI 
and XhoI restriction sites.  In order to generate stable zebrafish transgenic 
lines expressing the miRNA the construct is flanked by I-SceI restriction 
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sites.  Upon co-injection with the I-SceI meganuclease, these restriction sites 
aid integration of the construct into the zebrafish genome (Thermes et al., 
2002). For a full vector map see appendices section 8.1.1.  
 
Figure 3.1: Schematic Representation of the RNAi Vector.  A promoter of choice drives 
expression of both the miRNA and reporter gene.  Different promoters can be cloned into the 
promoter position using ApaI and XhoI restriction sites. miRNAs can be cloned in using KpnI 
and EcoRI restriction sites.  The silencing cassette is surrounded by I-SceI restriction sites 
which aids transgenesis when co-injected with I-SceI meganuclease into embryos.   
3.1.1 Aim 
The aim of this chapter is to develop and validate a method of vector-
mediated delivery of RNAi for use in zebrafish.  
3.1.2 Objectives 
 to clone and test control and GFP miRNAs in HEK 293 cells. 
 to develop a vector suitable for delivery of these miRNAs in vivo. 
 to demonstrate whether vector mediated delivery of miRNAs is 
sufficient to knockdown GFP in vivo in both a transient and stable 
transgenic manner. 
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3.2 Materials and Methods 
For general material and methods see chapter 2. 
3.2.1 Cloning miRNAs 
General cloning methods as described in section 2.4 were used to clone 
RNAi vectors with appropriate promoter and miRNA combinations.  ef1α, 
H2A.Zf and krt18 promoters were inserted using ApaI and XhoI restriction 
sites.  Control miRNA and miRNAs against the open-reading frame (ORF) of 
GFP were generated using the primers listed in Table 3.1, and cloned into 
the RNAi vectors using the incorporated KpnI and EcoRI restriction sites. 
miRNA  Primer sequence 5‟-3‟ 
 
GFP #1 
Fwd GCGGGGTACCTGCTGTTGACAGTGAGCGAGCACAAGCTGGAGTACAACTATAGTGAAGCCACAG
ATG 
Rev CCGCGAATTCCCTTGAAGTCCGAGGCAGTAGGCAGGCACAAGCTGGAGTACAACTATACATCTG
TGGCTTCAC 
 
GFP #2 
Fwd GCGGGGTACCTGCTGTTGACAGTGAGCGACGGCCACAAGTTCTCAGCGGGTCCTAGTGAAGCCA
CAGATG 
Rev CCGCGAATTCCCTTGAAGTCCGAGGCAGTAGGCAGCGGCCACAAGTTCAGCGTGTCCTACATCT
GTGGCTTCAC  
 
Control 
Fwd GCGGGGTACCTGCTGTTGACAGTGAGCGAAGTCTGTGCGCAGAAATATATTAGTGAAGCCACAG
ATG 
Rev CCGCGAATTCCCTTGAAGTCCGAGGCAGTAGGCAGAGTCTGTGCGCAGAAATATATTACATCTG
TGGCTTCAC 
 
Table 3.1: Primers used in the production of miRNAs.  The sense sequence of the target is 
shown in grey on the forward primer and red on the reverse primer.  KpnI and EcoRI sites 
are indicated in turquoise and yellow respectively.  The rest of the sequence is based on the 
hsa-miR-30a backbone identified by Zeng et al. (2002). 
 
3.2.2 Cloning a Gal4-VP16/UAS-responsive RNAi Vector 
To generate a Gal4-VP16/UAS-responsive RNAi vector KpnI and EcoRI 
restriction sites were removed from pBluescript I-SceI (Thermes et al., 2002) 
(for vector map see appendices section 8.1.2) by cutting the plasmid, 
blunting overhanging DNA bases and re-ligating the vector.  A Gal4-VP16 
SV40pA UAS E1b minimal promoter fragment was cut out of the SAGVG 
vector (Davison et al., 2007) (for vector map see appendices section 8.1.3) 
with MscI and ClaI restriction digest, overhangs were blunted and the insert 
was ligated into the modified pBluescript I-SceI vector digested with SmaI 
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and BamHI and also blunted.  The EcoRI restriction site in the Gal4-VP16 
sequence was then removed via site directed mutagenesis (see section 
2.4.11) using the forward primer, 5‟-
GGTCGACCCCGGGTATACAAATCTCTCGAG-3‟ and reverse primer, 5‟-
CTCGAGAGATTTGTATACCCGGGGTCGACC-3‟.  The non-coding first 
exon, miRNA-containing intron and mcherry fragment from the original RNAi 
vector was then removed by digestion with XhoI, then blunted and digested 
with SacII and cloned downstream of the pBluescript Gal4-VP16/ UAS I-SceI 
which had been cut with, BamHI, then bunted, followed by SacII.  Promoters 
where adapted by PCR amplification followed by pGEM-T cloning to contain 
an EcoRV restriction site at the 3‟ end.  The promoter of choice was then 
cloned into the Gal4-VP16-responsive RNAi vector using ApaI and EcoRV 
restriction sites.  For a full vector map of the Gal4-VP16-responsive I-SceI 
vector see appendices section 8.1.4  
3.2.2.1 Cloning a Gal4-VP16-responsive Tol2 Vector 
Tol2 vectors are based on the pT2KXIGdeltaIN plasmid which incorporates 
transposable sequences derived from the medaka Tol2 transposable 
element (Urasaki et al., 2006).  The pT2KXIGdeltaIN vector was modified by 
Dr. Stephen Renshaw, University of Sheffield, UK, to contain a multi-cloning 
site between the transposable arms and to remove a KpnI restriction site 
from the backbone.  The Gal4-VP16-responsive RNAi cassette was then 
cloned in to this Tol2 vector as an ApaI, SacII fragment (for full vector map 
see appendices section 8.1.5). 
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3.3 Results 
3.3.1 Production and Cloning of miRNAs 
To generate RNAi vectors containing customised miRNAs, primer pairs listed 
in Table 3.1 were annealed and extended in a PCR reaction described in 
section 2.5.1; a schematic of this can be seen in Figure 3.2 A.  The resulting 
PCR products were run on a 2.5% agarose gel (Figure 3.2 B).  Such a high 
percentage gel was required to allow good separation of the double stranded 
DNA (120bp) from single stranded (non-annealed) DNA.  Following gel 
extraction the double stranded PCR product was cloned into pGEM-T vector.  
Positive clones were identified by KpnI/EcoRI digestion of mini preps.  For 
each miRNA approximately 5 plasmids positive for insert were sequenced 
due to the high error rates in sequences observed. The miRNA from one 
positive clone, as identified by sequence analysis, was sub-cloned as a 
KpnI/EcoRI fragment into the intron of the RNAi vector (Figure 3.1).  Positive 
clones were identified by PCR colony screening with a forward primer 
specific for the hsa-miR-30a backbone (miRNA forward) and a mcherry 5‟ 
reverse primer (see section 2.5.2). Transcription of the intronic region of the 
RNAi vector results in a stem loop structure like that seen in Figure 3.2 D (as 
predicted by mfold, http://mfold.bioinfo.rpi.edu/). 
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Figure 3.2: Production and Cloning of miRNAs.  A: Schematic diagram showing the 
annealing of the two primers used to make the miRNAs.  The miRNA sequence is 
highlighted in red on the forward and reverse strands. KpnI and EcoRI restriction sites are 
indicated in blue and yellow respectively.  B: Annealed primers were run out on a 2.5% TAE 
agarose gel to allow good separation of annealed (120bp) and non-annealed product 
(smear) as seen in lanes 1-3. C: Example of a PCR colony screen used to identify 
constructs containing a miRNA.  A forward primer specific to the hsa-miR30 backbone and a 
mcherry 5‟ reverse primer were used.  PCR products were run on 1% agarose gels and 
positive clones were identified by a 1 Kb PCR product as can be seen in lanes 1-4 and 7-10.  
Previously identified constructs were used as positive controls (lane 10) and constructs 
lacking the miRNA were used as negative controls (lane 11). D: A schematic depiction of the 
transcribed pri-miRNA showing the hairpin loop, the position of the silencing sequence 
(highlighted in orange) and also the positions where Drosha and Dicer cut the primary and 
pre-miRNA respectively to form the mature miRNA. Folding predicted by mfold 
(http://mfold.bioinfo.rpi.edu/) 
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3.3.2 Efficient Vector–mediated RNAi in HEK 293 Cells 
In order to check that the RNAi vectors are correctly processed and capable 
of driving knockdown, their ability to knockdown GFP in HEK 293 cells was 
assessed.  To do this, HEK 293 cells were co-transfected with ef1α::GFP 
and the RNAi vector with either a GFP or control miRNA under the control of 
the H2A.Zf promoter in a 3:1 ratio.  Three days post transfection cells were 
prepared for flow cytometry analysis as per section 2.8.1.  Figure 3.4 shows 
an example of the flow cytometry data collected.  Cells singly transfected  
with empty pBluescript, ef1α::GFP or the RNAi vector were used as non-
labelled, GFP labelled and RFP labelled cells respectively to calibrate the 
flow cytometer (Figure 3.3 A, B and C ).  Measurements of the GFP intensity 
of cells are plotted on the y-axis and mcherry intensity on the x-axis.  In cells 
transfected with either GFP miRNAs a downward shift can be seen in the 
GFP values compared to the control miRNA-transfected cells (Figure 3.3 D, 
E and F).  This shift is greatest for cells transfected with the GFP #1 miRNA.  
To analyse the degree of knockdown in cells expressing control or GFP 
miRNAs the mean GFP:mcherry ratio of the mcherry positive cells 
(highlighted in red and labelled P3 in Figure 3.3) was used.  Analysis of the 
mcherry positive population showed a 95% and 72% knockdown of GFP in 
cells transfected with the GFP #1 and GFP #2 miRNAs respectively 
compared to cells transfected with control miRNA (Figure 3.4). 
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Figure 3.3: Fluorescent Flow Cytometry Analysis of GFP Knockdown in HEK 293 
Cells.  The x-axis is a measure the RFP signal intensity and the y-axis is a measure of GFP 
signal intensity.   A: non-labelled cells. B: GFP labelled cells. C: mcherry labelled cells.  D-F: 
Cells co-transfected with GFP and RNAi silencing vector. D: Control miRNA. E: GFP #1 
miRNA. F: GFP #2 miRNA.  In cells transfected with the GFP miRNAs a downward shift can 
be seen in the intensity of GFP expression compared to cells expressing the control miRNA.  
This shift is largest with the GFP #1 miRNA. 
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Figure 3.4:  Vector-mediated Knockdown of GFP in HEK 293 Cells. Relative GFP levels 
after transfection with vectors containing a control miRNA (purple bars, n=9), GFP#1 miRNA 
(gold bars, n=9) or GFP#2 miRNA (yellow bars, n=9).  GFP levels measured using 
fluorescent flow cytometry. Results were analysed by One-way ANOVA.  *= p < 0.05, **= p < 
0.01, ***= p <0.001. 
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3.3.3 in vivo GFP Knockdown  
3.3.3.1 Knockdown of Skin GFP in G0 Zebrafish 
To test whether the RNAi vector could induce silencing in zebrafish embryos, 
transgenic  krt4::GFP male zebrafish which express GFP in the keratinocytes 
of the skin were crossed with AB females, and the offspring  were injected 
with the RNAi vector containing either a control or GFP #1 miRNA under the 
control of the krt18 (keratinocyte-specific) promoter.  Three days post 
injection, larvae were analysed for GFP and RFP expression using an 
Axioplan 2 microscope equipped with an apoptome for optical sectioning.  In 
larvae which had been injected with the control miRNA co-localisation of the 
GFP and RFP in keratinocytes was detected, and there was no difference in 
the GFP content of RFP positive and RFP negative cells.  However, in larvae 
which had been injected with the GFP #1 miRNA reduced levels of GFP 
were detected in RFP positive cells compared to RFP negative cells (Figure 
3.5).  Therefore krt18-driven expression of GFP miRNA results in knockdown 
of GFP in zebrafish keratinocytes.  The amount of knockdown achieved 
seems to be dependent on the amount of RFP expression in cells, as in cells 
in which only a trace amount of RFP can be detected GFP is still present, 
whereas strong expression of RFP coincides with complete knockdown of 
GFP (Figure 3.5). 
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Figure 3.5: Krt18-driven Knockdown of Skin GFP in G0 zebrafish.  Krt4::GFP transgenic 
zebrafish embryos expressing GFP in keratinocytes were injected with silencing vector 
expressing either a control or GFP #1 miRNA under the control of the krt18 promoter.  Z 
stack images of the larvae were taken at 3 dpf and extended focus images analysed.  a-c: 
GFP and RFP in zebrafish larvae which had been injected with control miRNA.  Where the 
control miRNA is expressed, as indicated by RFP expression, co-expression of GFP and 
RFP can be seen (a). GFP levels in RFP positive cells are similar to levels in RFP negative 
cells as can be seen in the panel c.  d-e: GFP and RFP of Zebrafish larvae which had been 
injected with GFP #1 miRNA.  Where the GFP miRNA is expressed reduced levels of GFP 
can be detected (panels d and f).  The amount of GFP knockdown seems to be proportional 
to the amount of miRNA (RFP) expressed as can be seen by comparing panels e and f. 
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RNAi vectors containing control or GFP #1 miRNAs under control of 
the ubiquitous promoters, H2A.Zf and ef1α, were also injected into zebrafish 
expressing ubiquitous GFP.  However, the complexity of expression due to 
mosaics in G0 zebrafish meant that analysis of these fish in a G0 setting was 
not possible. 
3.3.3.2 Conditional Knockdown of GFP in G0 Zebrafish 
To test whether knockdown could be induced in a conditional manner 
krt4::GFP male zebrafish were crossed with female AB zebrafish and the 
resulting embryos were injected with the RNAi vector expressing either a 
control or GFP #1 miRNA under the control of the heat shock protein 70 
promoter (HSP70).  One day post injection the embryos were heat-shocked 
at 37°C for 16 hrs before analysing for GFP and RFP expression in the skin 
at 3 dpf.  In larvae which had been injected with the control miRNA but not 
heat-shocked, GFP but no RFP could be detected (Figure 3.6 a-c). In larvae 
which had been injected with the control miRNA and heat-shocked, co-
localisation of the GFP and RFP in keratinocytes was detected and there 
was no difference in the GFP content of RFP positive and RFP negative cells 
(Figure 3.6 d-f).  However, in larvae which had been injected with the GFP 
#1 miRNA and heat shocked, reduced levels of GFP were detected in RFP 
positive cells compared to RFP negative cells (Figure 3.6 g-i).   Therefore, 
conditional, HSP70-driven expression of GFP miRNA results in knockdown 
of GFP in zebrafish keratinocytes.  As with krt18-driven knockdown, the 
amount of knockdown achieved was dependent on the amount of RFP 
expression in cells.  Cells with low level expression of RFP have an 
increased level of GFP compared to cells which express high levels of RFP.  
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Figure 3.6: Conditional Knockdown of GFP in Skin of G0 Zebrafish.  Krt4::GFP 
transgenic zebrafish embryos expressing GFP in keratinocytes were injected with the RNAi 
vector expressing either a control or GFP #1 miRNA under the control of the HSP70 
promoter.  Zebrafish were heat shocked overnight at 37˚C at 30 hpf, Z stack images of the 
larvae were taken at 3 dpf and extended focus images analysed.  a-c: GFP and RFP in 
zebrafish larvae which had been injected with control miRNA with no heat-shock.  Panels a 
and c show uniform GFP expression.  Lack of expression of the RNAi vector as indicated by 
a lack of RFP expression can be seen in panel b.  d-f: GFP and RFP in zebrafish larvae 
injected with control miRNA after heat-shock.  Where the control miRNA is expressed, as 
indicated by RFP expression, co-expression of GFP and RFP can be seen (a). GFP levels in 
RFP positive cells are similar to levels in RFP negative cells as can be seen in panel f.  g-i: 
GFP and RFP in zebrafish injected with GFP #1 miRNA after heat-shock.  Where the GFP 
miRNA is expressed reduced levels of GFP can be detected (panels g and i).  The amount 
of GFP knockdown seems to be proportional to the amount of miRNA (RFP) expressed as 
can be seen by comparing panels h and i. 
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3.3.3.3 Generating Stable Transgenic (F1) Zebrafish 
To generate stable transgenic F1 zebrafish G0 injected zebrafish were raised 
to sexually maturity and then inbred and the resulting zebrafish embryos 
screened under a fluorescent microscope for RFP expression.  
Unfortunately, after screening off-spring from approximately 50 mating pairs 
for each miRNA and promoter (krt18, H2A.Zf and ef1α) combination only one 
transgenic line (control miRNA under control of the ef1α promoter) was 
detected.  RFP levels in these animals were weak, making detection of 
transgenic zebrafish difficult.  In order to be able to efficiently screen for 
transgenic zebrafish by virtue of RFP expression, increased levels of RFP 
would need to be expressed. 
3.3.4 Boosting Expression of miRNA and RFP Expression with 
Gal4/UAS 
3.3.4.1 The Gal4-responsive RNAi Vector 
In order to increase both the levels of RFP and miRNA expression achieved 
from RNAi vectors in stable transgenic zebrafish, the RNAi vector was 
modified to contain a tandem Gal4-VP16/UAS cassette (see section 3.2.2).  
A schematic representation of the final Gal4-VP16-responsive RNAi vector 
can be seen in Figure 3.7.   
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Figure 3.7: Schematic representation of the Gal4-VP16-responsive RNAi vector. This 
construct consists of a pol II-responsive promoter which drives expression the transcription 
factor Gal4/VP16.  Gal4/VP16 then binds the 14 tandem Upstream Activation Sequence 
(UAS) repeats, which results in transcription of the non-coding first exon, miRNA-containing 
intron, and the fluorescent protein, mcherry. Pol II-responsive promoters can be easily 
cloned in using the ApaI and EcoRV restriction sites.  miRNA sequences can be cloned in 
via KpnI and EcoRI restriction sites.  The silencing cassette is flanked by I-SceI 
meganuclease restriction sites which aid integration of the vector into the zebrafish genome 
upon co-injection with I-SceI meganuclease. 
 
In the Gal4-reponsive RNAi vector a pol II-responsive promoter of 
choice drives transcription of the transcription factor, Gal4/Vp16.  Gal4/Vp16 
then binds to the 14 tandem Upstream Activation Sequence (UAS) repeats 
and results in transcription of the non-coding first exon, miRNA containing 
intron, and mcherry.  The vector has been designed so that promoters can 
be easily exchanged via the ApaI and EcoRV restriction sites and miRNA 
sequences via the KpnI and EcoRI restriction sites. For a full vector map of 
Gal4-VP16-responsive RNAi vector see appendices 8.1.4. 
3.3.4.2 Gal4/UAS Increases Knockdown Efficiency in HEK 293 Cells 
To test whether the insertion of a Gal4-VP16/UAS cassette into the RNAi 
vector improved transgene expression, whilst still able to efficiently 
knockdown genes, HEK 293 cells were co-transfected with ef1α::GFP and 
equal moles of either the original RNAi vector containing control or GFP #1 
miRNA, or the Gal4-VP16-responsive RNAi vector containing control or GFP 
#1 miRNA.  Due to the amount of RFP signal produced by Gal4-VP16-
responsive RNAi vector being too high to accurately quantify, a 20-fold 
dilution of both the original and Gal4-VP16-responsive RNAi vector was 
used.  Three days post transfection cells were analysed for GFP and RFP 
expression via fluorescent flow cytometry.  Insertion of the Gal4-VP16/UAS 
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cassette into the RNAi vector led to a 30-fold increase in the expression of 
RFP (Figure 3.8 A).  Whereas the original, undiluted RNAi vector resulted in 
an 85% knockdown of GFP the diluted vector induced only minimal silencing 
of 7%, however this was not shown to be statistically significant.  The diluted 
Gal4-VP16-responsive vector on the other hand extremely significantly 
knocked down GFP by 65% (Figure 3.8 B).  Therefore, insertion of the Gal4-
VP16/UAS cassette led to an approximate 10-fold enhancement of 
knockdown efficiency. 
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Figure 3.8: Gal4-VP16/UAS Increases Transgene Expression and GFP Knockdown in 
HEK 293 cells.  A: Fold change in the level of RFP produced from the Gal4-VP16-
responsive RNAi vector compared to the original RNAi vector.  Equal moles of the original 
and Gal4-responsive RNAi vector were used.  RFP levels were analysed by Independent 
samples T test.  *= p < 0.05, **= p < 0.01, ***= p <0.001.   B: Relative GFP levels after 
transfection with the original RNAi vector, a 20-fold dilution of the original RNAi vector and a 
20-fold dilution of the Gal4-VP16-responsive RNAi vector.  Purple bars indicate GFP levels 
in control miRNA transfected cells. Gold bars indicate GFP levels in GFP #1 miRNA 
transfected cells. For each condition n=6.  The original RNAi vector knocked down GFP by 
86%.  A 20-fold dilution resulted in no significant knockdown of GFP, whereas the same 
molar quantity of the Gal4-responsive vector resulted in knockdown of 65%.  GFP and RFP 
levels measured using fluorescent flow cytometry. GFP levels in cells transfected with GFP 
#1 miRNA compared to the control miRNA were analysed by Independent samples T test.  
*= p < 0.05, **= p < 0.01, ***= p <0.001. 
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3.3.4.3 Generation of Gal4-responsive RNAi Transgenic Zebrafish 
To generate stable transgenic zebrafish, the Gal4-VP16-responsive RNAi 
vectors containing the control and GFP #1 miRNA under the control of the 
ubiquitous promoter H2A.Zf were co- injected into zebrafish along with I-SceI 
meganuclease.  Injected embryos were raised to adulthood and then inbred 
and the resulting off-spring screened under a fluorescent microscope for 
expression of the transgene.  This time approximately 10% of breeding pairs 
gave rise to transgenic offspring.  However, despite the use of a ubiquitous 
promoter, the expression pattern in all identified transgenic offspring was 
extremely mosaic with only a small minority of cells/tissues expressing the 
fluorescent protein.  Figure 3.9 shows an example of the type of expression 
seen in I-SceI-mediated transgenic zebrafish.  Expression is restricted to 
small clonal expansions of cells predominately in the brain.  Varying degrees 
of expression in the brain were the most consistent expression pattern 
observed.   
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Figure 3.9: I-SceI-mediated Transgenesis in F1 Zebrafish Expressing the Gal4-VP16-
reponsive RNAi Transgene under the Control of the Ubiquitous H2A.Zf Promoter.  A: 
merged brightfield and fluorescent image of F1 zebrafish at 4 dpf. B: fluorescent image of F1 
zebrafish.  Expression of the reporter gene mcherry is extremely mosaic in F1 zebrafish 
despite being under the control of the ubiquitous H2A.Zf promoter. 
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To see whether the rates of transgenesis could be improved and more 
ubiquitous expression of the transgene obtained, the Gal4-VP16-reponsive 
RNAi cassette was transferred into a Tol2 background (see section 3.2.2.1).  
The Tol2 Gal4-VP16-responsive RNAi vector with control or GFP #1 miRNA 
was then co-injected into zebrafish embryos along with transposase mRNA.  
Analysis of the resulting offspring revealed a 37% rate of transgenesis.  Of 
these the majority of fish still did not express the transgene ubiquitously, 
though the proportion of cells expressing the transgene was greatly 
improved. However, 32% of the founding zebrafish did give rise to embryos 
which appeared ubiquitous in fluorescent protein expression.  Of the 
founders identified the germ line transmission of the transgene to their 
offspring ranged from less than 10% up to 100%.  Figure 3.10 shows 
examples of the types of expression patterns detected in F1 zebrafish. 
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Figure 3.10: Tol2-mediated Transgenesis in F1 Zebrafish Expressing the Gal4-
reponsive RNAi Transgene under the Control of the Ubiquitous H2A.Zf Promoter.  A: 
merged brightfield and fluorescent image of F1 zebrafish at 2 dpf. B: fluorescent image of F1 
zebrafish.  The expression patterns achieved in the F1 generation varied from being 
extremely mosaic all over (i and ii) or being restricted to part of the zebrafish (iv) to being 
ubiquitous and uniform (iii). 
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3.3.4.4 GFP Knockdown in Stable Transgenic Zebrafish 
In order to test whether GFP can be knocked down in zebrafish stably 
expressing the Gal4-VP16-responsive RNAi vector under control of the 
H2A.Zf promoter, ubiquitous F1 zebrafish, expressing either the control or 
GFP #1 miRNA, as verified by genotyping (see section 2.6) were raised to 
adulthood and zebrafish with an approximate 50% transmission rate, 
indicative of single transgene integration were then crossed with the GFP 
transgenic line, ef1α::GFP.  The double transgenic off-spring of these 
zebrafish (the F2 generation) were again raised to adulthood and the off-
spring of adult male zebrafish (the F3 generation) were analysed for GFP 
and RFP expression.  Figure 3.11 A and C show GFP levels present in 
transgenic zebrafish expressing either the control or GFP #1 miRNA at 2 and 
5 dpf respectively.  GFP levels in double transgenic animals were compared 
to siblings which only express the ef1α::GFP transgene and are referred to 
here as non-transgenic siblings (NTS).  The presence of either the control 
miRNA or the GFP #1 miRNA, as indicated by the presence of red 
fluorescent protein, had no impact on the level of GFP compared to their 
relative NTS.  In order to quantify the level of GFP in zebrafish expressing 
either the control or GFP #1 miRNA, ef1α::GFP zebrafish expressing 
miRNAs and their relative NTS were homogenised in trypsin and analysed 
by flow cytometry (see section 2.8.2).  Figure 3.11 B and D shows that there 
is no significant difference in the relative GFP levels in zebrafish expressing 
either the control or GFP #1 miRNA compared to their NTS at 2 and 5 dpf 
respectively. 
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Figure 3.11: Lack of GFP Knockdown in Stable Transgenic Zebrafish Expressing 
ef1α::GFP and a GFP miRNA. A and C:  merged and fluorescent images of ef1α::GFP 
zebrafish expressing either the control (iv-vi) or GFP #1 miRNA (x-xii) alongside their 
respective non-transgenic sibs (NTS) (i-iii and vii-ix respectively) A: 2 dpf. C: 5 dpf.  B and D: 
flow cytometry quantification of GFP levels in ef1α::GFP zebrafish expressing either the 
control or GFP #1 miRNA. B: 2dpf zebrafish.  D: 5dpf zebrafish.  There is no significant 
reduction in GFP in zebrafish expressing the GFP #1 miRNA compared to zebrafish 
expressing the control miRNA (levels normalised to NTS levels).  For each condition n=3.  
Results were analysed by Independent samples T test.  *= p < 0.05, **= p < 0.01, ***= p 
<0.001. 
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The discrepancy between GFP knockdown in keratinocytes in a G0 
setting, but no global GFP knockdown in transgenic animals could be 
explained in one of two ways.  Firstly, it could be that RNAi-mediated 
knockdown is effective in keratinocytes but not in other cell types.  
Alternatively, RNAi-mediated knockdown may be possible in a G0 setting, 
but knockdown is not transmissible.  In order to try and address this, 
zebrafish transgenic lines expressing the Gal4-VP16-responsive RNAi 
transgene under the control of the krt18 promoter and GFP under the control 
of the krt4 promoter were created. It should be stated here however, that the 
identification of these lines was extremely difficult, as despite the use of 
Gal4-VP16-responsive vectors expression levels were extremely weak and 
expression was also, despite being a stable transgenic line, extremely 
mosaic.  Furthermore, the expression levels deteriorated between 1 dpf 
when the embryos were first screened and 3 dpf when GFP levels were 
analysed.  Figure 3.12, shows GFP levels in keratinocytes weakly expressing 
either the control or GFP #1 miRNA.  Although some cells expressing the 
GFP #1 miRNA do appear to have slightly reduced GFP expression, this 
variation in GFP is no greater than background variation, as some cells 
which are not expressing the transgene also have reduced levels.  
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Figure 3.12: Lack of GFP Knockdown in Stable Transgenic Zebrafish Expressing GFP 
and a GFP miRNA in Zebrafish Skin.   Double transgenic zebrafish expressing krt4::GFP 
and either the control (a-c) or GFP #1 (d-f) miRNA under the control of krt18-driven Gal4-
Vp16/UAS.  Where the control miRNA is expressed (a-c), as indicated by RFP expression, 
co-expression of GFP and RFP can be seen (a). GFP levels in RFP positive cells are similar 
to levels in RFP negative cells and can be seen in c.   Where the GFP #1 miRNA is 
expressed (d-f) co-expression of GFP can also be seen.  The level of GFP expression 
however, is reduced in some GFP #1 miRNA expressing cells, but this reduction is not 
beyond the background level of variation (f).    
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3.4 Discussion 
The use of RNAi in a vector-mediated approach has the potential to provide 
the zebrafish research community with a much needed cheap and efficient 
technique for gene knockdown.   The aim of this study was therefore to 
develop and validate a vector for vector-mediated RNAi and show that it can 
be used to knockdown genes in zebrafish in a stable and heritable fashion. 
3.4.1 Validating a Vector for Vector–mediated RNAi 
GFP miRNAs cloned into the pol II-responsive RNAi vector were shown to 
be able to effectively knockdown co-transfected GFP compared to the control 
miRNA in HEK 293 cells, thus demonstrating the vector is suitable for 
delivery of vector-mediated RNAi (Figure 3.4).  The co-expression of red-
fluorescent protein aids the analysis of knockdown as it is possible to 
evaluate the GFP content of the cherry red positive cells only.   
In order to determine whether this vector was also capable of 
knocking down genes in zebrafish, vectors containing either the control or 
the most potent GFP miRNA, as determined in HEK 293 cells, were injected 
into single-stage zebrafish embryos stably expressing GFP.   Detection of 
knockdown in a G0 setting is complicated by the fact that injection of 
plasmids into single stage zebrafish embryos results in a mosaic pattern of 
expression of the transgene due to progressive dilution of inherited episomal 
DNA and infrequent transgene insertion events.  For this reason the 
keratinocytes of the zebrafish skin were chosen as the target for GFP 
knockdown, as their uniform and flat shape make them easily visualised and 
analysed for RNAi vector expression, as indicated by presence of the 
reporter, mcherry, and GFP content.  In the first instance, efficient 
knockdown of skin-specific, Krt4-driven GFP was successfully demonstrated 
by Krt18-driven expression of the RNAi vectors containing the GFP miRNA 
compared to the control miRNA (Figure 3.5).  Secondly, the heat-shock 
promoter HSP70 was used to drive expression of control and GFP miRNAs 
and was also shown to induce effective knockdown of GFP in the 
keratinocytes of 3 dpf zebrafish larvae (Figure 3.6). Thus, vector-mediated 
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RNAi seems to be possible in a G0 setting in zebrafish keratinocytes and this 
knockdown can be made conditional by the use of a heat-inducible promoter.  
The demonstration of GFP knockdown in G0 zebrafish is in line with work by 
Wang et al., (2007) and Su et al., (2008) who demonstrate efficient 
knockdown (~70%) of GFP and no tail (ntl) by means of in vivo T7 
transcribed shRNAs and CMV transcribed shRNAs respectively. 
 To demonstrate that vector-mediated knockdown could be stably 
inherited from one generation to the next, G0 injected fish were raised to 
adulthood, inbred and the resulting offspring analysed for expression of the 
transgene.  Unfortunately, after exhaustive breeding of zebrafish injected 
with either the control or GFP miRNA under the control of the Krt18, H2A.Zf 
and ef1α promoters, only one stable transgenic line was identified.   The lack 
of stable lines identified is most likely due to very low germ line I-SceI-
mediated transmission rates combined with very low transgene expression 
levels which may have meant that some stable lines were missed because 
mcherry levels were not high enough to be detected on the Leica MZFIII 
fluorescent microscope.  In keeping with the later theory HSP70 stable 
transgenic zebrafish were later identified as the HSP70 promoter leads to 
much stronger expression of mcherry than any of the other promoters tested.  
In order to generate a user-friendly system of vector-mediated RNAi in which 
transgenic zebrafish can be easily identified and high levels of miRNA 
produced, a method of increasing promoter activity was required. 
3.4.1.1 Increasing Promoter Activity and miRNA Expression with Gal4-
VP16/UAS 
Gal4 is a transcription factor identified in the yeast Saccharomyces 
cerevisiae and induced by galactose.  It binds to 17 bp upstream activation 
sequences (UASs) and leads to expression of GAL10 and GAL1 genes 
(Hashimoto et al., 1983).  Since the identification of this system it has been 
widely used in Drosophila where transgenic expression of Gal4 binds to 
multiple tandem UAS sites and leads to high level expression of transgenes 
(Duffy, 2002).  It was first used in zebrafish by Scheer and Campos-Oriega in 
1999 to generate stable transgenic zebrafish expressing myc-notch:intra (a 
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fusion gene encoding 6 myc epitopes fused to the intracellular domain of 
notch1)(Scheer and Campos-Ortega, 1999). Despite reporting robust and 
stable expression of the effector, expression levels were low.  Use of Gal4 
fused to the transcriptional activator domain VP16 of the herpes simplex 
virus (developed by Sadowski et al., 1998) improved expression levels in 
transient zebrafish assays (Koster and Fraser, 2001), and recently the Gal4-
VP16/UAS system has been used as an enhancer trap in both a binary 
(separate Gal4-VP16 activator and UAS effector transgenic lines) and a 
tandem system (single vector with both Gal4-VP16 activator and UAS 
effector cassettes) in zebrafish and has resulted in the high level, stable and 
robust reporter expression in several different cell types (Davison et al., 
2007; Scott et al., 2007).  Insertion of a Gal4-VP16/UAS cassette into the 
RNAi vector downstream of the required promoter should lead to high level 
expression of the transgene in this case miRNA and mcherry.  This was 
tested in HEK293 cells and indeed the Gal4-VP16-responsive vector under 
control of the H2A.Zf promoter resulted in 30 times the amount of mcherry 
compared to the original RNAi vector and increased GFP knockdown 10-fold 
(Figure 3.8).  The difference in the fold increase in mcherry expression and 
GFP knockdown may suggest that at some point the available RNAi 
machinery in the cell may become limiting and thus prevent any further 
knockdown. 
 Gal4-VP16-responsive vectors were then used to generate stable 
transgenic lines.  Initially vectors incorporating I-SceI restriction sites either 
side of the transgene were used but these vectors although capable to 
driving high levels of transgenes resulted in extremely mosaic expression 
even when the ubiquitous promoter H2A.Zf was used (Figure 3.9).  Using an 
alternative vector, in which the transgene is surrounded by arms of the 
medaka Tol2 transposable element and injected along with transposase 
mRNA, lead to greatly improved levels transgenesis, and although transgene 
expression was in many cases still mosaic, many more cells were targeted, 
and it was possible to identify lines of zebrafish which expressed high levels 
of the transgene ubiquitously and uniformly (Figure 3.10).   
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Variegated expression of transgenes is a common problem in 
zebrafish transgenesis and there are three potential reasons for this. Firstly, 
transgene expression is extremely dependent on integration site, which at 
present cannot be easily controlled in zebrafish.  If a transgene integrates 
close to transcriptional enhancers or repressors the expression of the 
transgene may be affected.  Secondly, the heterochromatin state of DNA 
surrounding the insertion site may also play an important role, as 
heterochromatin renders DNA less accessible to transcription. Furthermore, 
the heterochromatin state of DNA may vary in a cell type dependent manner, 
thus generating variegated expression patterns of transgenes.  Thirdly, 
injection of plasmid DNA can result in the integration of large concatemers of 
DNA into the genome and these have been shown to be silenced through 
chromatin modification (Garrick et al., 1998).  The use of a meganuclease or 
transposon based system of transgenesis however, should prevent 
concatemer formation and aid single transgene integration (Kawakami et al., 
2000; Thermes et al., 2002) and so this is unlikely to be the cause for 
variegated expression in F1 zebrafish identified here.  Recently however, the 
tandem UAS repeats used in Gal4/UAS systems have been shown to be 
especially liable to silencing induced by DNA methylation  due to the large 
number  of CpG  dinucleotides in the UAS sequence (Goll et al., 2009).  
Methylation of the UAS sequences may therefore explain the variegation in 
expression patterns seen here.  As methylation events are inheritable UAS 
transgene expression may be subject to progressive silencing resulting in 
increased variegation with increasing generations.  However, despite the 
variegation seen in some F1 zebrafish, with the aid of in trans reporter gene 
expression it was possible to identify zebrafish with fairly uniform and 
ubiquitous expression patterns which were maintained through several 
generations.  Consistent with this, Davison and colleagues also report stable 
and robust expression patterns in most of their Gal4-VP16/UAS enhancer 
trap lines over 3 generations (Davison et al., 2007).  Where progressive loss 
of expression was seen, this was often associated with a greater than 50% 
germ line transmission rate, and so may simply reflect the segregation of 
multiple genome insertions.  For analysis of gene knockdown in zebrafish as 
well as selecting fish which gave rise to robust and uniform expression, fish 
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with a 50% transmission rate, indicative of single transgene insertion, were 
also selected.   Although it has been possible to identify appropriate 
zebrafish for analysis, the methylation induced silencing of tandem UAS 
sequences is a major limitation in the use of this transgenic technology.  It 
may be possible that reducing the number of UAS repeats will reduce the 
silencing effect.  Indeed, Asakawa and colleagues reported reproducible and 
robust expression patterns from their constructs containing 5 tandem UAS 
repeats (Asakawa and Kawakami, 2008).  Moreover, co-expression of two 
independent UAS transgenes were consistently detected in the same cells, 
suggesting that UAS transgenes were not being silenced (Asakawa and 
Kawakami, 2008). 
Differences in the amount of variegation observed between zebrafish 
generated by means of meganuclease and zebrafish generated by 
transposons may simply reflect the increased efficiency of transposon 
mediated transgenesis, which increases the likelihood of eventually 
identifying zebrafish with robust and uniform expression patterns.  
Alternatively, it may reflect differences in likely insertion sites.  Indeed,  
mapping of Tol2 insertion sites in human cells has revealed significant 
underrepresentation of chromosomal sites with H3K27me3 histone marks, 
which are  typically associated with transcriptionally repressive 
heterochromatin (Grabundzija et al., 2010).  Another possibility is that the 
transposon arms of Tol2 may act as insulators, protecting the transgene from 
the influences of heterochromatin.    
 As well as potential problems with the silencing of Gal4/UAS-
responsive transgenes, there have also been concerns over the use of the 
transcriptional enhancer VP16 as it has been shown to have toxic effects in 
vertebrate cells (Gill and Ptashne, 1988; Sadowski et al., 1988).  It is thought 
that these toxic effects are due to the over-exploitation of important 
transcription factors.  Whilst creating the transgenic lines required for this 
research a couple of the transgenic lines created did show signs of toxicity.  
In one case this coincided with multiple copy integration.  In another line, 
zebrafish larvae developed normally, but as adults the fish had a shortened 
axis, curvature of the spine and reduced fertility.  However, although widely 
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and strongly expressed, overall detectable toxicity was extremely low, <5%.  
Consistent with this Asakawa et al., (2008)  and Scott et al., (2007) both 
report Gal4-VP16 toxicity at 4%.  The toxic effects associated with Gal4-
VP16 can according to Asakawa et al., (2008) be eliminated altogether 
through the use of Gal4FF which consists of the DNA binding domain of Gal4 
combined with two of the transcriptional enhancer modules from VP16.   
 The benefit of using a Gal4/UAS system to express miRNAs and 
reporter genes is not only that it results is high level expression of both the 
primary miRNA and the reporter gene, but also that this system could be 
used as a binary system.  This means that separate transgenic lines could 
be identified, one expressing Gal4 (the activator line) and the other 
containing the UAS and transgene (the effector line).  Combining activator 
and effector lines would then lead to the expression of miRNA and reporter.  
This may be particularly useful to maintain transgenic lines in which 
knockdown of the target gene results in lethality or infertility.  In addition, it 
means that Gal4 driver lines could be employed to drive expression of 
miRNAs in particular lineages for which enhancer motifs have not yet been 
identified. 
3.4.2 Lack of GFP Knockdown in Zebrafish Stably Expressing miRNAs 
To test whether GFP knockdown is heritable, stable transgenic male 
zebrafish expressing both GFP and the Gal4-VP16-responsive RNAi vector 
with either the control or GFP miRNA under the control of the ubiquitous 
H2A.Zf promoter were crossed to wild type female zebrafish.  Visual and 
fluorescent flow cytometry analysis of the resulting offspring at 2 and 5 dpf 
showed no significant knockdown of GFP in fish expressing the GFP miRNA 
compared to fish expressing the control miRNA (Figure 3.11).  This is 
contrary to GFP knockdown seen in the keratinocytes of the G0 fish, raising 
the possibility that GFP knockdown is not heritable or, that keratinocytes are 
amenable to RNAi whereas other cells in the zebrafish are not.  To test this, I 
attempted to create double transgenic zebrafish expressing both the Gal4-
VP16 vector expressing the GFP or control miRNA under the control of the 
Krt18 promoter and Krt4::GFP.  Although, transgenic zebrafish were 
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identified the expression of the RNAi vector was extremely weak and mosaic 
throughout the zebrafish.  In addition, the level of expression of the RNAi 
vector appeared to reduce over time.  Limited and varied expression of the 
Gal4-VP16-repsonive transgene in keratinocytes possibly indicates that 
these cells are silencing the vector, most likely through DNA methylation as 
discussed previously.  Analysis of those zebrafish which did express both 
GFP and the RNAi vector, albeit in a mosaic manner, revealed however, that 
unlike in the G0 analysis where expression of the GFP #1 miRNA led to 
significant reductions in GFP beyond the background variation, expression of 
the GFP #1 miRNA in transgenic fish did not (Figure 3.12).  Although, this 
seems to indicate that knockdown is not transmissible through generations, 
the extremely low expression levels detected in the cells means this analysis 
is not sufficient to draw such conclusions.  However, taking together the 
results put forward here showing a lack of GFP knockdown in transgenic 
zebrafish expressing GFP miRNA ubiquitously, with previous reports by Su 
et al., (2008), and Wang et al., (2007) who detected knockdown of ubiquitous 
GFP in a G0 setting, seems to support the idea that while RNAi may be 
feasible in a G0 setting, knockdown is not stably transmitted to the next 
generation. There are several possible explanations for this.  Firstly, 
expression in G0 zebrafish is often extremely high due to the presence of 
multiple copies of the transgene and high level expression of the transgene 
may be required in order for enough miRNA to be produced to impact GFP 
levels.  If levels in stable transgenic zebrafish are lower, this may explain the 
lack of knockdown detected.  However, the use of Gal4-VP16-responsive 
vectors in combination with the H2A.Zf promoter resulted in very high levels 
of expression in stable transgenic lines and so it is unlikely that expression 
levels were the limiting factor in these fish.  Another, possible explanation is 
that the introduction of large amounts of foreign DNA into G0 zebrafish 
results in the induction of the RNAi machinery.  This seems a highly plausible 
explanation, especially since the RNAi pathway is thought to have evolved 
as an innate response to foreign nucleic acids (Obbard et al., 2009).  In 
stable transgenic lines the integrated transgene however may not elicit such 
a response, resulting in the lack of knockdown observed.  In order to test this 
hypothesis, stable transgenic embryos expressing both GFP and the RNAi 
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vector could have been injected with empty vector DNA or other components 
of the injection mix to see whether presence of exogenous DNA or any other 
injection mix component resulted in the induction of an RNAi response. 
3.4.3 Conclusion 
A vector suitable for the delivery of miRNAs has been identified and shown 
to effectively knockdown GFP in HEK 293 cells and in transient assays in 
zebrafish.  This vector however, led to extremely low level expression in 
transgenic zebrafish, making the identification of transgenic lines extremely 
difficult.  The introduction of the Gal4-VP16/UAS cassette boosted the 
expression level of miRNA and reporter in HEK 293 cells and in stable 
transgenic zebrafish.  However, despite being able to effectively knockdown 
GFP in HEK 293 cells, no knockdown was observed in stable transgenic 
lines.  The discrepancy between knockdown in G0 zebrafish and the lack of 
knockdown in stable transgenic lines may suggest that the introduction of 
exogenous DNA into G0 zebrafish may provoke an RNAi response which 
leads to GFP knockdown.  
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4 Chapter Four: Knocking Down PINK1  
4.1 Introduction 
At the same time as targeting GFP for knockdown, and encouraged by the 
preliminary results of chapter one other similarly encouraging results by 
Wang et al., (2007) and Su et al., (2008), I also set about targeting the 
endogenous Parkinson‟s disease-associated gene, PINK1.   
Parkinson‟s disease is the second most prevalent neurodegenerative 
disease and is characterised by the selective loss of the dopaminergic 
neurons of the substantia nigra pars compacta (SNpc) and accompanied by 
the development of proteinacious neuronal inclusions called Lewy bodies.   
P-TEN induced putative kinase 1 (PINK1) is a serine threonine kinase whose 
loss of function mutations have been shown to be the second most common 
cause of autosomal recessive juvenile Parkinson‟s disease (Valente et al., 
2004a) and mutations in PINK1 have also been shown to be involved in the 
sporadic forms of the disease (Valente et al., 2004b).   
PINK1 has been shown to localise to the mitochondria and to be 
important in protecting cells from oxidative stress induced cell death through 
the phosphorylation of TRAP1(Pridgeon et al., 2007), maintaining normal 
respiratory function (Liu et al., 2009) and regulating mitochondrial calcium 
flux (Marongiu et al., 2009).  It has also been shown to be involved in protein 
turnover through the regulation of parkin, an ubiquitin ligase also associated 
with early onset parkinsonism (Yang et al., 2006), and protein quality control 
through the association with HrtA2 (Plun-Favreau et al., 2007).    
Animal models PINK1 Parkinson‟s disease have so far predominantly 
relied on Drosophila and mice.  While Drosophila have proved valuable in 
understanding pathways associated with loss of PINK1, PINK1 knockouts fail 
to recapitulate the complex aetiology of Parkinson‟s disease (Clark et al., 
2006; Park et al., 2006; Yang et al., 2006).  Knockout mice on the other 
hand, although not showing signs of dopaminergic cell loss, do show some 
of the other hallmarks of Parkinson‟s disease, such as impaired 
mitochondrial respiration in the striatum, reduced striatal plasticity and 
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reduced dopamine release (Gautier et al., 2008; Kitada et al., 2007).   An 
animal model which successfully recapitulates the aetiology of the disease 
while providing the advantages of small size, ease of manipulation and 
amenability for high-throughput screening, would therefore be extremely 
valuable and it is hoped that zebrafish as a vertebrate with its complex and 
analogous neuroanatomy will provide such a system.  
In the hope of generating a PINK1 Parkinson‟s model, several groups 
have recently demonstrated and characterised knockdown of PINK1 by 
morpholinos in zebrafish embryos (Anichtchik et al., 2008; Xi et al., 2010).  
Reports by Anichtchik et al., (2008) reported  that PINK1 knockdown resulted 
in severe developmental defects with a >30% loss in tyrosine hydroxylase 
(TH, a marker of dopaminergic and noradrenic neurons) positive cells.  
However, others have reported much more modest dopaminergic neuron cell 
loss (Anichtchik et al., 2008; Sallinen et al., 2010; Xi et al., 2010).  The 
discrepancy in results is probably due to common off-target and non specific 
effects associated with morpholinos, thus further emphasising the need for a 
different approach to knockdown genes and to determine the true effect of 
loss of PINK1. 
Moreover, recent RNAi experiments in mice have demonstrated the 
accessibility of mouse PINK1 to vector-mediated RNAi gene knockdown 
(Zhou et al., 2007), raising the possibility that zebrafish PINK1 may also be 
an accessible target for RNAi gene knockdown. 
4.1.1 Aims 
The aims of this chapter are therefore to: 
 identify and characterise the zebrafish PINK1 homolog. 
 identify potential polymorphic regions in the PINK1 gene. 
 identify efficient PINK1 miRNAs in HEK293 cells. 
 generate transgenic lines expressing PINK1 and control miRNAs and 
analyse transgenic lines for knockdown of PINK1. 
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4.2 Material and Methods 
For general materials and methods see chapter two. 
4.2.1 Cloning miRNAs 
miRNAs against PINK1 were made using the primers listed in Table 4.1 as 
described in sections 2.5 and 3.3.1. 
miRNA  Primer sequence 
 
 
PINK1 
#1 
 
Fwd 
 
GCGGGGTACCTGCTGTTGACAGTGAGCGAGGGTTTGGGTCTGATTGAACATAGTGAAGCCACAG
ATG 
Rev CCGCGAATTCCCTTGAAGTCCGAGGCAGTAGGCAGGGGTTTGGGTCTGATTGAACATACATCTG
TGGCTTCAC 
 
 
PINK1 
#2 
 
Fwd 
 
GCGGGGTACCTGCTGTTGACAGTGAGCGAGCCTTCCGAAGCCCTTTACATTAGTGAAGCCACAG
ATG 
Rev CCGCGAATTCCCTTGAAGTCCGAGGCAGTAGGCAGGCCTTCCGAAGCCCTTTACATTACATCTG
TGGCTTCAC 
 
 
PINK1 
#3 
 
Fwd 
 
GCGGGGTACCTGCTGTTGACAGTGAGCGACCGACTCAATCCACATGGTTTTAGTGAAGCCACAG
ATG 
Rev CCGCGAATTCCCTTGAAGTCCGAGGCAGTAGGCAGCCGACTCAATCCACATGGTTTTACATCTG
TGGCTTCAC 
 
 
PINK1 
#4 
 
Fwd 
 
GCGGGGTACCTGCTGTTGACAGTGAGCGAGCAAGGAGAGCTGACTTTGAATAGTGAAGCCACAG
ATG 
Rev CCGCGAATTCCCTTGAAGTCCGAGGCAGTAGGCAGGCAAGGAGAGCTGACTTTGAATACATCTG
TGGCTTCAC 
 
 
PINK1 
#5 
 
Fwd 
 
GCGGGGTACCTGCTGTTGACAGTGAGCGAGGAAGATTATGTGATTGGGAATAGTGAAGCCACAG
ATG 
Rev CCGCGAATTCCCTTGAAGTCCGAGGCAGTAGGCAGGGAAGATTATGTGATTGGGAATACATCTG
TGGCTTCAC 
 
 
PINK1 
#6 
 
Fwd 
 
GCGGGGTACCTGCTGTTGACAGTGAGCGAGCAGTGGAGATACCTGCTGATTAGTGAAGCCACAG
ATG 
Rev CCGCGAATTCCCTTGAAGTCCGAGGCAGTAGGCAGGCAGTGGAGATACCTGCTGATTACATCTG
TGGCTTCAC 
 
 
Control  
 
Fwd 
 
GCGGGGTACCTGCTGTTGACAGTGAGCGAAGTCTGTGCGCAGAAATATATTAGTGAAGCCACAG
ATG 
Rev CCGCGAATTCCCTTGAAGTCCGAGGCAGTAGGCAGAGTCTGTGCGCAGAAATATATTACATCTG
TGGCTTCAC 
 
Table 4.1: Primers Used in the Production of PINK1 and Control miRNAs.  The sense 
sequence of the target is shown in grey on the forward primer and red on the reverse primer.  
KpnI and EcoRI sites are indicated in turquoise and yellow respectively.  The rest of the 
sequence is based on the miR-30 backbone identified by Zeng et al. (2002). 
 
4.2.2 Sequencing PINK1  
PINK1 was amplified from wild type zebrafish cDNA (extracted from equal 
numbers of embryos from 8 breeding pairs) using Pfu DNA polymerase 
(Promega) and following manufacturer‟s guidelines in a nested PCR 
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approach similar to that described in section 2.6.1.1. Cycling conditions for 
both rounds of PCR were: 95°C for 5 mins and then 24 cycles of 95°C for 30 
secs, 55°C for 40 secs and 72°C for 4 mins, followed by a final extension of 
72°C for 10 mins.  The primers for the first and second round PCR are listed 
in  
Table 4.2.  Amplified PINK1 was sequenced using M13 fwd and rev primers 
(Invitrogen). 
Primer Sequence 
PINK1 Fwd 1 GTAAAGCATGTTCTCAGCCG 
PINK1 Rev 1 GGCTGAGAGTTAGACATCAG 
PINK1 Fwd 2 (M13 fwd) TGTAAAACGACGGCCAGTGTTTTCCAGCTGGGACTTC 
PINK1 Rev2 (M13 Rev) CAGGAAACAGCTATGACGATGTTGGCGAGGAAAG 
 
Table 4.2: Primers used in Nested PCR to Amplify and Sequence PINK1.  Sequences 
are given in a 5‟ to 3‟ format.  M13 fwd and rev binding sites are underlined. 
 
4.2.3 Cloning GFP:PINK1 Fusion Expression Vector 
To create a GFP:PINK1 fusion expression vector, full-length PINK1 was 
amplified using general PCR methods (see section 2.4.1) with the  forward 
primer 5‟-ATGTCAGTAAAGCATGTTCTCAGCC-3‟ and reverse primer 5‟- 
CTATGGCTGAGAGTTAGACA-3‟ and cloned into NT-GFP Fusion TOPO ® 
TA Expression Kit (Invitrogen) following manufacturers‟ instructions 
4.2.4 Detecting PINK1 mRNA: RT-qPCR 
PINK1 transcript levels were measured using the primer listed below and 
following the RT- qPCR protocol detailed in section 2.9. 
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Gene Accession 
Number 
 Primer Sequence  
*β-actin1 
 
NM_131031.1 Forward  
Reverse 
CGAGCTGTCTTCCCATCCA 
TCACCAACGTAGCTGTCTTTCTG 
* ef1α NM_131263.1 Forward  
Reverse 
CTGGAGGCCAGCTCAAACAT 
ATCAAGAAGAGTAGTACCGCTAGCATTAC 
†ef1α 
(human) 
NM_001402.5 
 
Forward  
Reverse 
CTGAACCATCCAGGCCAAAT 
GCCGTGTGGCAATCCAAT 
PINK1 NM_001008628.1 Forward  
Reverse 
GCGAGGAGTATCCTGATGTC 
CAGGGGTAATTCTTCATGAC 
*rpl13 α NM_212784 
 
Forward  
Reverse 
TCTGGAGGACTGTAAGAGGTATGC 
AGACGCACAATCTTGAGAGCAG 
 
Table 4.3: RT-qPCR Primer Sets used in PINK1 Gene Transcript Analysis.  Primers 
used for qPCR analysis are listed in a 5‟ to 3‟ manner.  Reference genes used are 
highlighted in grey.  Accession numbers of genes analysed are also given. * indicates 
primers published by Tang et al.,(2007). † indicates primers published by Hamalainen et 
al.,(2001). 
 
4.2.5 Detection of PINK1 Protein 
PINK1 protein levels were detected by western blot using methods described 
in section 2.10.  The rabbit polyclonal anti-PINK1 antibody (Cayman 
Chemicals) was used at 1 μg/ml followed by an anti rabbit IgG HRP-
conjugate used at 1:10 000.   
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4.3 Results 
4.3.1 Identification and Expression of PINK1 
Zebrafish PINK1 was identified by performing tblastn analysis of the Ensembl 
zebrafish database for sequences with high homology to human PINK1.   A 
putative PINK1 transcript was identified and confirmed by PCR Topo cloning 
and sequencing.  Zebrafish PINK1, resides on chromosome 23 and encodes 
a 574 aa protein which is 53.8% identical and 66.2% similar to the human 
PINK1 protein.  The PKc (protein kinase catalytic) domain (amino acids 271 
to 501 in the human sequence) however is more highly conserved, being 
71% identical and 80.1% similar and the kinase active site (amino acids 358 
to 370 in the human sequence) is 92.3% identical and 100% similar.   For a 
full alignment of human and zebrafish PINK1 proteins see appendices 
section 8.2. 
4.3.1.1  Validation of qPCR Primers 
In order to analyse the expression of PINK1 throughout development and 
across tissues, Sybr green qPCR assays were designed and validated 
against zebrafish PINK1 and the house-keepers ef1α, β-actin and rpl13α.   
ef1α, β-actin and rpl13α were chosen as house-keepers because they were 
shown to have the greatest stability in a panel of zebrafish house-keepers 
throughout development and across tissues (Tang et al., 2007).  Sybr green 
qPCR works on the principle that Sybr green binds with high affinity to 
dsDNA and when it does it emits a green fluorescent signal.  As the PCR 
reaction progresses, there is an increasing amount of dsDNA and therefore 
an increase in fluorescent signal.  In order to compare the amount of PCR 
product, and hence the amount of starting DNA in different samples, a 
threshold fluorescent level is set and the number of cycles each sample 
takes to reach this threshold level is recorded.  This level is known as the 
cycle threshold or CT value of a sample.   The lower the CT value the higher 
the levels of starting template DNA.  In order to validate primers for their 
PCR efficiency, the CT value for each sample of a serial dilution of cDNA 
(Figure 4.1 A) was determined and plotted against the log quantity of cDNA 
used in each reaction (Figure 4.1 B) to produce a straight line.  A slope with 
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a gradient of -3.32 indicates that the primers are 100% efficient; i.e with each 
increase in cycle number there is a doubling in the amount of PCR product.  
Values of -3.1 and -3.58 are equivalent to 90% and 110% efficiency 
respectively.  Only primers which fell between these ranges and gave rise to 
a correlation coefficient (R2) of at least 0.97 were accepted for use in cDNA 
quantification.  A list of gradients and R2 values for each primer pair used 
can be seen in Figure 4.1 D. In order to further validate that qPCR primers 
were specific for a single cDNA species melting curve analysis between 
45°C and 95°C was performed.  Figure 4.1 C shows a drop in fluorescent 
intensity with increasing temperature, with a sharp drop appearing around 
82°C.  This drop in fluorescence is due to the strands of dsDNA dissociating 
and releasing the Sybr green (and thereby causing it to stop fluorescing) with 
increasing temperature.  The sharp drop at 82°C indicates the melting 
temperature of the PCR product.  The negative of the first derivative over 
time (-d1/dT), a measure of rate of change, is also plotted and shows a 
single peak at 82°C.  Presence of a single peak indicates the amplification of 
a single product, as other products would have a different melting 
temperature and so result in multiple peaks. 
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      D 
Zebrafish Gene Gradient R
2
 value 
PINK1 -3.319 0.986 
β-actin -3.331 0.981 
ef1α -3.321 0.993 
rpl13α -3.317 0.993 
 
Figure 4.1: Example of Validation of qPCR primers.  A: Plots of cycle number against 
fluorescent intensity across of serial dilution of cDNA.  The dotted line indicates the 
threshold level.  The number of cycles required for a sample to reach this threshold is known 
as the cycle threshold (CT) value of that sample.  B: Plot of log concentrations against CT 
values. A gradient of -3.32 is indicative of 100% primer efficiency. C: Melting curve analysis.  
A drop in fluorescent intensity can be seen with increasing temperature.  This drop in 
fluorescence is due to the strands of dsDNA dissociating and releasing the Sybr green.  The 
sharp drop at 82°C indicates the melting temperature of the PCR product.  The negative of 
the first derivative over time (-d1/dT), a measure of rate of change, is also plotted and shows 
a single peak at 82°C.  Presence of a single peak indicates the amplification of a single 
product, as other products would have a different melting temperature and so result in 
multiple peaks. D: Gradient and R
2
 values for primers used in the detection of PINK1, and 
the house-keepers β-actin, eflα and rpl13α mRNAs. 
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4.3.1.2 Quantification of PINK1 Expression throughout Development and 
Across Tissues 
PINK1 mRNA levels were quantified and normalised to the average of three 
house-keepers, ef1α, β-actin and rpl13α throughout development (from 1 dpf 
to 3 wks) and across 6 month old tissues (brain, fin, heart, intestines, kidney, 
liver, muscle, skin and testes) using the ΔΔCT method described in section 
2.9.5.  Throughout development PINK1 levels remained fairly constant, 
increasing slightly, but non-significantly out to 6 dpf and then dropping off 
again by 3 wks.  Across tissues, PINK1 levels are slightly elevated in many 
tissues including fin, heart, intestine and testes, but are only statistically 
significantly higher in brain and muscle which show an approximate 50-fold 
and 70-fold increase respectively above levels at 1 dpf (Figure 4.2). 
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Figure 4.2:  PINK1 mRNA Levels Throughout Development and Across Tissues.  
Relative fold changes in mRNA levels of PINK1 compared to 1 dpf levels.  Transcript levels 
were determined by real-time qPCR and normalised against the average of three house-
keepers ef1αa, rpl13α and β-actin. Quantification is based on three individual time courses 
and tissue banks.  Results were analysed by One-way ANOVA followed by the Dunnett test 
using 1 dpf values as the control. *= p < 0.05, **= p < 0.01, ***= p <0.001. 
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4.3.2 Identification of Putative PINK1 Polymorphisms 
In order to design effective miRNAs against zebrafish PINK1, it was 
important to avoid polymorphic regions within the gene.  To identify potential 
polymorphisms the open-reading frame (ORF) of the identified PINK1 cDNA 
was compared to pubmed-deposited EST sequences with high sequence 
homology to PINK1.  A region of alignment between PINK1 cDNA and the 
ESTs can be seen in Figure 4.3 A.  Conserved bases are highlighted 
(G=black, C=blue, T=red, A=green), non-conserved bases are non-
highlighted.  Base changes verified by two or more EST sequences were 
considered bona fide polymorphisms.  In order to establish whether there 
were any additional polymorphisms in our own AB fish stocks, embryos were 
collected from 8 breeding pairs, RNA extracted, cDNA synthesised and 
sequenced (see section 4.2.2).  Sequencing reactions were carried out in 
duplicate and only polymorphisms detected in both reactions were treated as 
bone fide.  Figure 4.3 B shows an example of a sequencing polygraph, which 
clearly shows dual peaks at both position 133 and 139, indicating the 
presence of polymorphisms at these positions.  Results of the EST and 
sequencing analysis were combined and a full sequence of PINK1 showing 
all identified putative polymorphisms can be seen in Figure 4.3 C.   miRNAs 
were then designed using BLOCK-ITTM RNAi designer (Invitrogen) to avoid 
overlapping with potential polymorphic positions and cloned into the RNAi 
silencing vectors using methods described in section 2.5 and 3.2.1.  The 
positioning of the six miRNAs designed against PINK1 is shown in grey 
(Figure 4.3 C). 
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Figure 4.3: Analysis of Polymorphisms in PINK1.  A: Alignment of PINK1 cDNA 
(accession number: NM_001008628) with deposited EST sequences.  Conserved bases are 
highlighted (G=black, C=blue, T=red, A=green), non-conserved bases are non-highlighted. 
B: Example of a sequencing polygraph showing evidence for polymorphisms at positions 
133 (G→A) and 139 (T→C) as indicated by multiple peaks at these positions.  C: PINK1 
cDNA sequence with potential polymorphic bases highlighted in red.  Positions of miRNA 
sequences designed are highlighted in grey. 
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4.3.3 Validating PINK1 miRNAs in HEK 293 Cells 
In order to determine the miRNAs which induce the most efficient knockdown 
of PINK1, a GFP:PINK1 fusion plasmid was created (see section 4.2.3) and 
co-transfected into HEK 293 cells along with either the control or one of the 
six PINK1 miRNAs under the control of the H2A.Zf promoter.  The amount of 
GFP present in the mcherry positive cells was then recorded using flow 
cytometry (see section 2.8.1).  Figure 4.4 shows the level of GFP:PINK1 
knockdown achieved by each of the miRNAs.  PINK1 #1 and PINK1 #3 
miRNA were the most efficient resulting in approximately 90% knockdown of 
the GFP:PINK1 fusion.  The PINK1 #6 was the most inefficient, only inducing 
70% knockdown in HEK 293 cells.   
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Figure 4.4:  Efficiency of PINK1 miRNAs in HEK 293 Cells.  Relative knockdown of 
GFP:PINK1 fusion by six distinct PINK1 miRNAs compared to control.  GFP and RFP 
measured by flow cytometry.  For each sample n=3.  Results were analysed by One-way 
ANOVA followed by the Dunnett test.  *= p < 0.05, **= p < 0.01, ***= p <0.001. 
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4.3.4 PINK1 Knockdown in F1 Transgenic Embryos 
Gal4-VP16-responsive transgenic zebrafish expressing the control and the 
two most efficient PINK1 miRNAs, PINK1 #1 and PINK1 #3 were generated 
using Tol2-mediated transgenesis methods (see section 2.3.1.2).  F1 
transgenic zebrafish which give rise to zebrafish embryos that express the 
transgene ubiquitously and uniformly were identified and out bred to wild 
type AB zebrafish.  Examples of the expression patterns of the resulting 
zebrafish embryos expressing the control and two PINK1 miRNAs are shown 
in Figure 4.5 A.  F2 transgenic and wild type zebrafish were harvested at 3 
and 5 dpf to analyse PINK1 mRNA levels.  Firstly however, to check that the 
PINK1 qPCR assay validated above in section 4.3.1.1 is sensitive enough to 
detect knockdown of PINK1, the assay was used on HEK 293 cells which 
had been transiently transfected with ef1a::PINK1 and either the control or 
PINK1 miRNAs.   In this assay the house-keeper used was human ef1α 
(gradient = -3.298, R2 = 0.985).  In HEK 293 cells, PINK1 #1 and PINK1#3 
miRNAs achieved 85% and 78% knockdown compared with the control 
miRNA respectively, as detected by qPCR (Figure 4.5 B).  The same assay, 
this time normalised to zebrafish ef1a, was used to quantify PINK1 levels in 
wild type AB and control miRNA, PINK1 #1 miRNA and PINK1 #3 miRNA 
expressing transgenic zebrafish.  For each sample 30 zebrafish embryos 
were used and three samples were measured for each group.  Figure 4.5 C 
and D show the qPCR results at 3 and 5 dpf respectively.  There is no 
statistically significant difference in PINK1 transcript levels relative to ef1α 
levels across any of the groups at either time point.  
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Figure 4.5:  Lack of Knockdown of PINK1 in Zebrafish Embryos.  A: Example of the 
expression of the RNAi transgene in transgenic F2 fish expressing either the control or 
PINK1 miRNAs.  B: Validation of the PINK1 qPCR assay in detecting knockdown of 
zebrafish PINK1 in HEK 293 cells. 85% and 78% knockdown of zebrafish PINK1 can be 
seen relative to the control in HEK 293 cells with the PINK1 #1 miRNA and PINK1 #3 
miRNA respectively.  C and D:  knockdown of PINK1 in transgenic F2 zebrafish expressing 
PINK1 miRNAs (pink bars, n=3) compared to control (black bars, n=3) and WT type (grey 
bars, n=3) zebrafish. C: 3dpf.  D: 5 dpf.  Results were analysed using One-way ANOVA 
followed by Dunnett test.  *= p < 0.05, **= p < 0.01, ***= p <0.001. 
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4.3.5 PINK1 Knockdown in Adult Zebrafish Brains 
To test whether there is any PINK1 knockdown in the brains of adult 
zebrafish, brains from size- and aged-matched, 6 months old zebrafish 
(Figure 4.6 A) that were wild type or expressing either a control miRNA or 
Pink1 miRNAs were dissected out.  Following RNA extraction and cDNA 
synthesis, RT- qPCR was performed to quantify PINK1 transcript levels 
relative to the house-keeper, ef1α.  A slight, but not statistically significant 
reduction in PINK1 was seen in zebrafish expressing the control miRNA 
compared to wild type zebrafish.  However, a statistically significant 
reduction of 55% and a highly statistically significant reduction of 57% 
compared to control miRNA levels was seen in zebrafish expressing the 
PINK #1 and PINK1 #3 miRNAs respectively (Figure 4.6 B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter Four: Knocking Down PINK1 
114 
 
 
 
Figure 4.6: PINK1 mRNA Knockdown in Adult Zebrafish Brain. A: Images of age- and 
sized- matched zebrafish used in the analysis of brain PINK1 transcript levels. B: PINK1 
transcript levels in PINK1 #1 miRNA and PINK1 #3 miRNA brain samples compared to 
control miRNA and wild type brain samples, as determined by RT-qPCR.  There is a 55% 
and 57% reductive in relative PINK1 transcript levels in zebrafish expressing PINK1 #1 and 
PINK1 #3 miRNAs respectively compared to the control miRNA.  Results were analysed by 
One-way ANOVA followed by the Dunnett test. *= p < 0.05, **= p < 0.01, ***= p <0.001. 
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To check that this loss of PINK1 mRNA is also detected at the protein level, 
protein extracts from the brains of three control and PINK1 #1 and PINK1 #3 
miRNA zebrafish were analysed by western blot (Figure 4.7 A) and 
quantified relative to the house-keeper β-actin.  Quantification of PINK1 
levels relative to β-actin levels can be seen in Figure 4.7 B.  PINK1 levels in 
zebrafish expressing the PINK1 #1 miRNA are reduced by 28%; however 
this difference is not statistically significant due to the high variation in PINK1 
levels across the PINK1 #1 miRNA expressing zebrafish brains.  Zebrafish 
brains expressing the PINK1 #3 miRNA show a 43% reduction in PINK1 
protein levels which is statistically significant at the 5% significance level and 
similar to the reduction in transcript levels (see Figure 4.6 B). 
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Figure 4.7:  PINK1 Protein Knockdown in Adult Zebrafish Brain. A: Western blot 
analysis of three independent brain extracts expressing control, PINK1 #1 and PINK1 #3 
miRNAs.  Top panel is probed with anti-PINK1 antibody.  Bottom panel is probed with the 
house-keeper anti-β-actin antibody. B: Densitometry analysis of PINK1 protein levels relative 
to the house-keeper β-actin.  PINK1 protein levels in PINK1 #1 miRNA expressing zebrafish 
are 28% lower than in control miRNA expressing zebrafish, though this difference is not 
statistically significant.  PINK1 protein levels in PINK1 #3 miRNA expressing zebrafish are 
43% lower than in control miRNA expressing zebrafish.  Results were analysed by One-way 
ANOVA followed by the Dunnett test.  *= p < 0.05, **= p < 0.01, ***= p <0.001. 
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4.4 Discussion 
Preliminary results of chapter one and research of others (Su et al., 2008; 
Wang et al., 2007) suggested that vector-mediated RNAi could be used as 
an efficient means to knockdown genes in zebrafish.  Loss of function 
mutations in the PINK1 gene are the second most common form of 
autosomal recessive Parkinson‟s disease.   It was hoped that targeting 
zebrafish PINK1 by vector-mediated RNAi might result in the development of 
a zebrafish Parkinson‟s disease model, which could be used to further 
characterise PINK1 induced Parkinsonism and in high-throughput screening 
for potential therapeutic agents. 
4.4.1 Identification and Characterisation of PINK1 
The zebrafish PINK1 gene has been identified and is currently assigned to 
chromosome 23.  It encodes a 574 amino acid protein with a highly 
conserved protein kinase domain with close to 100% conservation at the 
active site.  The identity and location of PINK1 has in the meantime also 
been confirmed by Anichtchik et al.,(2008) and Xi et al.,(2010).  PINK1 
mRNA is expressed at low and increasing levels throughout development up 
to three weeks, but is expressed more strongly in adult (6 month) tissues, 
with particularly high expression in the brain and muscle (Figure 4.2).  
Consistent with this Anichtchik et al.,(2008) showed increased PINK1 mRNA 
signal intensity in the central nervous system and muscle of larval zebrafish 
by in situ hybridisation. 
4.4.2 Designing and Validation of miRNAs Targeting PINK1 
In order to design effective miRNAs against target genes, it is important that 
the target region is not polymorphic.  Polymorphisms within the PINK1 gene 
were identified by analysis of deposited EST sequences and direct 
sequencing of our wild type AB zebrafish cDNA.  Where potential 
polymorphic sequences were identified these regions were avoided when 
designing miRNAs (Figure 4.3).  Six potential miRNAs were identified, 
produced and cloned into the RNAi vector under the control of the H2A.Zf 
promoter, and validated by their ability to knockdown a zebrafish PINK1: 
GFP fusion in HEK 293 cells as determined by fluorescent flow cytometry 
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(Figure 4.4).  This technique is similar to that used by Zhou et al., (2007), to 
identify miRNAs which were later effectively used in a vector-mediated RNAi 
approach to knockdown mouse PINK1 by more than 95% in mouse brain.  
All the miRNAs effectively knocked down the PINK1:GFP fusion, the best 
being miRNAs 1 and 3 which both achieved approximately 90% knockdown.  
These two miRNAs were then used in the generation of H2A.Zf driven Gal4-
VP16-responsive RNAi transgenic lines.  Although this method is a 
convenient and effective means of determining the ability of miRNAs to 
target the PINK1 transcript, validating miRNAs in HEK 293 cells may fail to 
take into account some of the potential off-target effects in zebrafish.   In 
future, validation in zebrafish cell lines may be a more reliable method of 
validation. The use of a PINK1:GFP fusion may also alter the efficacy of 
miRNAs by potentially altering the folding of the mRNA and hence the 
accessibility to miRNAs.  To reduce these affects, in contrast to Zhou et al., 
(2007) who used a mouse PINK1 partial sequence,  we used full-length 
PINK1 in our fusion constructs.   It should also be noted that while this 
system worked well for the validation of PINK1 miRNAs, other GFP fusions 
created failed to express efficiently in HEK 293 cells (data not shown), so the 
use of this technique may be limited in a target dependent manner. 
4.4.3 Lack of PINK1 Knockdown in Transgenic Zebrafish Larvae 
Transgenic F1 zebrafish displaying ubiquitous and robust expression of the 
H2A.Zf driven Gal4-VP16-responsive RNAi transgene with either control or 
PINK1 miRNAs were identified and their off-spring analysed by RT-qPCR for 
PINK1 expression relative to the house keeper ef1α.  Despite this PINK1 
qPCR assay being shown in HEK 293 cells to efficiently detect the 
knockdown of PINK1 by PINK1 #1 and #3 miRNAs compared to the control 
(Figure 4.5 B), no knockdown of PINK1 was detected in transgenic zebrafish 
expressing either PINK1 miRNA compared to the control at 3 or 5 dpf (Figure 
4.5 C and D).  This is consistent with the lack of knockdown of GFP detected 
in transgenic zebrafish in chapter one. 
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4.4.4 PINK1 Knockdown in Adult Brain 
In order to see whether any knockdown was being achieved in adults, the 
brains of transgenic zebrafish expressing either PINK1 miRNA or the control 
miRNA were analysed for PINK1 message.  The brain was chosen as the 
tissue of choice due to the consistent high level and uniform expression seen 
in transgenic zebrafish throughout development and also due to its relevance 
in the generation of a Parkinson‟s disease model.  Brains taken from 6 month 
old adult zebrafish expressing the PINK1 miRNAs did show similar and 
efficient knockdown of about 50% of PINK1 compared to controls, as 
determined by qPCR.  Interestingly, control miRNA expressing zebrafish 
brains also had slightly reduced levels of PINK1 compared to wild type AB 
zebrafish brains, though this was not significantly different.  This may 
suggest that the Gal4-VP16 RNAi vector may have a slight “squelching” 
affect on the transcription of other genes.   
In order to check that the reduction in PINK1 mRNA had a 
corresponding reduction on PINK1 protein levels, western blot analysis was 
performed on brain protein extracts.  Brains expressing the PINK1 #3 miRNA 
had a 50% reduction in level of PINK1 protein levels, however the extracts 
from PINK1 #1 miRNA brains had no significant decrease in PINK1 protein 
despite having reduced levels of PINK1 mRNA. There was however, a large 
amount of variation in the protein levels detected in PINK1 #1 miRNA brains, 
and so this discrepancy may simply be an anomaly brought about by the 
small sample number of brains analysed by western blot.  Further individual 
brain extracts or a pool of brain extracts would need to be analysed to 
address this.   
The fact that knockdown of PINK1 mRNA was detected in zebrafish 
brains expressing two independent miRNAs is quite compelling evidence of 
RNAi-mediated knockdown.  However, in order to prove categorically that the 
knockdown detected is due to vector-mediated RNAi, further controls should 
be considered.  In larvae, the ideal experiment to validate knockdown would 
have been to knockdown part of the RNAi machinery by means of 
morpholino, in order to demonstrate that knockdown is dependent on the 
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production of mature miRNAs.  Effective Dicer morpholinos have already 
been described (Wienholds et al., 2003) and could have been used in this 
type of analysis.  However, it is currently not possible to knockdown genes in 
adult zebrafish, so this could not be used to control for knockdown seen in 
adult brains.  An alternative control, which could be used on adults, is to 
generate a transgenic line expressing an RNAi resistant form of PINK1.  This 
is a good control for demonstrating that any phenotypes observed are due to 
loss of the target gene, as replenishment with an RNAi resistant version 
should eliminate or alleviate any phenotype.  However, the flaw with this 
technique is that it is not possible to ensure physiological levels of the 
transcript/protein are put back and so other phenotypes may emerge as a 
result of over-expression.    
4.4.5 An Adult Model of Parkinson’s Disease? 
Recent morpholino approaches to knocking down PINK1 have revealed 
conflicting results.  Although Anichtchik (2008) reported severe 
developmental phenotypes and substantial loss of dopaminergic neurons, Xi 
et al., (2010) and Sallinen et al., (2010) report much more modest effects, 
such as disorganised patterning of the neurons in the ventral diencephalon 
and shortened axonal projections.  The lack of a severe larval phenotype 
induced by PINK1 knockdown is also consistent with the unpublished data 
from the Bandmann lab who have generated a pink1-/- stable line by use of 
TILLING (Bandmann and Burton, 2010).  Furthermore, pink1-/- medaka 
(Oryzias latipes) also had no larval phenotypes (Matsui et al., 2009).  Adult 
medaka however, had a slightly shortened life span, developed a late-onset 
reduction in spontaneous swimming and displayed deregulated dopamine 
metabolism by 4 months, although dopaminergic neuron survival was 
unaffected.  These late-onset effects, together with the fact that Parkinson‟s 
disease is a progressive disease affecting humans in adulthood, suggests 
that effects of PINK1 knockdown in adults may be more apparent and 
biologically relevant.  It would therefore be interesting to see whether the 
knockdown of PINK1 achieved here in adult zebrafish brains is sufficient to 
bring about any of the changes associated with PINK1 loss and Parkinson‟s 
disease, such as disrupted mitochondrial function, deregulated dopamine 
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metabolism or perturbed swimming behaviour.  Analysis of the proteome of 
these transgenic zebrafish may also help elucidate other pathways affected 
by loss of PINK1.  However, as PINK1 mutations are responsible for an 
autosomal recessive form of Parkinsonism, it is conceivable that 50% 
knockdown of PINK1 is insufficient to have any pathological affect.  It should 
be pointed out, that this 50% knockdown of PINK1 in adult brains was seen 
in fish heterozygous for the RNAi transgene.  Breeding the fish to 
homozygosity may therefore improve the levels of knockdown detected.   
4.4.6 Conclusions  
The zebrafish PINK1 homolog has been identified, characterised and 
analysed for PINK1 polymorphisms.  Based on this PINK1 miRNAs were 
designed and validated in HEK 293 cells.  Transgenic zebrafish larvae 
expressing the two most potent miRNAs did not have reduced levels of 
PINK1 mRNA compared to control.  However, brains from adult 6 month old 
zebrafish expressing the PINK1 miRNAs did have a 50% reduction in PINK1 
mRNA levels.  Consistent with this, protein levels were also shown to be 
down by about 50% in PINK1 #3 miRNA expressing brains. 
4.4.7 Future Work 
Over the course of this and the previous chapter it has been apparent that 
although vector-mediated RNAi has been demonstrated in a G0 setting by 
this and other research, knockdown does not appear to be heritable as no 
knockdown of GFP or PINK1 were detected in transgenic zebrafish larvae.  
Future work should therefore focus on why this is the case. In particular, it 
would be interesting to look at the level of expression of RNAi components 
and the production of customised mature miRNA in zebrafish larvae and 
adult tissues.  In addition, it would be interesting to see whether over-
expression of components of the RNAi machinery is able to induce 
knockdown. Finally, future research may look at whether altering the type of 
RNAi vector used or the miRNA backbone can improve knockdown.  In 
addition, the effect of concatermerisation of the miRNA so that each miRNA 
transcript gives rise to multiple mature miRNAs or breeding the fish to 
homozygosity so that each fish expresses twice the amount of miRNA could 
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be investigated.  If increasing the amount of primary miRNA transcript 
improves knockdown then it would suggest that the levels of transcript 
miRNA are what is limiting knockdown in zebrafish.  However, if increasing 
levels of primary miRNA transcript has no effect then knockdown must be 
limited by factors downstream of miRNA transcription. 
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5 Analysis and Over-expression of the RNAi Machinery 
5.1 Introduction 
The previous two chapters have demonstrated that stable and heritable 
knockdown by vector-mediated RNAi do not seem to be feasible in zebrafish 
embryos.  However, possible knockdown has been detected in adult brains, 
suggesting that zebrafish are capable of processing the RNAi vector.  Lack 
of knockdown in embryos despite the presence of functional RNAi machinery 
and the importance of endogenous miRNAs during zebrafish development 
(Giraldez et al., 2005; Wienholds et al., 2003), suggests that something must 
be limiting RNAi in embryos.  The limiting factor could be at the 
transcriptional or posttranscriptional level.    
Though seemingly high level expression of the RNAi vector has been 
achieved in zebrafish, especially through combining pol II-responsive 
promoters with a Gal-4-VP16/UAS system it is possible that this still does not 
result in high enough expression of customised miRNA transcripts.  Pol III 
promoters drive much higher levels of transcript than most pol II promoters, 
and therefore it is possible that use of a zebrafish pol III promoter to drive 
shRNA may be more efficient at knockdown.  A vector suitable for pol III-
responsive delivery of shRNA by use of a zebrafish H1 promoter has been 
created by Dr. Paul Walker, the Hurlstone laboratory, and is depicted below 
in Figure 5.1. 
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Figure 5.1: Pol III RNAi vector.  The zebrafish H1 pol III promoter drives expression of  
shRNA.  Termination of the transcript is determined by a run of Ts at the end of the shRNA. 
shRNAs can be easily cloned in using BamHI and NotI sites.  A separate cassette contains 
the ef1α promoter which drives expression of mcherry, allowing for easy identification of 
transfected cells/transgenic zebrafish. 
 
As well as containing a zebrafish H1 promoter which drives expression of a 
shRNA with stem loop based on that of hsa-miR-30a, the vector also 
contains an ef1α::mcherry cassette to enable identification of 
transfected/transgenic cells (for a full vector map see appendices section 
8.1.6).  
Instead, or in addition to transcriptional limitations, it is also possible 
that components involved in the processing of customised pri- and pre-
miRNA or in the functioning of mature miRNAs could be limiting.  In various 
organisms, over-expression of components of the RNAi machinery has 
improved levels of knockdown.  For example, over-expression of Dicer2 
enhances RNAi in Drosophila (Dietzl et al., 2007).  While over-expression of 
Ago2 and Xpo5 have been shown to significantly improve RNAi in 
mammalian cells (Diederichs et al., 2008; Yi et al., 2005).  Ago2 has also 
been shown to enhance specificity of RNAi for targets with complete 
complementarity, thereby reducing off-target effects (Diederichs et al., 2008).    
Another potential limit to RNAi in zebrafish may be the backbone of 
the miRNA being used.  At present the backbone miRNA is that of human 
miR-30a with the miRNA placed in the 3‟ arm, which was shown by Zeng et 
al., (2005a; 2002) to produce efficient knockdown in human cells.  Whether 
or not it is efficient in zebrafish cells however is unknown, and so it is 
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possible that changing the backbone of the miRNA may improve knockdown 
in zebrafish.  In particular, it would be interesting to know what effect 
changing the strand orientation of the guide strand or using a zebrafish 
miRNA backbone has on the efficiency of RNAi. 
5.1.1 Aims 
The aims of this chapter are therefore to: 
 check for the expression of the major components of the RNAi 
machinery, Ago2, Dicer, Drosha and Xpo5 and see how they change 
throughout development and across tissues. 
 see whether mature miRNA, indicative of correct processing of pri- 
and pre- miRNA can be detected and how levels of mature miRNA 
change throughout development and across tissues. 
 determine whether pol II- or pol III-responsive vectors are capable of 
delivering RNAi in zebrafish tissue culture. 
 see whether over-expression of Ago2, Dicer, Drosha or Xpo5 can 
induce RNAi in zebrafish cells 
 see whether changes to the miRNA backbone enhances RNAi in 
zebrafish cells. 
 test the effect of any beneficial factors to RNAi detected in zebrafish 
cells in vivo. 
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5.2 Materials and Methods 
For general material and methods see chapter 2. 
5.2.1 Ago2, Dicer1 and Xpo5 RT-qPCR/ Drosha PCR 
Primers used for the detection of zebrafish Ago2, Dicer, Xpo5 and Drosha 
mRNA transcripts are given in Table 5.1 below, as are the primers for house-
keepers ef1α, β-actin and rpl13α.  For sybr-green based qPCR and normal 
PCR methods see sections 2.9 and 2.4.1 respectively. 
Gene 
 
Accession Number  Primer sequence (5‟- 3‟) 
Ago2 XM_694134 Forward  
Reverse 
CTCTCTGGACGGCTACCAAAC 
CTCCACCAAGAGGGTTAGAGC 
*β-actin NM_131031.1 Forward  
Reverse 
CGAGCTGTCTTCCCATCCA 
TCACCAACGTAGCTGTCTTTCTG 
Dicer XM_678382 Forward  
Reverse 
GGACAAAAGCAGCACAGACA 
TAGATGGCTCGACCTCTGCT 
Drosha (722 
bp fragment) 
NM_001110472.1 Forward  
Reverse 
GGAGACCCGCAGTATCAAAA 
TGGGCATATAGCATGAAACG 
* ef1α NM_131263.1 Forward  
Reverse 
CTGGAGGCCAGCTCAAACAT 
ATCAAGAAGAGTAGTACCGCTAGCATTAC 
ef1α (448 bp 
fragment) 
NM_131263.1 Forward  
Reverse 
CTGGAGGCCAGCTCAAACAT 
CAGGGTGGTTCAGGATGATG 
Xpo5 XM_001921387.1 Forward  
Reverse 
ACCTTCTGGCACTCATCAGG  
TGAGCCGGGTGATGTTCT 
*rpl13 α NM_212784 Forward  
Reverse 
TCTGGAGGACTGTAAGAGGTATGC 
AGACGCACAATCTTGAGAGCAG 
Table 5.1:  RT-qPCR/PCR Primer Sets used in Gene Transcript Analysis.  Primers used 
for qPCR and PCR analysis are listed in a 5‟ to 3‟ manner.  Reference genes used are 
highlighted in grey.  Accession numbers of genes analysed are also given. * indicates 
primers published by Tang et al.,(2007) 
5.2.2 Detecting Production of Mature miRNAs 
5.2.2.1 Overview of Technique 
In order to detect production of mature miRNA, a qPCR based assay which 
detects mature miRNA with sequence corresponding to the Arabidopsis 
miRNA ath-miR-162a was used.  Ath-miR-162a was chosen due to the 
availability of an assay and lack of similar zebrafish endogenous miRNAs.  
Transgenic zebrafish expressing ath-miR-162a under the control of the 
H2A.Zf Gal4-VP16/UAS promoter were generated and the resulting off-
spring were analysed for the expression of mature miRNA relative to the 
levels of mcherry expression.  Primers used to generate the ath-miR-162a 
miRNA were as follows:  
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Fwd:GCGGGGTACCGCGGGGATCCTGCTGTTGACAGTGAGCGACTGGATGCAGA
GGTTTATCGATAGTGAAGCCACAGATG, 
Rev:CCGCGAATTCCCGCAGATCTCCTTGAAGTCCGAGGCAGTAGGCAGCTGGA
TGCAGAGGTTTATCGATACATCTGTGGCTTCAC. 
To quantify mature miRNA production, mature ath-miR-162a miRNA was 
reverse transcribed from total RNA using a stem loop RT primer whose stem 
binds to the first 8 bases of the Dicer cut end of the mature miRNA.  During 
reverse transcription the mature miRNA serves as a template for the addition 
of bases to the end of the stem loop primer.  The resulting template is then 
used in a TaqMan based qPCR assay.  During PCR the reverse transcribed 
product unfolds and a forward primer binds to the mature miRNA, a reverse 
primer binds to the stem loop primer and an appropriate TaqMan probe binds 
in between the two.  Polymerase catalyses the addition of new 
complementary dNTPS to the 3‟ ends of the primers and as it moves along 
the template DNA the fluorescent dye, FAM is released from the TaqMan 
probe.  Once released from the proximity of the quencher, FAM emits a 
fluorescent signal which can be detected by a qPCR machine (Figure 5.2). 
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Figure 5.2: Schematic Representation of the Mature miRNA Assay from Applied 
Biosystems.  During reverse transcription the stem loop primer binds to the last 8 bases of 
the Dicer cut end of the mature miRNA.  The mature miRNA then serves as a template for 
the addition of dNTPs to the stem loop primer.  During RT-qPCR a forward primer binds to 
the mature miRNA (red), a reverse primer binds to the stem loop primer (blue) and an 
appropriate TaqMan probe (black) binds in between the two.  Polymerase catalyses the 
addition of new complementary dNTPS to the 3‟ ends of the primers and as it moves along 
the template DNA releases the fluorescent dye, FAM from the TaqMan probe.  Once 
released from the proximity of the quencher, FAM emits a fluorescent signal which can be 
detected by a qPCR machine. 
 
  
F Q 
Mature miRNA 
Stem loop RT primer 
Reverse transcription 
Real-time qPCR 
Taq-man probe 
Forward primer 
Reverse primer 
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5.2.2.2 RNA Extraction for miRNA Detection  
5.2.2.2.1 From Adult Tissues and Pools of Embryos/Larvae 
RNA was extracted from transgenic zebrafish expressing the ath-miR-162a 
miRNA using Trizol ® (Invitrogen) reagent and following manufacturers‟ 
guidelines.  Adult tissue RNA was extracted from 6 (3 male and 3 female) 6 
month old zebrafish.  Embryo/larval RNA was extracted from a pool of 30 
transgenic zebrafish using the same methods.  Samples were diluted to 100 
ng/μl, aliquoted into 1 μg samples and stored at -80ºC 
5.2.2.2.2 From Individual Embryos/Larvae 
For the analysis of ath-miR-162a mature miRNA production in single 
embryos/larvae, a Cells-to-CT kit (Applied Biosystems) was used.  
Embryos/larvae were lysed in 50 μl lysis buffer containing 0.5 μl DNase and 
incubated at rt for 8 mins with regular agitation.  After the incubation period 5 
µl of stop solution was added and the sample incubated at rt for a further 2 
mins.  Samples were then stored at -80oC. 
5.2.2.3 Reverse Transcription of Mature miRNA 
Mature ath-miR-162a miRNAs were reversed transcribed in a reaction 
consisting of 1 x RT buffer (Applied Biosystems), 1 mM dNTP mix, 0.2 u 
RNase Inhibitor, 1 μl  Multiscribe reverse transcriptase (Applied Biosystems) 
and either 1 μg RNA or 5 μl  Cells-to-CT RNA (see section 5.2.2.2.2) and 
made up to 15 μl in DEPC H2O.  The reaction was then incubated at 16ºC for 
30 mins (annealing), 42ºC for 30 min (extending) and 85ºC for 5 min 
(inactivation of enzyme). mcherry mRNA, used as the normaliser was 
reverse transcribed as described in section 2.9.2.  
5.2.2.4 Real-time TaqMan qPCR 
5.2.2.4.1 For Detection of mature miRNA 
Real-time TaqMan qPCR reactions for miRNA detection consisted of 1 x 
TaqMan Master Mix (Applied Biosystems), 1 μl Ath-mir 162a TaqMan 
MicroRNA assay (Applied Biosystems), 1 μl RT reaction and made up to 20 
μl with DEPC H2O.  A Peltier Thermal Cycler (PTC-200) connected to a 
Chromo4 Continuous Fluorescence Detector (MJ Research) was used with 
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the following cycling conditions: 95ºC for 10 mins and then 40 cycles of 95ºC 
for 15 secs and 60ºC for 1 min.  After each cycle the fluorescent signal from 
the fluorescent dye FAM was recorded. 
5.2.2.4.2 For Detection of mCherry 
Real-time TaqMan qPCR reactions consisted of 1 x TaqMan Master Mix 
(Applied Biosystems), 0.2 μM forward (5‟-AGGGCGAGATCAAGCAGAG-3‟) 
and reverse primers (5‟-TTGACCTCAGCGTCGTAGTG-3‟), 0.5 μl TaqMan 
assay #161 (Roche Applied Science), 2 μl cDNA  and made up to 20 μl with 
DEPC H2O.  The same qPCR machine as above was used with the following 
cycling conditions: 95ºC for 10 mins and then 40 cycles of 95ºC for 15 secs 
and 60ºC for 1 min.  After each cycle the fluorescent signal from the 
fluorescent dye FAM was recorded. 
The amount of mature miRNA relative to the amount of mcherry production 
was then calculated using the ∆∆CT method described in section 2.9.5. 
5.2.3 Dicer Morpholino Injection in Transgenic Zebrafish 
Single-cell transgenic embryos expressing the ath-miR-162a miRNA under 
the control of a H2A Gal4-VP16/UAS promoter were injected with 5 ng Dicer 
morpholino (5‟-CTGTAGGCCAGCCATGCTTAGAGAC-3‟) (Wienholds et al., 
2003) or standard control (5-CCTCTTACCTCAGTTACAATTTATA-3‟) 
morpholino as described in section 2.3 and animals were assessed for 
mature miRNA production as described above in section 5.2.2 
5.2.4 Cloning shRNA into the Pol III-responsive RNAi vector 
A list of the primers used to make sequence encoding GFP and control 
shRNAs are listed in Table 5.2 below.  shRNAs sequences were generated 
by annealing 200 ng of each primer pair in 98 μl annealing buffer (10 mM tris 
pH 8.0, 50 mM NaCl, 1 mM EDTA) and heating to 100°C for 5 mins and then 
allowing to cool to rt.  Annealed primers have asymmetric ends 
complementary to those generated through BamHI, NotI digestion of the pol 
III-responsive vector.  Once annealed, primers were diluted 10-fold and 
ligated into the BamHI, NotI digested pol III-responsive vector using 
methods described in section 2.4. 
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shRNA Primer Sequence (5‟ to 3‟) 
Control Fwd 
 
Rev 
GATCCAGTCTGTGCGCAGAAATATATGTGAAGCCACAGATGAGTCTGTG
CGCAGAAATATATTTTTT 
GGCCAAAAAAGTCTGTGCGCAGAAATATATGTGAAGCCACAGATGAGTC
TGTGCGCAGAAATATATG 
GFP Fwd 
 
Rev 
GATCCGCACAAGCTGGAGTACAACTAGTGAAGCCACAGATGTAGTTGTA 
CTCCAGCTTGTGCTTTTT 
GGCCAAAAAGCACAAGCTGGAGTACAACTACATCTGTGGCTTCACTAGT
TGTACTCCAGCTTGTGCG 
Table 5.2: Primer used to make control and GFP shRNAs.  Sequences used to generate 
passenger and guide strands are highlighted in grey and red respectively. 
 
5.2.5 Cloning Ago2, Dicer1, Xpo5 and Drosha into Expression 
Cassettes 
Ago2 and Xpo5 cDNA were amplified from pIRESneo-FLAG/HA Ago2 
corrected (Addgene: 10822) and pQE60-Exp5 (Addgene: 12553) 
respectively, using methods described in section 2.4.1and primers listed in  
Table 5.3.   Zebrafish Drosha cDNA was amplified from 3 dpf zebrafish 
cDNA using the same methods.   
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cDNA  Primer sequence (5‟ to 3‟) Restriction 
site 
Ago2 
(human) 
Fwd 
Rev 
AGGAGGATCCACCATGTACTCGGGAGCCGGCCCC 
ATGAGCGGCCGCTCAAGCAAAGTACATGGTGCGCAGAGTGT
CTTGG 
BamHI 
NotI 
Drosha 
(zebrafish) 
Fwd 
Rev 
AGGACCGCGGACCATGTCTTTCCATGCTGGCCGTGGATG 
AGGAGCGGCCGCCTATCCTTCATCACTATCTCTCTC 
SacII 
NotI 
Xpo5 
(human) 
Fwd 
Rev 
AGGACCGCGGACCATGGCGATGGATCAAGTAAAC 
AGTAGCGGCCGCTCAGGGTTCAAAGATGGTGGC 
SacII 
NotI 
 
Table 5.3: Primers used in the amplification of human Ago2 and Xpo5 and zebrafish 
drosha cDNA.  Restriction enzymes incorporated into the primer sequence for ease of 
subsequent cloning are indicated in yellow.  An adaptor sequence of ACC was used in the 
forward primers to introduce a KOZAK sequence (highlighted in blue). 
 
PCR products were cloned into pGEM-T before sub-cloning into the 
pcGlobin 2 vector (Figure 5.3) using restriction sites incorporated into the 
amplified product by the primers.  Dicer cDNA, a kind gift of Dr. Patrick 
Provost, Quebec, Canada, was sub-cloned from pCMV6 –XL4 Dicer 
(accession number: AJ132261) by cutting out Dicer with KpnI/NotI restriction 
digest and inserting into the pcGlobin2 vector linearised with KpnI/NotI.  
 
Figure 5.3: pcGlobin Vector.  The pcGlobin vector has been modified from pcDNA3 to 
contain zebrafish 5‟ and 3‟ β-globin UTRs. Cloned cDNAs are transcribed in vitro/in vivo 
under the control of CMV promoter or in vitro through the use of a T7 primer. Diagram 
modified from Ro et al., (2004). 
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Human Dicer, Ago2 and Xpo5 were used due to very high sequence 
similarity between the human and zebrafish proteins, particularly in the 
functional domains.   For a full alignment and comparison of sequences see 
appendices section 8.3. 
5.2.5.1 Detection of Over-expression of Ago2, Dicer, Xpo5 and Drosha 
Over-expression of Ago2, Dicer and Xpo5 were detected by western blot 
using methods described in section 2.10.  The rat monoclonal anti-Ago2 
(11A9) antibody was a kind gift of Dr. Gunter Meister, the Max Planck 
Institute of Biochemistry, Munich, Germany (Rudel et al., 2008).  It was used 
at a 1:50 dilution, followed by an anti rat IgG HRP-conjugate used at 1:10 
000. Rabbit polyclonal anti-Dicer (ab13502) and anti-Xpo5 (Abcam: 
ab31351) were used at 1 μg/ml followed by an anti rabbit IgG HRP-conjugate 
used at 1:10 000.  For detection of full-length zebrafish Drosha mRNA 
forward (5‟-ATGTCTTTCCATGCTGGCCGTGGATG-3‟), and reverse, (5‟- 
CTATCCTTCATCACTATCTCTCTC-3‟) primers were used along with 
general PCR methods described in section 2.4.1. 
5.2.5.2 Mutating the RNase H Domain of Ago2 
The RNAse H domain of Ago2 in pGEM T  was destroyed by mutating the 
amino acid residue 597 from a aspartic acid residue to an alanine residue 
using a Quikchange® site directed mutagenesis kit (Stratagene), the forward 
primer (5‟-CTTTCTGGGAGCCGCGGTCACTCACC-3‟) reverse primer (5‟- 
GGTGAGTGACCGCGGCTCCCAGAAAG-3‟) and following manufacturers‟ 
instructions.  As well as mutating the aspartic acid (D) residue at position 597 
to an alanine (A) the primers also introduce a SacII site for the easy 
identification of positive clones.  The mutated Ago2 was then subcloned into 
pcGlobin using BamHI and NotI restriction digest of Ago2 D597A pGEM T 
and pcGlobin using methods described in section 2.4. 
5.2.6 Cloning miRNAs with Different Stem Loops 
To test whether altering the stem loop or strand orientation of the miRNA 
alters the efficiency of knockdown, additional miRNAs were made based on 
the human hsa-miR-30a and the zebrafish dre-miR-30a backbone using 
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methods described in sections 2.5 and 3.2.1.  Primers used to clone the new 
miRNAs are listed in  
Table 5.4. 
miRNA 
Backbone 
Target Primer Sequence (5‟ to 3‟) 
hsa-mir-30a 
(miRNA in 5‟ 
arm) 
Control Fwd GCGGGGTACCTGCTGTTGACAGTGAGCGACTCGATAAACCTCTG
CATCCAGCTGTGAAGCCACAGATG 
Rev CCGCGAATTCCCTTGAAGTCCGAGGCAGTAGGCAGTCGATAAAC
CTCTGCATCCAGCCCATCTGTGGCTTCAC 
GFP Fwd GCGGGGTACCTGCTGTTGACAGTGAGCGACTAGTTGTACTCCAG
CTTGTGCCUGTGAAGCCACAGATG 
Rev CCGCGAATTCCCTTGAAGTCCGAGGCAGTAGGCAGTAGTTGTAC
TCCAGCTTGTGCCCCATCTGTGGCTTCAC 
dre-mir-30a 
(miRNA in 5‟ 
arm) 
Control Fwd GCGGGGTACCTGCTGTTGACAGTGAGGCTCCTTGCAGTTCGATA
AACCTCTGCATCCAGTTGTAATGCAGAAAATCTCAG 
Rev CCGCGAATTCCCTTGAAGTCCGAGGCAGTAGGGCCACCAG
TAGCACGATAAACCTCTGCATCCAGCTGAGATTTTCTGCA
TTACAA  
GFP Fwd GCGGGGTACCTGCTGTTGACAGTGAGGCTCCTTGCAGTTAGTTG
TACTCCAGCTTGTGCTTGTAATGCAGAAAATCTCAG 
Rev CCGCGAATTCCCTTGAAGTCCGAGGCAGTAGGGCCACCAGTAGC
AAGTTGTACTCCAGCTTGTGCCTGAGATTTTCTGCATTACAA 
 
Table 5.4: Primers used to make miRNAs with Different Stem Loops.   The sense 
sequence of the target is shown in grey on the forward primer.  The anti-sense sequence of 
the target (equivalent to the mature miRNA sequence) is shown in red on the reverse primer.  
KpnI and EcoRI sites are indicated in turquoise and yellow respectively. 
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5.3 Results 
5.3.1 Ago2, Dicer, Xpo5 and Drosha Transcript Levels in Zebrafish  
To assess whether zebrafish have the necessary machinery to process 
vector embedded miRNAs levels of Ago2, Dicer, Xpo5 and Drosha were 
detected and quantified across zebrafish time-courses, tissue banks and cell 
types (Figure 5.4).  For Ago2, Dicer1 and Xpo5 levels of transcript were 
assessed via RT-qPCR and normalised against the average of three house-
keepers, ef1α, β-actin and rpl13α and three tissue banks and time courses 
were used.  Before selecting primers for use in RT-qPCR they were validated 
for efficiency as described in sections 2.9.4 and 4.3.1.1.  Table 5.5 shows the 
relevant gradient and correlation coefficient (R2) values for the primers used.  
A slope with a gradient of -3.32 indicates that the primers are 100% efficient.   
-3.1 is equivalent to 90% efficiency and -3.58 110% efficiency.  Only primers 
which fell between these ranges and gave rise to a correlation coefficient 
(R2) of at least 0.97 were accepted for use in cDNA quantification. 
Zebrafish Gene Gradient R
2
 value 
Ago2 -3.319 0.986 
β-actin -3.331 0.981 
Dicer -3.322 0.989 
ef1α -3.321 0.993 
rpl13α -3.317 0.993 
Xpo5 -3.464 0.971 
 
Table 5.5: Gradient and R
2
 values of validated primers used in the detection of 
zebrafish Ago2, Dicer and Xpo5 mRNA.  House-keepers used were β-actin, eflα and 
rpl13α mRNAs.  A slope with a gradient of -3.32 indicates that the primers are 100% 
efficient.   -3.1 is equivalent to 90% efficiency and -3.58 110% efficiency.  Only primers 
which fell between these ranges and gave rise to a correlation coefficient (R
2
) of at least 
0.97 were accepted for use in cDNA quantification. 
 
Transcript levels of Ago2, Dicer and Xpo5 all start off extremely 
significantly higher in single-cell and 4 hpf embryos relative to the 
housekeepers and in comparison to 1 dpf embryos.  After 1 dpf Ago2, Dicer 
and Xpo5 transcript levels remain significantly unchanged across the rest of 
the time course (Figure 5.4 A, B and C).   
Across the tissue banks and zebrafish cells Ago2 levels in brain were 
increased extremely significantly by 6 fold on 1 dpf levels.  Levels in skin, 
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testes, PAC.2 cells and ZFL cells were significantly increased by 5-6-fold on 
1 dpf levels.  Ago2 levels in fin, heart, intestine, kidney, liver, muscle and 
AB.9 cells remained unchanged (Figure 5.4 A).   
Dicer levels are slightly, but not significantly increased in brain, skin, 
testes, PAC.2 and ZFL cells.  In the case of brain, transcript levels were very 
nearly significantly different (p < 0.051).  Across all other tissues Dicer 
transcript levels remained unchanged (Figure 5.4 B).   
Xpo5 transcript levels showed the greatest fluctuations in mRNA 
relative to housekeepers.  In PAC.2 cells transcript levels were extremely 
significantly increased by 25-fold compared to 1 dpf levels.  In ZFL and skin 
there was a 13-fold increase.  There were no other significant differences in 
Xpo5 transcript levels across the remaining tissues, although slight increases 
were observed in brain and intestines (Figure 5.4 C).    
Drosha transcripts were detected by normal gel based PCR methods 
as an appropriate qPCR assay could not be identified.  Drosha could be 
detected across all time points and in all tissues and cell types.  Drosha 
levels were fairly consistent, across the time course but seemed up-
regulated in all three cell types and especially in PAC.2 cells.  Across the 
tissue bank, brain and kidney have slightly higher levels of Drosha, whereas 
in intestine and liver Drosha mRNA levels were slightly reduced.  The 
housekeeper used was ef1α which seemed consistent across the tissue 
bank, cell types and across the time course apart from at the single-cell 
embryo stage where levels of the housekeeper where considerably lower.  
Therefore, Drosha levels relative to the housekeeper at this stage are 
considerably higher (Figure 5.4 D).   
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Figure 5.4: Detection and Quantification of Zebrafish Ago2, Dicer, Xpo5 and Drosha 
mRNA levels throughout Development and across Tissues.  A-C: Relative fold changes 
in mRNA levels of Ago2 (A), Dicer1 (B) and Xpo5 (C) compared to 1 dpf levels.  Transcript 
levels were determined by real-time qPCR and normalised against the average of three 
housekeepers (ef1α, rpl13α and β-actin). Quantification is based on three individual time 
courses and tissue banks.  Results were analysed by One-way ANOVA followed by the 
Dunnett test using 1 dpf values as the control. *= p < 0.05, **= p < 0.01, ***= p <0.001.  D: 
Detection of a 722 bp fragment of Drosha mRNA across a time course (i) and a tissue bank 
(iii).  Transcript levels of the housekeeper ef1alpha (448 bp fragment) across the time course 
and tissue bank are shown in ii and iv respectively.  A minus RT reaction was used as a 
negative control to check successful digestion of genomic DNA. 
 
Chapter Five: Analysis and Over-expression of the RNAi Machinery 
139 
 
5.3.2 Detection and Quantification of mature miRNA 
To investigate whether the efficiency of mature miRNA synthesis varied in a 
time- or tissue-specific fashion, and whether this correlated with expression 
of components of the RNAi machinery, a transgenic line expressing an 
miRNA with sequence corresponding to the Arabidopsis ath-miR-162a was 
established and assessed for mature miRNA production relative to the 
amount of mcherry (a measure of RNAi vector expression).  Gradient and R2 
values for validated TaqMan qPCR assays are shown in  
Table 5.6.   
Transcript Gradient R
2
 value 
ath-miR-162a -3.148 0.998 
mcherry -3.224 0.982 
 
Table 5.6: Gradient and R
2
 values of validated TaqMan assays used in the detection of 
mature ath-miR-162a and mcherry mRNA.  A slope with a gradient of -3.32 indicates that 
the primers are 100% efficient.   -3.1 is equivalent to 90% efficiency and -3.58 110% 
efficiency.  Only primers which fell between these ranges and gave rise to a correlation 
coefficient (R
2
) of at least 0.97 were accepted for use in cDNA quantification. 
 
The amount of mature miRNA relative to the amount of mcherry 
mRNA produced was measured in individual embryos at 1,2,3 and 5 dpf and 
is shown in Figure 5.5 A  as a relative fold change above 1 dpf levels.  The 
amount of miRNA per mcherry mRNA increases (though non-significantly) by 
approx. 23-fold between 1 and 2 dpf at which point it remains stable to 3 dpf 
before increasing extremely significantly by 5 dpf to approx. 180 times 1 dpf 
levels.  Though the general trend is towards increased miRNA production, 
there is a large amount of variation among individual embryos in the amount 
of mature miRNA produced. 
Figure 5.5 B compares mature miRNA relative to mcherry production 
between that detected in a pool of 30 5 dpf embryos to a pool of 6 month old 
adult tissues.  Relative miRNA production is extremely significantly increased 
in brain and muscle and highly significantly increased in fin.  Gill and skin 
also show slight increases, though these are not significant.  As a negative 
control this assay was also performed on zebrafish embryos/larvae and adult 
tissues expressing the control miRNA.  In these samples no ath-miR-162a 
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mature miRNA was detected.  Unfortunately, the amount of mature miRNA 
produced in AB.9, PAC.2 and ZFL cells could not be assessed due to the 
extremely poor transfection efficiencies of these cells.  
5.3.2.1 Mature miRNA Production is Dicer Dependent 
To validate that the ath-miR-162a TaqMan assay was specific for mature 
miRNA and does not detect primary or precursor forms of the miRNA, 
transgenic fish expressing the ath-miR-162a miRNA were injected with a 
standard control or Dicer morpholino and individual zebrafish were assessed 
at 2 dpf for mature miRNA production.  Figure 5.5 C shows that injection with 
Dicer morpholino leads to a statistically significant 67% reduction in mature 
miRNA relative to mcherry mRNA. 
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Figure 5.5: Detection and Quantification of Mature miRNA Production.  Mature miRNA 
production in individual embryos at 1,2,3 and 5 dpf normalised to mcherry mRNA levels and 
relative to 1 dpf levels.  One-way Anova followed by Dunnett test was carried out using 1 dpf 
values as the control (n=3).  B: Mature miRNA production across tissues normalised to 
mcherry mRNA levels and relative to 5 dpf levels. One-way Anova followed by Dunnett test 
was carried out using 5 dpf values as the control (n=3).   C: Mature miRNA production 
normalised to mcherry mRNA levels in individual 2 dpf embryos injected with a standard 
control or Dicer morpholino.   Independent samples T test was carried out (n=5).  *= p < 
0.05, **= p < 0.01, ***= p <0.001. 
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5.3.3 RNAi Mediated Knockdown in Zebrafish Cells 
In order to test whether zebrafish cells were capable of vector-mediated 
RNAi, and whether pol III-responsive vectors were more efficient that pol II-
responsive vectors, both pol II- and pol III-responsive non-gal4-VP16/UAS 
vectors were tested for their ability to knockdown GFP/YFP in AB.9, stable 
PAC.2 YFP (a kind gift from Ewa Snaar-Jagalska, University of Leiden, 
Netherlands)   and stable ZFL GFP cells.   
5.3.3.1 Pol II-responsive Vector-mediated Gene Knockdown 
Pol II-responsive, non-gal4 RNAi vectors under the control of the H2A.Zf 
promoter containing either the control or GFP miRNAs were transiently 
transfected into human HEK 293 cells (co-transfected with ef1α GFP in a 3:1 
molar ratio of RNAi vector:GFP), zebrafish AB.9 cells (co-transfected with 
ef1α GFP in a 3:1 ratio of RNAi vector:GFP), stable PAC.2 YFP cells and 
stable ZFL GFP cells.  After transfection cells were grown for three days and 
then analysed via flow cytometry for GFP/YFP content.  As before, Figure 
5.6 A shows the extremely significant level of GFP knockdown achieved in 
HEK 293 cells with GFP#1 (95% knockdown) and GFP#2 (72% knockdown) 
miRNAs.  In AB.9 cells and ZFL GFP cells no knockdown with either miRNA 
was detected (Figure 5.6 B and D).  In PAC.2 YFP cells a slight but non-
significant level of YFP knockdown was detected with both miRNAs (Figure 
5.6 C). 
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Figure 5.6: Pol II-mediated GFP/YFP Knockdown in Human (HEK 293) and Zebrafish  
(PAC.2 YFP and ZFL GFP) Cell Lines.  Relative GFP/YFP levels after transfection with 
vectors containing a control miRNA (purple bars), GFP#1 miRNA (gold bars) or GFP#2 
miRNA (yellow bars).  A: HEK 293 cells (n=9).  B: PAC.2 YFP cells (n=9).  C: ZFL cells 
(n=9).  GFP/YFP levels measured using fluorescent flow cytometry. Results were analysed 
by One-way ANOVA. *= p < 0.05, **= p < 0.01, ***= p <0.001. 
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5.3.3.2 Pol III-responsive Vector-mediated Gene Knockdown 
Pol III-responsive RNAi vectors containing control or GFP shRNAs were 
transiently transfected into human HEK 293 cells (co-transfected with ef1α 
GFP in a 3:1 molar ratio of RNAi vector:GFP), stable PAC.2 YFP cells and 
stable ZFL GFP cells.   Three days post transfection the cells were analysed 
for GFP/YFP content via flow cytometry.  In HEK 293 cells, cells transfected 
with GFP#1 shRNAs have an extremely significant 97% reduction in GFP 
compared to control shRNA transfected cells.  However, in PAC.2 YFP and 
ZFL GFP cells the same GFP#1 shRNA was unable to produce any 
knockdown of YFP/GFP relative to the control shRNA.  
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Figure 5.7: Pol III-mediated GFP/YFP Knockdown in Human (HEK 293) and Zebrafish  
(PAC.2 YFP and ZFL GFP) Cell Lines.  Relative GFP/YFP levels after transfection with 
vectors containing a control miRNA (purple bars) or GFP#1 miRNA (gold bars).  A: HEK 293 
cells (n=3).  B: PAC.2 YFP cells (n=9).  C: ZFL cells (n=3).  GFP/YFP levels measured using 
fluorescent flow cytometry. Results were analysed by One-way ANOVA. *= p < 0.05, **= p < 
0.01, ***= p <0.001. 
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5.3.4 Improving Knockdown by Over-expressing Components of the 
RNAi Machinery 
In order to test whether knockdown could be achieved by over-expressing 
components of the RNAi machinery, human Ago2, Dicer and Xpo5 and 
zebrafish Drosha were cloned into pcGlobin vector (see section 5.2.5), and 
correct expression of the vectors was confirmed  by over-expression in HEK 
293 cells (Figure 5.8).  Over-expression of Ago2, Dicer and Xpo5 above 
background levels was confirmed by western blot using β-actin as a house-
keeper to control for equal loading (Figure 5.8 A,B and C).  Over-expression 
of pcGlobin Drosha was confirmed by RT-PCR of the full-length (3070 bp) 
Drosha transcript from cDNA synthesised from transfected cells.  Mock-
transfected cells were used as a negative control as primers only recognise 
the zebrafish Drosha and not endogenous human Drosha.  A minus RT 
reaction was also carried out using mRNA from pcGlobin Drosha transfected 
cells to confirm that the amplicon originated from cDNA and not transfected 
plasmid DNA (Figure 5.8 D). 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter Five: Analysis and Over-expression of the RNAi Machinery 
147 
 
 
 
 
Figure 5.8: Confirming Expression of pcGlobin Ago2, pcGlobin Dicer, pcGlobin Xpo5 
and pcGlobin Drosha in HEK 293 cells. A: (top panel) Detection of Ago2 in pcGlobin Ago 
2 transfected cells compared to mock transfected cells by western blot.  B: (top panel) 
Detection of Dicer in pcGlobin Dicer transfected cells compared to mock transfected cells by 
western blot.  C: (to panel) Detection of Xpo5 in pcGlobin Xpo5 transfected cells compared 
to mock transfected cells by western blot.  A-C: (bottom panels) Detection of the house-
keeper β-actin by western blot to check equal loading of proteins. D: (top panel) Detection of 
full-length (3870 bp) Drosha in pcGlobin Drosha transfected cells compared to mock 
transfected cells by RT-PCR.  A minus RT reaction was used as a negative control. D: 
(bottom panel) Detection of an 800 bp fragment of the house keeper ef1α in both mock 
transfected and pcGlobin Drosha transfected cells, but not in the minus RT control by 
reverse transcription PCR. 
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Equal ratios of pcGlobin vectors containing either Ago2, Dicer, Xpo5 
Drosha or no (empty pcGlobin) cDNA and either the pol II-responsive (Figure 
5.9)  or pol III-responsive (Figure 5.10) RNAi vectors containing control and 
GFP miRNAs/shRNAs were co-transfected into PAC.2 YFP cells and ZFL 
GFP cells (pol II-responsive vector only).  HEK 293 cells were co-transfected 
with a 10-fold dilution of the RNAi vector and a 3:1 ratio of RNAi component: 
GFP (a 10-fold dilution of the RNAi vector was necessary due to the high 
efficiency of RNAi in HEK 293 cells).  GFP/YFP levels were then measured 
in mcherry positive cells using fluorescent flow cytometry. 
Using a pol II-responsive RNAi vector (Figure 5.9) in HEK 293 cells a 
10-fold decrease in RNAi vector diminished knockdown efficiency from 
approx. 95% to 50% using the GFP#1 miRNA.  Over-expression of Ago2 
significantly improved this knockdown to 72% (a 1.5-fold improvement).  
None of the other components (Dicer, Xpo5 or Drosha) had any significant 
affect on knockdown efficiency (Figure 5.9 A).  In PAC.2 YFP cells GFP#1 
and GFP#2 miRNAs result in a slight, but non-significant reduction in YFP 
levels.  Over-expression of Ago2 significantly improved this knockdown to 
approx. 43% and 28% with GFP#1 and GFP#2 miRNAs respectively.  As in 
HEK 293 cells, over-expression of Dicer, Xpo5 and Drosha did not improve 
knockdown (Figure 5.9 B).  In ZFL GFP cells GFP#1 and GFP#2 miRNAs 
result in no knockdown of GFP.  Over-expression of Ago2 resulted in a slight 
but significant GFP knockdown of approx. 16% and 10% with GFP#1 and 
GFP#2 miRNAs respectively.  As in HEK 293 cells and PAC.2 YFP cells, 
over-expression of Dicer1, Xpo5 and Drosha had no affect on GFP 
knockdown (Figure 5.9 C). 
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Figure 5.9:  Enhancing Pol II-driven Knockdown of GFP/YFP in Human and Zebrafish 
Cells Through Over-expression of RNAi Components. Relative GFP/YFP levels after co-
transfection with vectors containing a control miRNA (purple bars), GFP#1 miRNA (gold 
bars) or GFP#2 miRNA (yellow bars) plus RNAi components (Ago2, Dicer, Xpo5 or Drosha 
in pcGlobin).  A: HEK 293 cells (n=9, due to extremely high knockdown efficiencies in HEK 
293 cells, RNAi vectors were diluted 10-fold).  B: PAC.2 YFP cells (n=9).  C: ZFL cells (n=9).  
GFP levels measured using fluorescent flow cytometry. Results were analysed by One-way 
ANOVA. *= p < 0.05, **= p < 0.01, ***= p <0.001. 
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Figure 5.10 shows the results of knockdown using the pol III-
responsive vector and over-expressing RNAi components.  In HEK 293 cells 
a 10-fold dilution of the pol III-responsive RNAi vector still leads to a 90% 
knockdown in GFP.  As with the pol II-responsive vector over-expression of 
Ago2 results in an extremely significant improvement in knockdown.  The 
extent of this improvement however, is smaller than with the pol II-
responsive vector as knockdown efficiency even with a 10-fold dilution of the 
pol III-vector was already extremely high.   With Dicer and Xpo5 over-
expression there was also a very slight, but significant improvement in 
knockdown efficiency.  No such improvement was seen with Drosha over-
expression.  In PAC.2 YFP cells over-expression of Ago2 led to a 23% 
reduction in YFP levels in cells expressing the GFP #1 shRNA compared to 
the control.  No knockdown was seen in cells over-expressing Dicer, Xpo5 or 
Drosha. 
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Figure 5.10: Enhancing Pol III-responsive Knockdown of GFP/YFP in cells through 
Over-expression of RNAi components. Relative GFP/YFP levels after co-transfection with 
vectors containing a control miRNA (purple bars) or GFP#1 miRNA (gold bars) plus RNAi 
components (Ago2, Dicer, Xpo5 or Drosha in pcGlobin).  A: HEK 293 cells (n=3, due to 
extremely high knockdown efficiencies in HEK 293 cells, RNAi vectors were diluted 10-fold).  
B: PAC.2 YFP cells (n=9).  GFP/YFP levels measured using fluorescent flow cytometry. 
Results were analysed by One-way ANOVA. *= p < 0.05, **= p < 0.01, ***= p <0.001. 
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5.3.4.1 Ago2 Enhanced Gene Knockdown is Dependent of Functional 
RNase Domain 
In order to ascertain whether the improved knockdown detected with Ago2 
over-expression is mediated through its intrinsic slicer activity, Ago2 cDNA 
was mutated to create an RNase dead version, Ago2 D597A by changing 
bases A and C at position 1790 and 1791 to C and G respectively.  Base 
1788 was also changed from A to C to introduce a SacII restriction site which 
aided in the identification of mutagenised clones (Figure 5.11 A).   After sub-
cloning into the pcGlobin vector the expression of Ago2 D597A was checked 
by transfecting into HEK 293 and western blotting for Ago2.  Figure 5.11 B 
shows the detection of Ago2 and Ago2 D597A in transfected cells.  A very 
faint band was also detectable in mock transfected cells and represents the 
endogenous Ago2 expression.   
 Co-transfection of PAC.2 YFP cells with Ago2 D597A and either the 
pol II - (Figure 5.11 C.i) or pol III - (Figure 5.11 C.ii) responsive RNAi vectors 
containing GFP#1 and GFP#2 miRNAs and GFP#1 shRNA respectively led 
to a loss of the Ago2 induced knockdown of YFP relative to control 
miRNA/shRNA. 
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Figure 5.11:  Ago2 Enhanced Gene Knockdown is due to a Functional RNase Domain.  
A: Schematic showing the mutagenesis of an aspartic acid (D) residue at position 597 to an 
alanine (A) residue by mutating bases AC at position 1790 and 1791 to CG to create an 
endonuclease dead Ago2, Ago2 D597A.  Base 1788 was also changed from A to C to 
introduce a SacII restriction site, used for identifying mutagenised clones.  B: Western blot 
for Ago2 in Ago2 and Ago2 D597A transfected HEK 293 cells.  β-actin was used as control 
for equal loading.  C. Relative YFP levels in PAC.2 YFP cells after co-transfection with 
vectors containing a control miRNA/shRNA (purple bars), GFP#1 miRNA/shRNA (gold bars) 
or GFP#2 miRNA (yellow bars) plus either pcGlobin Ago2 or pcGlobin Ago2 D597A. C. i: pol 
II- responsive vector-mediated YFP knockdown (n=9). C.ii: pol III-responsive vector-
mediated YFP knockdown (n=9).  YFP levels measured using fluorescent flow cytometry. 
Results were analysed by One-way ANOVA followed by the Dunnett test. *= p < 0.05, **= p 
< 0.01, ***= p <0.001. 
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5.3.5 Testing Different Stem Loops for Knockdown Efficiencies 
Up until this point the backbone of the miRNA being used was the hsa-mir-
30a backbone (miRBase accession number: MI0000088, Figure 5.12 A i) 
and the designed miRNAs were placed in the 3‟ arm (Figure 5.12 A ii).  In 
order to test whether placement of the of the mature miRNA in the 5‟ arm or 
using an endogenous zebrafish backbone could further improve the 
knockdown efficiency achieved in PAC.2 YFP cells co-transfected with Ago2, 
the hsa-mir-30a backbone was adapted to contain the miRNA encoding 
sequence in the 5‟ arm (Figure 5.12 A iii) and the zebrafish dre-mir-30a 
(miRBase accession number: MI0001940, Figure 5.12 B i) was also likewise 
adapted to contain the miRNA sequence in the 5‟ arm (Figure 5.12 B ii).   
miRNA strand selection is based upon the thermodynamic stability at 
each end of the miRNA, with the strand  with the least thermodynamically 
stable 5‟ end being preferentially unwound and incorporated into RISC.  The 
Invitrogen BlockIT® miRNA designer used to design miRNAs throughout this 
thesis selects miRNAs based on this principle.  Therefore, the 5‟ end of the 
miRNA are always more AT rich and the 3‟ end are more GC rich.  Simply 
moving the mature miRNA sequence from the 3‟ arm to the 5‟ arm but 
keeping their 5‟ to 3‟ orientation the same should therefore change which 
strand is incorporated into RISC, but the sequence of the mature miRNA will 
remain the same. 
Co-transfection of the silencing vectors with ef1α::GFP into HEK 293 
cells resulted in silencing by each of the miRNAs.  However, the most 
efficient silencing was induced by the original miRNA backbone, hsa-mir-30a 
with miRNA encoded in the 3‟ arm (~70%).  Placement of the miRNA in the 
5‟ arm of both the hsa-mir-30a and the dre-mir-30a backbone lead to similar 
less efficient silencing of between 40 and 50% (Figure 5.12 C).  
 Transfection of the silencing vectors containing the hsa-mir-30a 
backbone with the miRNA in either the 5‟ or 3‟ arm led to similar and 
extremely significant silencing in PAC.2 YFP cells co-transfected with Ago2 
pcGlobin.  The dre-mir-30a backbone miRNA also induced significant 
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silencing, although it was not as efficient as either of the hsa-mir-30a 
miRNAs (Figure 5.12 D).  
 
 
 
Chapter Five: Analysis and Over-expression of the RNAi Machinery 
156 
 
 
Figure 5.12: Testing Different Stem Loops for Knockdown Efficiencies.  A. i: the original 
has-mir30a stem loop showing the position of the mature miRNA in the 5‟ arm (red) and the 
3‟ arm (purple) (miRBase accession number: MI0000088) A.  ii and iii: adaptation of the has-
mir30a stem loop to contain the GFP #1 miRNA in the 3‟ and 5‟ arms respectively. ii is the 
miRNA sequence used up until now. B. i: the original dre-mir-30a (miRBase accession 
number: MI0001940) stem loop showing the position of the mature miRNA in the 5‟ arm 
(red). ii: Adapted dre-mir-30a to contain the GFP #1 miRNA sequence in the 5‟ arm (red).  C.  
Level of GFP knockdown achieved in HEK 293 cells co-transfected with the original vector 
containing the miRNA in the 3‟ arm of hsa-mir-30a or in the 5‟ arm of hsa-mir-30a or the 5‟ 
arm of dre-mir-30a and ef1α:GFP (n=3).  D: Level of YFP knockdown achieved in PAC.2 
YFP cells co-transfected with the original vector containing the miRNA in the 3‟ arm of hsa-
mir-30a or in the 5‟ arm of hsa-mir-30a or the 5‟ arm of dre-mir-30a  and Ago2 pcGlobin 
(n=6).  Results were analysed bu One-way ANOVA followed by the Dunnett test.  *= p < 
0.05, **= p < 0.01, ***= p <0.001.  
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5.3.6 Over-expression of Ago2 in Zebrafish Embryos 
As over-expression of Ago2 enhanced RNAi in PAC.2 and ZFL cells, next I 
investigated whether Ago2 over-expression is tolerated and is sufficient 
enough to induce silencing in vivo.  To do this, Ago2 and Ago2 D597A 
mRNA was transcribed in vitro using T7 primers from the Ago2 and Ago2 
D597A pcGlobin vectors respectively.  The RNA was then analysed on a bio-
analyser to check the integrity of the RNA (Figure 5.13 A).  The presence of 
a single band of approximately 3000 nt suggested that the RNA was intact.  
Ago2 mRNA was then injected into single-cell stage embryos at doses from 
100 pg up to 600 pg RNA.  Figure 5.13 B shows a western blot for Ago 2 
protein.  Endogenous Ago2 is not detectable in non-injected embryos.  
However, injection of Ago2 mRNA leads to detectable levels of Ago2 protein 
and the Ago2 signal becomes increasingly strong with increasing amounts of 
mRNA injected. The house-keeper β-actin remains unchanged. Compared to 
non-injected zebrafish, injection of mRNA led to between 10-15% increase in 
embryo mortality.  However, amongst embryos injected with Ago2 mRNA 
there was no significant association between dose of mRNA injected and 
lethality (Χ2 = 7.338, 3 d.f, p > 0.05).  Injection of mRNA into embryos did 
lead to a slight developmental delay as can be seen in Figure 5.13 D.  
However, despite the delay, embryos developed normally and by 5 dpf were 
indistinguishable from non-injected controls.  A small percentage around 3% 
did develop abnormally, the majority of these abnormalities involved under 
development of the head and curvature of the spine (Figure 5.13 D iii).  Such 
abnormalities however did also arise in non-injected zebrafish.  Due to little 
apparent toxicity of Ago2 mRNA, an injection concentration of 600 pg was 
chosen for future injections.  In order to see how long protein generated from 
Ago2 mRNA injection is detectable, Ago2 was injected at 600 pg and 
embryos/larvae were harvested and protein extracted at 1, 3 and 4 dpf.  
Figure 5.13 E shows the western blot for the detection of Ago2 across the 
time course.  Levels in injected embryos are highest at 1 dpf, but can still be 
detected out to 4 dpf.  Endogenous Ago2 protein levels in non-injected 
zebrafish are barely detectable. 
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Figure 5.13: Over-expression of Argonaute 2 in Zebrafish Embryos.  A: Electrophoresis 
of in vitro transcribed Ago2 and Ago2 D597A mRNA.  A single band at 3300 nt indicates the 
presence of intact mRNA.  B: Western blot for Ago2 in embryos injected with Ago2 mRNA 
ranging from 100 pg to 600 pg.  β-actin was used to control for equal loading.  C: % survival 
among embryos injected with varying doses of Ago2 mRNA compared to non-injected 
embryos.  There is no association between Ago2 mRNA dosage and lethality (Χ
2
 = 7.338, 3 
d.f, p > 0.05).  D: Non-injected (i) and Ago2 mRNA injected embryos (ii and iii) at 2 dpf.  
Injection of Ago2 mRNA leads to a slight developmental delay (ii) and in a minority of cases 
(<3%) more severe developmental defects (iii), such as malformation of the head and 
truncation and curvature of the spine. E: Western blot of Ago2 protein expression after 
injection with 600 pg Ago2 mRNA at 1, 3 and 4 dpf.  β-actin was used to control for equal 
loading. 
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To test whether Ago2 mRNA injection could lead to knockdown of 
GFP, the highest tolerated dose (600 pg) of Ago2 or Ago2 D597A mRNA 
was injected into doubly transgenic zebrafish expressing both ubiquitous 
GFP and either the control or GFP #1 miRNA.  At 2 dpf zebrafish over-
expressing either the control or GFP #1 miRNA were analysed for GFP 
expression relative to their non-transgenic siblings (NTS).  Figure 5.14 A 
shows a selection of the control and GFP #1 expressing embryos either non-
injected or injected with Ago2.  Although GFP levels vary, there was no 
obvious knockdown of GFP in Ago2 injected fish expressing the GFP #1 
miRNA compared to their NTS.  To analyse this further batches containing 
between 10-15 zebrafish embryos were trypsinised and the GFP content was 
analysed by flow cytometry.  This analysis can be seen in Figure 5.14 B.  
Although there was some knockdown of GFP in zebrafish injected with Ago2 
mRNA and expressing the GFP #1 miRNA this was not statistically 
significant, and a similar effect was also seen with injection of the RNase 
dead version of Ago2.   
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Figure 5.14: GFP Knockdown in Zebrafish Injected with Ago2 mRNA. A: Images of 
transgenic zebrafish expressing either the control or GFP #1 miRNA next to their relative 
NTSs and either non-injected or injected with Ago2 mRNA B: GFP levels relative to control 
in transgenic zebrafish expressing either the control or GFP #1 miRNA and either non- 
injected (control miRNA n=4, GFP miRNA n=3) injected with Ago2 mRNA (control miRNA 
n=4, GFP miRNA n=4) or injected with Ago2 D597A mRNA (control miRNA n=3, GFP 
miRNA n=3).  Results were analysed by One-way ANOVA followed by the Dunnett test 
using control non-injected as the reference data set. There is no significant difference 
between any of the experimental groups compared to the control. *= p < 0.05, **= p < 0.01, 
***= p <0.001. 
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5.4 Discussion 
The lack of knockdown detected in zebrafish embryos, as demonstrated in 
the previous two chapters, came as a surprise given the importance of the 
RNAi machinery in zebrafish development and the efficiency of our RNAi 
vectors at gene knockdown in HEK 293 cells.  In this chapter I have therefore 
taken a closer look at the expression of the RNAi machinery and the ability of 
our vector to drive expression of mature miRNAs in embryos and across 
adult tissues.  This chapter has also explored the possibility that use of a pol 
III- rather than a pol II-responsive vector or over-expression of components 
of the RNAi machinery might induce RNAi in zebrafish cells and embryos. 
5.4.1 Expression of RNAi Components and Mature miRNA 
Analysis of the expression of zebrafish Drosha, Dicer, Xpo5 and Ago2 
revealed that all four components are expressed throughout development 
and in all tissues and cell types tested.  Transcript levels of all components 
were especially high compared to house-keepers at the very early time 
points tested and decreased rapidly upon the onset of zygotic transcription 
(around 4 hpf), suggesting that high levels of the transcript of each of the 
components are maternally inherited and play an important role in early 
development.  By 1 dpf the levels of all components are substantially 
reduced relative to the house-keepers and remain fairly constant throughout 
development.  In contrast, levels of customised mature miRNA, as measured 
via a TaqMan qPCR against the miRNA ath-miR-162a, relative to the amount 
of mcherry produced, increases approx 180-fold on 1 dpf levels by 5 dpf 
(although a high amount of variation was seen here).   One possible 
explanation for this may be low turn-over of the RNAi component proteins, 
causing an accumulation of RNAi components and hence more efficient 
processing of pri- and pre-miRNAs over time. Indeed the half life of Ago2 has 
been shown to vary from between 1-12 hrs in MDA-231 cells dependent on 
the presence of epithelial growth factor (EGF) (Adams et al., 2009).  
Alternatively, the delay in mature miRNA production, despite high levels of 
maternally contributed RNAi component mRNAs, may be due to the RNAi 
machinery being otherwise occupied with miRNAs essential for the early 
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zebrafish development.  One such miRNA is miR-430 which has been shown 
to be essential for normal gastrulation and brain morphogenesis and whose 
over-expression rescues defects associated with loss of maternal and 
zygotic Dicer (Giraldez et al., 2005) and over-saturation of the RNAi 
machinery by siRNAs (Zhao et al., 2008).  Finally, the build up in mature 
miRNA could be due to low turnover of the miRNA leading to a rapid build 
up. 
 In the majority of tissues, transcript levels of RNAi components remain 
statistically unchanged from 1 dpf levels.  The exception to this is the brain, 
which has elevated levels of all of the components analysed and the skin 
which has elevated levels of Dicer and Ago2 and extremely high levels of 
Xpo5. Relative levels of the mature miRNA ath-miR-162a however, were 
consistently at least as high as levels in 5 dpf larvae and therefore 
substantially higher than 1 dpf levels.  Similar levels of RNAi component 
transcripts but increased amounts of mature miRNA produced in adult 
tissues, may suggest a decreased demand of the RNAi machinery by 
endogenous miRNAs in fully developed organs, or the stable build-up of 
customised miRNA.  Mature miRNA expression levels were particularly high 
in the brain and muscle of 6 month old adult zebrafish.  An increased level of 
mature miRNA in the brain is consistent with increased transcript levels of 
the RNAi components.  However, muscle did not show increased transcript 
levels of any of the components tested, so seems to suggest a lower load on 
the RNAi machinery in muscle.  Conversely, the skin which showed high 
level expression of Dicer, Xpo5 and Ago2 did not show increased levels of 
mature miRNA production, suggesting high demand on the RNAi machinery.   
Increased RNAi component expression and production of mature customised 
miRNAs in the brain compared to zebrafish embryos/larvae may explain why 
PINK1 knockdown was detected in the brain, but no knockdown of GFP or 
PINK1 was detected in zebrafish embryos/larvae up to 5 dpf. 
 Transcript levels of components of the RNAi machinery were also 
analysed in a panel of zebrafish cell lines, including AB.9 cells form adult 
caudal fin, PAC.2 cells, derived from 24 hpf embryos and ZFL cells, an adult 
liver epithelial cell line.  AB.9 cells showed consistently similar transcript 
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levels to 1 dpf levels.  However, PAC.2 cells and ZFL cells had consistently 
higher transcript levels for all the components tested, levels of Xpo5 being 
particularly high and levels of all components being higher in PAC.2 cells 
than in ZFL cells.  Unfortunately however, it was not possible to determine 
the amount of mature miRNA produced from our vector in these cells, as the 
transfection efficiencies were too low for quantification of the mature miRNA. 
In future, to try to quantify miRNA expression in these cells, cells could be 
transfected and then FAC sorted for mcherry positive cells.  RNA extractions 
could then be harvested from the sorted cells and analysed for mature 
miRNA production. 
The validity of the TaqMan assay to detect only fully processed, 
mature miRNA was also demonstrated by the fact that morpholino 
knockdown of Dicer resulted in a significant decrease in mature miRNA 
detected.  Residual detection of mature miRNA might reflect incomplete 
knockdown of Dicer and/or the presence of maternally contributed Dicer 
protein. 
The measurement of mature miRNA production is extremely valuable 
as it tells us if, when and where mature miRNA is being expressed.  
However, it would also be informative to know the level of expression of 
customised mature miRNA in comparison to that of endogenous miRNAs 
such as miR430 which have been shown to extremely efficiently knockdown 
its targets.  Absolute quantification of customised mature miRNA compared 
to miR430 could now be achieved using the TaqMan assay described in 
section 5.2.2. 
5.4.2 Knockdown in Zebrafish Cell Lines 
Both PAC.2 and ZFL cells have high levels of RNAi components.  This 
combined with the fact that the RNAi vector being used has been shown to 
be fit for purpose by driving expression of mature miRNA throughout 
zebrafish development and in a variety of zebrafish tissues and achieves 
good levels of knockdown in HEK 293 cells, suggests that if zebrafish are at 
all capable of vector-mediated RNAi, it would be most likely detected in these 
cells.  Despite this, no knockdown of GFP/YFP was detected in AB.9, PAC.2 
Chapter Five: Analysis and Over-expression of the RNAi Machinery 
165 
 
or ZFL cells using the pol II-responsive RNAi vector with H2A.Zf promoter 
(Figure 5.6).  A pol III-responsive vector, utilising a zebrafish H1 promoter, 
was also tested.  In HEK 293 cells this produced highly efficient knockdown 
of GFP, but in zebrafish PAC.2 cells no knockdown was detected (Figure 
5.7).  Pol III-responsive promoters are known to give rise to very high levels 
of transcript and have been shown to be extremely efficient in the delivery of 
shRNA for gene silencing (Paddison et al., 2004).  Indeed, in these 
experiments a 10-fold dilution of the pol III-responsive RNAi vector was able 
to produce similar levels of knockdown as the undiluted pol II-responsive 
vector in HEK 293 (Figure 5.9 and Figure 5.10), clearly demonstrating how 
efficient this vector is at producing shRNA.  The fact that the pol III vector 
also failed to produce any knockdown in these cells, may suggest that the 
production of primary miRNA or shRNA is not the limiting factor to achieving 
knockdown in zebrafish cells. Instead, factors downstream of miRNA/shRNA 
transcription must be limiting.  Equally, it is unlikely that levels of Drosha are 
limiting, or at least it is probably not the only limiting factor, as pol III-driven 
shRNAs enter the RNAi pathway downstream of Drosha processing, but are 
still incapable of producing knockdown in zebrafish cells.   
5.4.2.1 Co-expression of Ago2 Results in Knockdown in Zebrafish Cells 
In order to see whether over-expression of Dicer, Drosha, Ago2 or Xpo5 
enhances RNAi in zebrafish cell lines, Ago2, Dicer, Drosha  and Xpo5 
cDNAs were cloned into the pcGlobin vector, a vector based on pcDNA3 
which has been modified for efficient expression in zebrafish (Ro et al., 
2004).  After confirming correct expression of  these vectors in HEK 293 cells 
(Figure 5.8), their effect on RNAi in HEK 293 and zebrafish cells was 
assessed (Figure 5.9, Figure 5.10).  Of all 4 components tested only Ago2 
had any significant positive effect on RNAi efficiency and this effect was seen 
in both HEK 293 and zebrafish PAC.2 and ZFL cells.  Within the zebrafish 
cells, PAC.2 cells, which also had the higher transcript levels of RNAi 
components, the effect was most pronounced.  In PAC.2 cells, the pol II-
responsive vector also achieved slightly better knockdown than the pol III-
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responsive vector, perhaps suggesting that the pol III vector needs further 
optimisation for use in zebrafish. 
In contrast to previous reports (Diederichs et al., 2008; Yi et al., 2005), 
I found no evidence of Xpo5 induced enhancement of RNAi in zebrafish 
PAC.2 or ZFL cells, and only slight enhancement in HEK 293 cells when 
using the pol III-responsive vector, suggesting that in our hands, Xpo5 is not 
the limiting component to effective RNAi.  Like Diederichs et al., (2008) we 
also saw no enhancement of RNAi by over-expression of Dicer in PAC.2 or 
ZFL cells and again only slight enhancement in HEK 293 cells when using 
the pol III-responsive vector. This is in contrast to previous reports in 
Drosophila in which over-expression of Dicer2 substantially improved the 
potency of RNAi (Dietzl et al., 2007).   
That over-expression of Ago2 results in increased knockdown in cells 
is in line with the work undertaken  by Diederichs et al., (2008), who showed 
a 7-fold enhancement in RNAi  in HEK 293 cells over-expressing Ago2.  The 
same group had also previously demonstrated that, over-expression of each 
of the four Ago proteins enhances levels of mature miRNA, possibly through 
the stabilisation of the miRNA (Diederichs and Haber, 2007).  They went on 
to show however, that improvements in RNAi brought about by Ago2 over-
expression were not due to increased miRNA expression, as over-
expression of each of the other Ago proteins do not improve RNAi efficiency.  
Instead, the enhancement of RNAi brought about by Ago2 was shown to be 
due to its intrinsic RNase activity as mutations in the RNase domain 
abrogate Ago2-mediated enhancement of RNAi.  Likewise, by creating the 
D597A mutation of Ago2, I have demonstrated that the enhancement 
detected here in zebrafish cells is due to the catalytic RNase domain of Ago2 
(Figure 5.11).  In addition to demonstrating that Ago2 enhancement of RNAi 
was dependent on RNase activity of Ago2, Diederichs et al (2008) also 
demonstrated that the enhancement was only toward perfectly matched 
binding sites, as mutation of the base pairs either side of the cleavage site 
and mutation of 2 bases in the seed region of the miRNA inhibited any effect 
of Ago2. Furthermore, they reported no deleterious effects of over-
expression of Ago2 on endogenous RNAi activity.  This is most likely due to 
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the fact that by over-expressing Ago2 there is less competition with 
endogenous miRNAs for assembly into RISC.  Moreover, as Ago2 can 
function both as a slicer and in translational repression (Wu et al., 2008) 
where endogenous miRNA are incorporated into RISC containing Ago2, 
silencing via translational repression/mRNA destabilisation may still ensue.    
Recently, truncated forms of pre-miRNAs have been detected in cell 
lysates and their presence shown to be dependent on Ago2 expression.  
This has led to a further role of Ago2 being proposed in the biogenesis of 
miRNAs (Diederichs and Haber, 2007).  In this proposed model Ago2 binds 
to pre-miRNA along with Dicer and TRBP and makes a cut in the passenger 
strand miRNA to produce an Ago2-cleaved precursor miRNA (ac-pre-
miRNA).  This ac-pre-miRNA is then further processed by Dicer and the 
guide strand is loaded into RISC (Figure 5.15).  Cleavage of the passenger 
strand by Ago2 may help in strand selection and the unwinding of the duplex 
and hence loading into RISC.  At the same time, cleavage of the passenger 
strand of customised miRNAs would prevent passenger strand loading into 
RISC and its ensuing off-target effects.  Thus, if Ago2 interacts with 
customised miRNAs embedded in the hsa-miR-30a backbone in the same 
way, this is further advantage to the over-expression of Ago2 to induce 
knockdown. 
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Figure 5.15: Proposed Role of Ago2 in miRNA Biogenesis.  Ago2 binds to the pre-
miRNA along with Dicer and TRBP and cleaves the passenger strand of the pre-miRNA.  
The pre-miRNA is then processed by Dicer to create the miRNA duplex and then the guide 
strand is loaded into RISC, while the passenger strand is degraded.  Cleavage of the 
passenger strand prevents its incorporation into RISC and also aids in the unwinding of 
guide and passenger strands (modified from Diederichs et al., (2007)). 
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5.4.2.2 Strand Orientation and Other Changes to Stem-loop 
In all experiments up to this point, the miRNA backbone used was that of 
hsa-miR30a described by Zeng et al., (2002) with the guide strand orientated 
in the 3‟ arm.  To see whether the efficiency of RNAi could be further 
enhanced by changing the orientation of the guide strand or by using a 
zebrafish miRNA backbone, the efficiencies of RNAi with the guide strand 
orientated in the 5‟ or the 3‟ arm and the efficiency of the zebrafish as 
opposed to human miR30a backbone were tested in both HEK 293 cells and 
PAC.2 cells over-expressing Ago2.  In HEK 293 cells the original miR30 
backbone with the miRNA located in the 3‟ arm was clearly the most efficient 
at inducing silencing.   In PAC.2 cells over-expressing Ago2 however, there 
was no such strand preference; the human miR-30a backbone with miRNA 
orientated in either the 5‟ or 3‟ arms had similar knockdown efficiencies.  
Surprisingly, however the zebrafish miR30a backbone, which you might 
expect to be more suited to expression in zebrafish cells, was slightly less 
efficient than the human versions at inducing silencing (Figure 5.12).  In 
future, the efficiencies of other zebrafish backbones might also be tested to 
see whether any of these are capable of improving knockdown.  In particular, 
it would be interesting to see whether using the backbone of the dre-miR-430 
miRNA, an early acting and highly expressed miRNA could improve 
knockdown in zebrafish embryos. 
5.4.3 Over-expression of Ago2 in Zebrafish Embryos 
As over-expression of Ago2 in zebrafish cells enables RNAi, the next step 
was to see whether its over-expression in vivo is feasible and sufficient to 
bring about silencing.  Injections of increasing doses of Ago2 mRNA resulted 
in dose-dependent protein production in vivo and had very little effect on 
mortality or development, suggesting that over-expression of Ago2 is feasible 
and non-toxic (Figure 5.13).  However, injection of Ago2 mRNA failed to 
significantly reduce GFP levels in double transgenic zebrafish expressing 
GFP and the GFP miRNA (Figure 5.14).  There are several potential reasons 
for this discrepancy between the knockdown seen in zebrafish cell lines 
expressing Ago2 and lack of knockdown in zebrafish embryos expressing 
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Ago2.  Firstly, the amount of mRNA injected may not have been sufficient to 
produce high enough levels of Ago2 to significantly improve knockdown.   
Secondly, mRNA injected into single-cell embryos will become increasingly 
diluted as the embryo grows, and may not be uniformly inherited throughout 
all cells of the embryo causing very high levels of variation in the level of 
Ago2 expression in each cell.  Thirdly, mRNA is highly susceptible to 
degradation, and despite the use of the pcGlobin vector which contains 
zebrafish β-Globin 5‟ and 3‟ UTRs which have been shown to increase the 
stability of mRNAs injected into zebrafish embryos, there may be a high level 
of decay of mRNA, and variation in the amount of decay of mRNA from 
embryo to embryo.  Finally, in order to assess the effects of over-expression 
of Ago2, embryos were assessed at 2 dpf so that miRNAs had time to 
function on their target, but the levels of Ago2 would still be reasonably high.  
2 dpf may be too early a time point to achieve/detect knockdown, particularly 
as expression of customised mature miRNA produced from our constructs 
were shown to increase dramatically by 5 dpf.  Therefore, to assess properly 
whether over-expression of Ago2 can induce knockdown in zebrafish 
embryos/larvae and adults, it will be necessary to create a transgenic line 
over-expressing Ago2.  Work on generating a 5 x UAS::Ago2 vector which 
leads to over-expression of Ago2 when combined with animals expressing 
Gal4 has already began.    
Recently vector-mediated co-expression of Ago2 and shRNA in intact 
xenopus was shown to moderately improve RNAi in xenopus optic tectal 
neurons to a similar extent as that observed here in PAC.2 and ZFL cells 
(Chen et al., 2009).  They also noticed no morphological or functioning 
defects in neurons over-expressing Ago2. The ability of Ago2 to improve 
knockdown in xenopus lends further support to the suggestion that stable 
expression of Ago2 may be the key to inducing RNAi in zebrafish embryos.  
However, it is important to note, that this study only looked at one type of 
neuron, and so it remains to be seen whether over-expression of Ago2 will 
enhance RNAi in other xenopus cell types.  In addition, while moderate 
levels of knockdown were achieved in some cells, other cells did not appear 
to respond to Ago2 over-expression at all, suggesting that in some cells 
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Ago2 expression may not be, or at least is not, the only limiting factor to 
RNAi (Chen et al., 2009).  Other potential limiting factors could be Dicer, 
Drosha or Xpo5, but equally it could also be any one of the many accessory 
proteins involved in pri- and pre-miRNA production and RISC assembly and 
function.  Due to potential cell type-dependent differences in the RNAi ability 
of cells over-expressing Ago2, it may be more informative to look at the 
effect of Ago2 over-expression in individual zebrafish cell types.  
5.4.4 Targeting the 3’UTR Causes Gene Knockdown in Zebrafish Cells 
and in vivo 
The majority of research utilising RNAi to knockdown genes in zebrafish to 
date has been carried out by creating miRNAs/shRNAs with complete 
complementarity to the open reading frame of the gene (Blidner et al., 2008; 
Chang and Nie, 2008; Dodd et al., 2004; Gruber et al., 2005; Liu et al., 
2005c; Su et al., 2008; Wang et al., 2007; Zhao et al., 2008).  It was/is 
believed that by targeting open reading frames (ORFs) with miRNAs/siRNAs 
which are completely complementary to their targets rather than targeting the 
3‟ UTRs, where targeting relies on only a seed region within the miRNA, off-
target effects would be reduced.  Indeed, targeting the ORF is extremely 
efficient in cells such as HEK 293 cells and in many other systems.  
However, the work carried out for this thesis has highlighted the difficulty of 
this approach in zebrafish.   A report recently by Dong et al., (2009) also 
confirmed lack of knockdown achieved when targeting ORFs.  However, they 
also showed that targeting the 3‟ UTRs of exogenous GFP and the 
endogenous gene gata1 resulted in the stable and heritable knockdown of 
about 50%.  To confirm and evaluate the effect of targeting the 3‟ UTR, I 
used the vectors and miRNA sequences against the GFP ORF and SV40pA 
described by Dong et al., (2009) to knockdown YFP in PAC.2 YFP cells (see 
appendices section Figure 8.12).  Indeed targeting the ORF resulted in very 
little knockdown, but by targeting the 3‟ UTR two independent miRNAs 
achieved around 50% knockdown.  The difference in the ability of miRNAs 
against the ORF and miRNAs against the 3‟ UTR to induce silencing reflects 
the differences in mechanisms employed.  All four argonaute proteins are 
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able to bind to the 3‟ UTR of their targets and induce knockdown either by 
translation repression or mRNA destabilisation.  However, when targeting the 
ORF knockdown is largely dependent on Ago2, the only argonaute which 
can induce mRNA decay via mRNA cleavage, as binding of miRNA/siRNA to 
the ORF at best only weakly effects translation (Wu et al., 2008).  In animals 
the majority of endogenous miRNAs silence their targets by binding to a 
seed region of the 3‟ UTR and inducing translational repression or mRNA 
destabilisation.  The only known exception to this is miR196, which is 
completely complementary to its target and induces cleavage (Yekta et al., 
2004).  It is therefore perhaps not surprising that targeting the 3‟ UTR should 
be more efficient.  However, caution should be taken in utilising Ago1,3 and 
4 for targeted gene knockdown, as recognition of the target relies only on a 
seed region (usually bases 2-8 of the miRNA).  The greater probability of 
finding at 7-8 bp match as opposed to a 21 bp match therefore increases the 
potential for off-target effects.  Indeed most of the off-target targets of 
completely complementary miRNAs/siRNAs targeted against ORFs have 
been shown to be on targets which share seed region complementarity in 
their 3‟UTRs (Birmingham et al., 2006; Jackson et al., 2003).  However, as 
customised miRNAs/shRNAs targeted to the ORF are equally as likely to be 
incorporated into RISCs containing Ago1,3 or 4 as miRNAs/shRNAs targeted 
to the 3‟ UTR, the potential for off-target effects will be similar.  Therefore 
rather than the position of target being the important determining factor, 
relative levels of Ago2 are likely to have greatest effect on the possible off-
targeting of customised miRNA/shRNAs.  Indeed, work by Wu et al, (2008) 
has demonstrated that reduced off-target effects of siRNAs correlate with 
higher levels of Ago2 expression relative to the other Ago proteins and vice 
versa.  Therefore, although targeting the 3‟ UTR does indeed give rise to 
moderate silencing, due to the enhancing effect of Ago2 towards perfect-
match binding sites,  a system in which Ago2 is over-expressed may be 
more desirable and could alleviate off-target effects both when targeting the 
ORF and the 3‟ UTR.  
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5.4.5 Conclusion 
The major RNAi components Ago2, Dicer, Drosha and Xpo5 are expressed 
throughout development and across tissues.  In addition, the RNAi vector 
used has been shown to be capable of driving expression of customised 
mature miRNAs and eliciting knockdown in HEK 293 cells.  However, despite 
this zebrafish embryos and cells remain resistant to vector-mediated RNAi.  
Over-expression of Ago2, the major component of RISC enables vector-
mediated RNAi in cells, and this has been shown to be dependent on its 
intrinsic RNase activity.  Results in vivo however have been less promising, 
but this may be due to the variable and unreliable effects of mRNA injections. 
5.4.5.1 Future Work 
In order to determine whether Ago2 over-expression will enable vector-
mediated RNAi targeted against ORFs in zebrafish, an Ago2 expressing 
transgenic zebrafish needs to be created and assessed for its RNAi ability.  
As the potential for different cell types to perform RNAi may vary, it may be 
better to assess the RNAi ability in individual cell types/tissues.  The success 
of RNAi targeted against 3‟ UTRs opens another potential possibility to 
achieving good knockdown; however, the potential for off-target effects 
should not be overlooked.  Therefore, combining targeting of the 3‟ UTR with 
Ago2 over-expression may be beneficial.  The efficiency of silencing both by 
targeting the 3‟ UTR and by targeting the ORF while over-expressing Ago2 
are very similar and knockdown seems to be limited to around 50%.  This 
suggests that at this point other factors become limiting.  Therefore, future 
experiments may look at the effect of over-expression of multiple 
components of the RNAi machinery. 
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6 General Discussion 
At present the use of zebrafish to model diseases which may then be used to 
further understand the biology of the disease and for use in drug discovery is 
hampered by a lack of an efficient and reliable means for knocking down 
target genes.  The work of this thesis has therefore focused on trying to 
develop a method of vector-mediated RNAi which would achieve stable and 
heritable knockdown.   The efficacy of vector-mediated RNAi in zebrafish 
was first addressed through knocking down GFP.  However, I was also 
interested in knocking down PINK1, a gene whose loss of function has been 
associated with early onset Parkinson‟s disease.  
Initial results of vector-mediated RNAi in a G0 setting shown here and 
reported by Su et al., (2008) and Wang et al.,(2007) were encouraging.  
However, in stable transgenic lines, with strong expression of the RNAi 
vector made possible through the insertion of a Gal4-VP16/UAS amplification 
cassette, no knockdown of GFP or the Parkinson‟s disease associated gene, 
PINK1 was detected in zebrafish embryos.  This lack of knockdown was 
despite the expression of the main components required for mRNA 
cleavage-induced silencing and the production of customised mature 
miRNAs throughout development and across all tissues tested.   
Although RNAi appears to not be working in zebrafish embryos, 
evidence of moderate knockdown of PINK1 was detected in the adult 
zebrafish brains of F2 transgenic zebrafish.  Importantly, it was the brain 
which had the highest transcript levels of RNAi components and produced 
the highest amounts of customised mature miRNA relative to the expression 
of the RNAi vector.   With this in mind it would now be extremely interesting 
to see whether knockdown of GFP is detectable in doubly transgenic fish 
brains expressing both GFP and the RNAi silencing vector.  Detection of 
GFP knockdown in zebrafish brains would lend further support to the results 
of PINK1 knockdown.  Much lower expression of the RNAi components and 
mature miRNA was seen in embryos and may explain the lack of knockdown 
detected.  Although in the brain higher levels of RNAi components correlated 
with higher levels of mature miRNA production, the correlation between 
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component expression and mature miRNA production did not hold true in all 
tissues, and may reflect differences in the endogenous load levels of miRNA 
and differences in post-transcriptional regulation of RNAi.  It remains to be 
tested whether any other adult tissues are amenable to RNAi.  Whether or 
not partial knockdown of PINK1 in the brain leads to any Parkinson‟s-like 
pathology also need to be addressed.   
Despite modest but successful knockdown in the brain, a method of 
gene silencing that functions in embryos and throughout development is the 
ultimate goal if RNAi is to be the method of choice in knocking down genes in 
zebrafish.  In other systems the efficiency of RNAi has been improved by the 
over-expression of various components of the RNAi machinery (Diederichs 
et al., 2008; Dietzl et al., 2007; Yi et al., 2005).  Here, I have demonstrated 
that over-expression of Ago2 but not Dicer, Drosha or Xpo5 induces RNAi-
mediated knockdown in zebrafish cell lines which prior to over-expression of 
Ago2 were resistant to RNAi.  This induction is dependent on the RNase 
domain of Ago2 which cleaves RNA with fully complementary sequences to 
the miRNA/siRNA.  The amount of knockdown detected however, was at 
best in PAC.2 cells only approximately 50%, suggesting that although Ago2 
may be the primary limiting factor to RNAi, other factors must soon also 
become limiting.  These other limiting factors may be proteins such as 
Drosha, Dicer or Xpo5, but equally could be one of the many accessory 
proteins involved in processing pri- and pre-miRNA or in the silencing 
complex RISC itself.  Despite the induction of RNAi in zebrafish cells through 
over-expression of Ago2, no knockdown of GFP was detected in double 
transgenic zebrafish expressing GFP and the RNAi vector injected with Ago2 
mRNA.  This may reflect problems with the delivery of Ago2 or may suggest 
that factors other than Ago2 are limiting in embryos.  In future, it may be 
more appropriate to look at the knockdown capabilities of individual cell types 
as the ability of different cell types is likely to vary a lot and cells which are 
amenable to RNAi may be missed when looking at global levels.  
 Throughout this research and indeed in most published attempts at 
RNAi in zebrafish to date, efforts at RNAi have focussed on targeting the 
ORF of the target gene with complete complementarity.  However, whilst 
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undertaking this research another group have demonstrated that although 
targeting the ORF is not effective at delivering RNAi, by targeting the 3‟ UTR 
effective RNAi can be achieved in a stable and inheritable manner (Dong et 
al., 2009).   That targeting the ORF doesn‟t work but targeting the 3‟ UTR 
does, suggest that the Ago2-mediated cleavage part of the RNAi pathway is 
limiting in zebrafish, but that silencing via translational repression/mRNA 
destabilisation mediated through Ago1,3 and 4 is fully functional and can be 
manipulated.  However, silencing mediated by RISC containing Ago1, 3 and 
4 is dependent on only seed region complementarity between the 
miRNA/siRNA and the target mRNA, which means that miRNA/siRNAs 
incorporated into RISC containing Ago1, 3 or 4 are much more likely to have 
off-target effects due to the increased probability of finding seed region 
matches compared to completely complementary matches.  Thus, while this 
method does seem to be effective, it is important to be aware of potential off-
target effects.  Recently, off-target effects of miRNAs/siRNAs targeted to 
both the ORF and 3‟ UTR have shown to be reduced with increasing levels 
of Ago2 (Diederichs et al., 2008; Wu et al., 2008), suggesting that a system 
in which Ago2 is over-expressed would be advantageous both when 
targeting ORFs or 3‟ UTRs.   
 Although I have been unable to demonstrate effective vector-mediated 
RNAi of target genes in zebrafish embryos in this thesis, I have 
demonstrated that the RNAi vectors described herein are able to deliver 
mature miRNA in zebrafish.  Therefore, the vectors described in this thesis 
could be used to over-express endogenous miRNAs.  Indeed, Nicoli et al., 
(2010) used the original RNAi vector created by Dr. Paul Walker, the 
Hurlstone lab, to tissue-specifically over-express miR-126.  This over-
expression successfully rescued the effects of loss of its upstream activator, 
the mechano-sensitive zinc finger transcription factor klf2a. 
In plants and invertebrates such as C. elegans and Drosophila 
targeted Ago2-mediated cleavage of mRNAs is highly efficient.  However, 
the efficiency of Ago2-mediated cleavage of targets in mammalian and other 
vertebrate systems has proved to be extremely variable.  This suggests that 
there may have been some evolutionary change in RNAi during the 
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invertebrate to vertebrate transition.  The Ago2-mediated cleavage part of 
the RNAi pathway is proposed to have originally evolved as a defence 
mechanism against viruses and transposable elements (Obbard et al., 2009).  
dsRNA from viruses is recognised by Dicer and cut up into siRNAs.  One 
strand of the siRNA is then incorporated into Ago2-containing RISC which 
binds to complementary viral sequences and cleaves the viral RNA.  While 
this form of defence has been demonstrated as important in Drosophila C. 
elegans and fungi, there is a lack of evidence suggesting RNAi plays an 
important role in vertebrate systems (Cullen, 2006; Obbard et al., 2009).  
Instead, in these systems contact with dsRNA results in an interferon 
response resulting in global mRNA degradation and translational inhibition 
(Stark et al., 1998; Williams, 1997).  This transition between RNAi playing an 
important role in antiviral defences to the more general interferon response, 
may explain why Ago2-mediated cleavage of targets is less efficient in 
vertebrate systems. However, despite this several vertebrate cell types are 
capable of efficient Ago2-mediated RNAi.  Most notably, HEK 293 cells 
which have been used throughout this thesis and extensively by the wider 
scientific community in RNAi experiments. 
 
In conclusion, the inefficiency of RNAi in zebrafish, both when targeting the 
ORF or the 3‟ UTR suggests that its use to model diseases which result from 
loss of function of a gene is not at present a viable option.  It is possible 
however, that this technology could be used to model the effects of 
haploinsufficiency of target genes.  For development of animal models 
resulting from complete loss of gene function, mutagenesis, zinc fingers and 
in a transient setting morpholinos, despite their relative disadvantages, are 
much better suited. 
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8 Appendices 
8.1 Vector Maps 
8.1.1 Pol II-responsive RNAi Vector 
 
Figure 8.1: Pol II-responsive RNAi Vector Map Depicted Here with H2A.Zf Promoter. 
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8.1.2 pBluescript I-SceI Vector Map 
 
Figure 8.2: pBluescript I-SceI Vector Map.  Multicloning site (MCS) of pBluescript is 
flanked by I-SceI meganuclease restriction site. 
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8.1.3 SAGVG Vector Map 
 
 
Figure 8.3: SAGVG Vector Map.  Tol2 vector containing splice acceptor followed by Gal4-
VP16 and 14 UAS sequences and GFP. 
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8.1.4 I-SceI Gal4-VP16-resposnive RNAi Vector 
 
 
Figure 8.4: I-SceI Gal4-VP16-responsive RNAi Vector Depicted Here with H2A.Zf 
Promoter. 
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8.1.5 Tol2 Gal4-VP16-responsive RNAi Vector  
 
 
Figure 8.5:  Tol2 Gal4-VP16-responsive RNAi Vector Depicted Here with H2A.Zf 
Promoter. 
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8.1.6 Pol III-responsive RNAi Vector 
 
Figure 8.6: Pol III-responsive RNAi Vector.  The zebrafish H1 promoter drives expression of an 
shRNA.  In a separate tandem cassette, ef1α drives expression of mcherry, allowing for easy 
identification of transfected/transgenic cells. 
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8.2 Comparison of Human and Zebrafish PINK1 Proteins 
HuPINK1         MAVRQALGRGLQLGRALLLRFTGKPGRAYGLGRPGPAAGCVRGERPGWAAGPGAEPRRVG 60 
ZfPINK1         MSVKHVLSRGLELGRSVFQLGLLKP--------AGRIAAKFRGER--LRVSRPTHTAQPQ 50 
                *:*::.*.***:***:::     **        .*  *. .****    ..  :.. :   
 
HuPINK1         LGLPNRLRFFRQSVAGLAARLQRQFVVRAWGCAGPCGRAVFLAFGLGLGLIEEKQAESRR 120 
ZfPINK1         TFLPGRYRFFRLSVSGLAAQLQSGAFRRVIGGGSARNRAVFLAFGVGLGLIEQEQEEDRT 110 
                  **.* **** **:****:**   . *. * ... .********:******::* *.*  
 
HuPINK1         AVSACQEIQAIFTQK-SKPGPDPLDTRRLQGFRLEEYLIGQSIGKGCSAAVYEATMPTLP 179 
ZfPINK1         SAALCQEIQAVFRKKKFQSLPKPFTS----GYRLEDYVIGKQIGKGCNAAVYEAAAPFAP 166 
                :.: ******:* :*  :. *.*: :    *:***:*:**:.*****.******: *  * 
 
HuPINK1         QNLEVTKSTGLLPGRGPGTSAPGEGQERAPGAPAFPLAIKMMWNISAGSSSEAILNTMSQ 239 
ZfPINK1         PVESKKCSLVELNPKEAEDDNKKEEPLRLSASPSFPLAMKMMWNIGAGSSSDAILRSMSM 226 
                   . . *   *  : .  .   *   * ..:*:****:******.*****:***.:**  
 
HuPINK1         ELVPASRVALAGEYGAVTYR-KSKRGPKQLAPHPNIIRVLRAFTSSVPLLPGALVDYPDV 298 
ZfPINK1         ELVPSCPQALRKEQGELTLNGHFGAVPKRLSAHPNVITVYRAFTAEVPLLPGAREEYPDV 286 
                ****:.  **  * * :* . :    **:*:.***:* * ****:.*******  :**** 
 
HuPINK1         LPSRLHPEGLGHGRTLFLVMKNYPCTLRQYLCVNTPSPRLAAMMLLQLLEGVDHLVQQGI 358 
ZfPINK1         LPTRLNPHGLGSNRTLFLVMKNYPCTLRQYLEVCVPKRTQASLMFLQLLEGVDHLCRQNI 346 
                **:**:*.*** .****************** * .*.   *::*:********** :*.* 
 
HuPINK1         AHRDLKSDNILVELDPDGCPWLVIADFGCCLADESIGLQLPFSSWYVDRGGNGCLMAPEV 418 
ZfPINK1         AHRDLKSDNILLEFDNTGCPRLVITDFGCCLAEDS-GLKLPFSSWWVNRGGNSCLMAPEV 405 
                ***********:*:*  *** ***:*******::* **:******:*:****.******* 
 
HuPINK1         STARPGPRAVIDYSKADAWAVGAIAYEIFGLVNPFYGQGKAHLESRSYQEAQLPALPESV 478 
ZfPINK1         STAVPGPGVVIDYSKADVWAVGAIAYELFGQPNPFY-----TLESRSYQEKQLPALPAAA 460 
                *** *** .********.*********:**  ****      ******** ****** :. 
 
HuPINK1         PPDVRQLVRALLQREASKRPSARVAANVLHLSLWGEHILA-LKNLKLDKMVGWLLQQSAA 537 
ZfPINK1         PDDVQLVVKLLLRKNPHKRPSARVAANILHISLWGRRVLAGLDKVQMAEMMAWLQCQSAV 520 
                * **: :*: **:::. **********:**:****.::** *.:::: :*:.**  ***. 
 
HuPINK1         TLLANRLTEKCCVETKMKMLFLANLECETLCQAALLLCS----WRAAL------ 581 
ZfPINK1         VLLKGRGRDQSSVEAELQRSFLANIELEDLRTAVSFLTYKRKQWRYLLMSNSQP 574 
                .** .*  ::..**::::  ****:* * *  *. :*      **  *       
Figure 8.7: Human and Zebrafish PINK1 Protein Sequence Alignment.  The Protein 
Kinase catalytic (PKc) domain is highlighted in grey. 
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8.3 Comparison of Human and Zebrafish RNAi Proteins 
8.3.1 Argonaute 2 
HuEIF2C2        -----------MYSG---AGPALAPPAPPPPIQGYAFKPPPRPDFGTSGRTIKLQANFFE 46 
ZfEIF2C2        MYPIGAAGATELFQGRPSSGSDVSAPASPPAPQEYVFKPPQRPDFGTMGRTIKLQANFFE 60 
                           ::.*   :*. ::.**.**. * *.**** ****** ************ 
 
HuEIF2C2        MDIPKIDIYHYELDIKPEKCPRRVNREIVEHMVQHFKTQIFGDRKPVFDGRKNLYTAMPL 106 
ZfEIF2C2        MEIPKLEVYHYEIDIKPEKCPRRVNREIVEHMVQHFKTQIFGDRKPVYDGRKNLYTAMPL 120 
                *:***:::****:**********************************:************ 
 
HuEIF2C2        PIGRDKVELEVTLPGEGKDRIFKVSIKWVSCVSLQALHDALSGRLPSVPFETIQALDVVM 166 
ZfEIF2C2        PIGRDKVELEVTIPGEGKDRSFKVAIKWMSCVSLQALHEALSGRLPNIPFETIQALDVVM 180 
                ************:******* ***:***:*********:*******.:************ 
 
HuEIF2C2        RHLPSMRYTPVGRSFFTASEGCSNPLGGGREVWFGFHQSVRPSLWKMMLNIDVSATAFYK 226 
ZfEIF2C2        RHLPSMRYTPVGRSFFTPSEGCSNPLGGGREVWFGFHQSVRPSLWKMMLNIDVSATAFYK 240 
                *****************.****************************************** 
 
HuEIF2C2        AQPVIEFVCEVLDFKSIEEQQKPLTDSQRVKFTKEIKGLKVEITHCGQMKRKYRVCNVTR 286 
ZfEIF2C2        AQPVIEFMCEVLDFKSIEEQQKPLTDSQRVKFTKEIKGLKVEITHCGQMKRKYRVCNVTR 300 
                *******:**************************************************** 
 
HuEIF2C2        RPASHQTFPLQQESGQTVECTVAQYFKDRHKLVLRYPHLPCLQVGQEQKHTYLPLEVCNI 346 
ZfEIF2C2        RPASHQTFPLQQENGQTIECTVAQYFKDKYKLVLRYPHLPCLQVGQEQKHTYLPLEVCNI 360 
                *************.***:**********::****************************** 
 
HuEIF2C2        VAGQRCIKKLTDNQTSTMIRATARSAPDRQEEISKLMRSASFNTDPYVREFGIMVKDEMT 406 
ZfEIF2C2        VAGQRCIKKLTDNQTSTMIRATARSAPDRQDEISKLMRSANFNTDPYVREFGVMVRDDMT 420 
                ******************************:*********.***********:**:*:** 
 
HuEIF2C2        DVTGRVLQPPSILYGGRNKAIATPVQGVWDMRNKQFHTGIEIKVWAIACFAPQRQCTEVH 466 
ZfEIF2C2        EVNGRVLQAPSILYGGRNKAIATPVQGVWDMRNKQFHTGIEIKVWAIACFAPQRQCTELL 480 
                :*.*****.*************************************************:  
 
HuEIF2C2        LKSFTEQLRKISRDAGMPIQGQPCFCKYAQGADSVEPMFRHLKNTYAGLQLVVVILPGKT 526 
ZfEIF2C2        LKAFTDQLRKISRDAGMPIQGQPCFCKYAQGADSVEPMFKHLKYTYQGLQLVVVILPGKT 540 
                **:**:*********************************:*** ** ************* 
 
HuEIF2C2        PVYAEVKRVGDTVLGMATQCVQMKNVQRTTPQTLSNLCLKINVKLGGVNNILLPQGRPPV 586 
ZfEIF2C2        PVYAEVKRVGDTVLGMATQCVQVKNVQKTTPQTLSNLCLKINVKLGGVNNILLPQGRPLV 600 
                **********************:****:****************************** * 
 
HuEIF2C2        FQQPVIFLGADVTHPPAGDGKKPSIAAVVGSMDAHPNRYCATVRVQQHRQEIIQDLAAMV 646 
ZfEIF2C2        FQQPVIFLGADVTHPPAGDGKKPSIAAVVGSMDAHPSRYCATVRVQQHRQDIIQDLATMV 660 
                ************************************.*************:******:** 
 
HuEIF2C2        RELLIQFYKSTRFKPTRIIFYRDGVSEGQFQQVLHHELLAIREACIKLEKDYQPGITFIV 706 
ZfEIF2C2        RELLIQFYKSTRFKPTRIIYYRDGISEGQFNQVLQHELLAIREACIKLEKDYQPGITFVV 720 
                *******************:****:*****:***:***********************:* 
 
HuEIF2C2        VQKRHHTRLFCTDKNERVGKSGNIPAGTTVDTKITHPTEFDFYLCSHAGIQGTSRPSHYH 766 
ZfEIF2C2        VQKRHHTRLFCMDRNERVGKSGNIPAGTTVDTKITHPFEFDFYLCSHAGIQGTSRPSHYH 780 
                *********** *:*********************** ********************** 
 
HuEIF2C2        VLWDDNRFSSDELQILTYQLCHTYVRCTRSVSIPAPAYYAHLVAFRARYHLVDKEHDSAE 826 
ZfEIF2C2        VLWDDNHFTSDELQVLTYQLCHTYVRCTRSVSIPAPAYYAHLVAFRARYHLVDKEHDSAE 840 
                ******:*:*****:********************************************* 
 
HuEIF2C2        GSHTSGQSNGRDHQALAKAVQVHQDTLRTMYFA 859 
ZfEIF2C2        GSHTSGQSNGRDQQALAKAVQIHQDTLRTMYFA 873 
                ************:********:*********** 
 
Figure 8.8: Comparison of Human (NP_036286.2) and Zebrafish (XP_699226.2) 
Argonaute 2 Proteins.  Red indicates small, hydrophobic amino acids (A,F,I,L,M,P,V,W). 
Blue indicates acidic amino acids (D,E). Pink indicates basic amino acids (K,R). Green 
indicates hydroxyl+amine+basic amino acids (C,G,H,N,Q,S,T,Y).  Identical amino acids are 
indicated with a *. : indicates a conservative substitution and . indicates a semi-conservative 
substitution.  Human and zebrafish protein sequences are 90.5% identical and 95.4% 
similar. 
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Domain name 
 
Corresponding 
amino acid 
(Human) 
 
 
Function 
 
Identity 
 
Similarity 
 
DUF1785 
 
 
175 – 227 
 
Unknown 
 
98.1% 
 
98.1% 
 
PAZ_argonaute_like; 
PAZ domain, 
argonaute_like subfamily 
 
 
227 – 347 
 
Nucleic acid binding 
domain, with a strong 
preference for single-
stranded nucleic acids 
(RNA or DNA) or RNA 
duplexes with single-
stranded 3' overhangs. 
 
 
95.9% 
 
100% 
 
Piwi_ago-like; Piwi_ago-
like: PIWI domain, 
Argonaute-like subfamily 
 
 
392 – 783 
 
Two sub-domains.  One 
provides the 5' 
anchoring of the guide 
RNA and the other, the 
catalytic site for slicing. 
 
 
92.3% 
 
96.9% 
 
Piwi domain 
 
 
517 – 784 
 
dsRNA guided 
hydrolysis of ssRNA. 
  
 
93.7% 
 
97.4% 
Table 8.1: Comparison of Functional Domains of Argonaute 2.   
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8.3.2 Dicer 
HuDicer1        ------------------------------------------------------------ 
ZfDicer1        MAGLQLVTPASSPMGPFFGLPWQQEAIHDNIYTPRKYQVELLEAALEHNTIVCLNTGSGK 60 
                                                                             
 
HuDicer1        TFIAVLLTKELSYQIRGDFSRNGKRTVFLVNSANQVAQQVSAVRTHSDLKVGEYSNLEVN 60 
ZfDicer1        TFIAVLLIKELSHQIRGE---NGKRTVFLVNAASSVAQQASTVRTHSDLQVGDYMSEDMT 117 
                ******* ****:****:   **********:*..****.*:*******:**:* . ::. 
 
HuDicer1        ASWTKERWNQEFTKHQVLIMTCYVALNVLKNGYLSLSDINLLVFDECHLAILDHPYREIM 120 
ZfDicer1        S-WPEEMWNREMIENQVLVMTCHIFLHVLKNGVLPLSKINLLVFDECHLAITGHPYREIM 176 
                : *.:* **:*: ::***:***:: *:***** *.**.************* .******* 
 
HuDicer1        KLCENCPSCPRILGLTASILNGKCDPEELEEKIQKLEKILKSNAETATDLVVLDRYTSQP 180 
ZfDicer1        KICEGCPSCPRILGLTASILNGKCDPCDLEEKIQNLEKILQSNAETATDLVVLDRYASQP 236 
                *:**.********************* :******:*****:***************:*** 
 
HuDicer1        CEIVVDCGPFTDRSGLYERLLMELEEALNFINDCNISVHSKERDSTLISKQILSDCRAVL 240 
ZfDicer1        REEVLDCGQYQDQSGLSERLLNELDEALNFLNDCNLSVHREDRDPTFISKQVLNDCRAVL 296 
                 * *:*** : *:*** **** **:*****:****:*** ::**.*:****:*.****** 
 
HuDicer1        VVLGPWCADKVAGMMVRELQKYIKHEQEELHRKFLLFTDTFLRKIHALCEEHFSPASLDL 300 
ZfDicer1        TVLGPWCADKAAGIMVRELQKYIKHEQEELNRKFLLFTDTILRKIHALCEEHFSPASLDL 356 
                .*********.**:****************:*********:******************* 
 
HuDicer1        KFVTPKVIKLLEILRKYKPYERQQFESVEWYNNRNQDNYVSWSDSEDDDEDEEIEEKEKP 360 
ZfDicer1        KFVTPKVIRLLEILHEYKPFERQQFESVEWYNNRNQDNYVSWSDSEDDDEDEEAEAKEKT 416 
                ********:*****::***:********************************* * ***. 
 
HuDicer1        ETNFPSPFTNILCGIIFVERRYTAVVLNRLIKEAGKQDPELAYISSNFITGHGIGKNQPR 420 
ZfDicer1        EANFPSPFTNILCGIIFVERRYTAVVLNRLIKEAGKQDPELAYISSNFITGHSIGKNQPR 476 
                *:**************************************************.******* 
 
HuDicer1        NKQMEAEFRKQEEVLRKFRAHETNLLIATSIVEEGVDIPKCNLVVRFDLPTEYRSYVQSK 480 
ZfDicer1        NKQMEVEFRKQEEVLRKFRAHETNLLIATSIVEEGVDIPKCNLVVRFDLPTEYRSYVQSK 536 
                *****.****************************************************** 
 
HuDicer1        GRARAPISNYIMLADTDKIKSFEEDLKTYKAIEKILRNKCSKSVDTGETDIDPVMDDDDV 540 
ZfDicer1        GRARAPVSNYIMLADSERTKTFQEDLKTYKAIEKILRNKCSKSAECNDFELEPVTDDDNV 596 
                ******:********::: *:*:********************.: .: :::** ***:* 
 
HuDicer1        FPPYVLRPDDGGPRVTINTAIGHINRYCARLPSDPFTHLAPKCRTRELPDGTFYSTLYLP 600 
ZfDicer1        LPPYVLRSEDGGPRVTMNTAIGHVNRYCARLPSDPFTHLAPKCKTVEMNTGGYRSTLFLP 656 
                :******.:*******:******:*******************:* *:  * : ***:** 
 
HuDicer1        INSPLRASIVGPPMSCVRLAERVVALICCEKLHKIGELDDHLMPVGKETVKYEEELDLHD 660 
ZfDicer1        INSPLRVPVTGPVMNCARLAEKAVALLCCEKLHKIGELDDHLMPVGKETVKYEEELDLHD 716 
                ******..:.** *.*.****:.***:********************************* 
 
HuDicer1        EEETSVPGRPGSTKRRQCYPKAIPECLRDSYPRPDQPCYLYVIGMVLTTPLPDELNFRRR 720 
ZfDicer1        EEETSVPGRPGSTKRRQCSPKAIPECLRGCYPVPEQPCYLYVIGMVLTTPLPDELNFRRR 776 
                ****************** *********..** *:************************* 
 
HuDicer1        KLYPPEDTTRCFGILTAKPIPQIPHFPVYTRSGEVTISIELKKSGFMLSLQMLELITRLH 780 
ZfDicer1        KLYPPEDTTRCFGILTAKPIPRIPHFPVYTRSGEVTISIELQKSGFSLSAEQLELITRLH 836 
                *********************:*******************:**** ** : ******** 
 
HuDicer1        QYIFSHILRLEKPALEFKPTDADSAYCVLPLNVVNDSSTLDIDFKFMEDIEKSEARIGIP 840 
ZfDicer1        QYIFSHILRLEKPALEFKPVEADSAYCVLPLNIVEDSNTLDLDFKFMEDIEKSEARIGIP 896 
                *******************.:***********:*:**.***:****************** 
 
HuDicer1        STKYTKETPFVFKLEDYQDAVIIPRYRNFDQPHRFYVADVYTDLTPLSKFPSPEYETFAE 900 
ZfDicer1        NTQYTKQNPFIFKLEDYQDAVIIPRYRNFDQPHRFYVADVYTDLTPLSKFPSPEYETFAE 956 
                .*:***:.**:************************************************* 
 
HuDicer1        YYKTKYNLDLTNLNQPLLDVDHTSSRLNLLTPRHLNQKGKALPLSSAEKRKAKWESLQNK 960 
ZfDicer1        YYKTKYNLDLSNVNQPLLDVDHTSSRLNLLTPRHLNQKGKALPLSSAEKRKAKWESLQNK 1016 
                **********:*:*********************************************** 
 
HuDicer1        QILVPELCAIHPIPASLWRKAVCLPSILYRLHCLLTAEELRAQTASDAGVGVRSLPADFR 1020 
ZfDicer1        QILVPELCAIHPIPASLWRKAVCLPSILYRLHCLLTAEELRSQTAIDAGVGAQTLPPDFR 1076 
                *****************************************:*** *****.::**.*** 
 
HuDicer1        YPNLDFGWKKSIDSKSFISISNSSSAENDNYCKHSTIVPENAAHQGANRTSSLENHDQMS 1080 
ZfDicer1        YPNLDFGWKKSIDSKSFISCPSACMEEDDDHCKLGTSS---DSNHTAPESCSMEVS-QPP 1132 
Appendices 
203 
 
                ******************* ..:.  *:*::** .*      ::: * .:.*:*   * . 
 
HuDicer1        VNCRTLLSESPGKLHVEVSADLTAINGLSYNQNLANGSYDLANR-DFCQGNQLNYYKQEI 1139 
ZfDicer1        EGAPNTPDEKLETLTLPVTDLNKDCFPNLPNGTQAD-SDDLPHRSDVCQCSQLGPLERDL 1191 
                 .. .  .*.  .* : *:   .       * . *: * **.:* *.** .**.  :::: 
 
HuDicer1        PVQPTTSYSIQNLYSYENQPQPSDECTLLSNKYLDGNANKSTSDGSPVMAVMPGTTDTIQ 1199 
ZfDicer1        STQTTTSVSVRPSPAGEPQPWPSDECTGRSSDLCDPHVKKPTSKHCPKSETATSTPAPSE 1251 
                ..*.*** *::   : * ** ******  *..  * :.:*.**. .*   . ..*. . : 
 
HuDicer1        VLKGRMDSEQSPSIGYSSRTLGPNPGLILQALTLSNASDGFNLERLEMLGDSFLKHAITT 1259 
ZfDicer1        TSSEDCRSACAGPAWDSPKTLGPNPGLILQALTLSNASDGFNLERLEMLGDSFLKHAITT 1311 
                . .    *  : .   *.:***************************************** 
 
HuDicer1        YLFCTYPDAHEGRLSYMRSKKVSNCNLYRLGKKKGLPSRMVVSIFDPPVNWLPPGYVVNQ 1319 
ZfDicer1        YLFCTYPDAHEGRLSYMRSKKVSNCNLYRLGKKKGLPSRMVVSIFDPPVNWLPPGYVVNQ 1371 
                ************************************************************ 
 
HuDicer1        DKSNTDKWEKDEMTKDCMLANGKLDEDYEEEDEEEESLMWRAPKEEADYEDDFLEYDQEH 1379 
ZfDicer1        DKSSTDKWDSDENKD---LANGKASDDEDEDDDDEPEEAEVEPSKEDVNVEDDLEYYYEH 1428 
                ***.****:.** ..   ***** .:* :*:*::* .     *.:*    :* ***  ** 
 
HuDicer1        IRFIDNMLMGSGAFVKKISLSPFSTTDSAYEWKMPKKSSLGSMPFSSDFEDFDYSSWDAM 1439 
ZfDicer1        IRFIDSMLIGSGAFGKKISLQP---TDPGYEWKAPKKAHNSHFSPDGGADEFDYSSWDAM 1485 
                *****.**:***** *****.*   **..**** ***:  . :. ... ::********* 
 
HuDicer1        CYLDPSKAVEEDDFVVGFWNPSEENCGVDTGKQSISYDLHTEQCIADKSIADCVEALLGC 1499 
ZfDicer1        CYLDPSKAGEEDDFVVGFWNPSEENCGTDIGKQSISYDLHTEQCIADKSIADCVEALLGC 1545 
                ******** ******************.* ****************************** 
 
HuDicer1        YLTSCGERAAQLFLCSLGLKVLPVIKRTDREKALCPTRENFNSQQKNLSVSCAAASVASS 1559 
ZfDicer1        YLTSCGERAAQLFLCSLGLKVLPPEKQS-------------------------------- 1573 
                ***********************  *::                                 
 
HuDicer1        RSSVLKDSEYGCLKIPPRCMFDHPDADKTLNHLISGFENFEKKINYRFKNKAYLLQAFTH 1619 
ZfDicer1        -SGGSAELQYGWLKIPPRCMFEHPDAERTLNHLISGFLNFESKINYTFKNKAYLLQAFTH 1632 
                 *.   : :** *********:****::********* ***.**** ************* 
 
HuDicer1        ASYHYNTITDCYQRLEFLGDAILDYLITKHLYEDPRQHSPGVLTDLRSALVNNTIFASLA 1679 
ZfDicer1        ASYHYNTITDCYQRLEFLGDAILDYLITKHLYEDPRQHSPGVLTDLRSALVNNTIFASLA 1692 
                ************************************************************ 
 
HuDicer1        VKYDYHKYFKAVSPELFHVIDDFVQFQLEKNEMQGMDSELRRSEEDEEKEEDIEVPKAMG 1739 
ZfDicer1        VKYDYHKYFKAVSPELFHVIDDFVQFQLEKNEMQGMDSELRRSEEDEEKEEDIEVPKAMG 1752 
                ************************************************************ 
 
HuDicer1        DIFESLAGAIYMDSGMSLETVWQVYYPMMRPLIEKFSANVPRSPVRELLEMEPETAKFSP 1799 
ZfDicer1        DIFESLAGAIYMDSGMSLETVWQVYYPMMRPLIEKFSANVPRSPVRELLEMEPETAKFSP 1812 
                ************************************************************ 
 
HuDicer1        AERTYDGKVRVTVEVVGKGKFKGVGRSYRIAKSAAARRALRSLKANQPQVPNS 1852 
ZfDicer1        AERTYDGKVRVTVEVVGKGKFKGVGRSYRIAKSAAARRALRSLKANQPQVQNN 1865 
                ************************************************** *. 
 
Figure 8.9: Comparison of Human (NP_085124.2) and Zebrafish (NP_001154925.1) Dicer1 
proteins.  Red indicates small, hydrophobic amino acids (A,F,I,L,M,P,V,W). Blue indicates acidic 
amino acids (D,E). Pink indicates basic amino acids (K,R). Green indicates hydroxyl+amine+basic 
amino acids (C,G,H,N,Q,S,T,Y).  Identical amino acids are indicated with a *. : indicates a conservative 
substitution and . indicates a semi-conservative substitution.  Human and zebrafish dicer are 76.3% 
identical and 82.6% similar.   
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Domain name 
 
Corresponding 
amino acid 
(Human) 
 
 
Function 
 
Identity 
 
Similarity 
 
DEXDc; Dead-
like helicase 
 
 
58-209 
 
ATP-dependent RNA and DNA 
unwinding 
 
74.3% 
 
84.2% 
 
HELICc; 
Helicase 
superfamily c-
terminal domain 
 
 
444-553 
 
ATP-dependent RNA and DNA 
unwinding 
 
80.9% 
 
92.7% 
 
double stranded 
RNA binding 
domain 
 
 
630-722 
 
Binding double stranded RNA 
 
94.6% 
 
95.7% 
 
PAZ-domain 
 
886-1008 
 
nucleic-acid binding domain, 
with a strong preference for 
single-stranded nucleic acids 
(RNA or DNA) or RNA 
duplexes with single-stranded 
3' overhangs 
 
 
96.5% 
 
99.1% 
Table 8.2: Comparison of Functional Domains of Dicer1. 
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8.3.3 Drosha 
HuRNASEN        MMQGNTCHRMSFHPGRGCPRGRGGHGARPSAPSFRPQNLRLLHPQQPPVQYQYEPPSAPS 60 
ZfRNASEN        ---------MSFHAGRGCPRGR------------LPAPGQIYHPAPP--RYHYDPSAAPG 37 
                         ****.********             *   :: **  *  :*:*:*.:**. 
 
HuRNASEN        TTFSNSPAPNFLPPRPDFVPFPPPMPPSAQGPLPPCPIRPPFPNHQMRHPFPVPPCFPPM 120 
ZfRNASEN        PVYNPQGGSSYMPPHPDFMSFHFPPPSQASNTLPQCPIRPPV--------FTEPPPFPP- 88 
                ..:. . ...::**:***:.*  * *..*...** ******.        *. ** ***  
 
HuRNASEN        PPPMPCPNNPPVPGAPPGQGTFPFMMP---PPSMPHPPP--PPVMPQQVNYQYPPGYSHH 175 
ZfRNASEN        PPPHSSDGSTPMP----IQNSYPYMMPNIPPPPLPPMPPSVPPTMPYPPTYPMSYPPQPQ 144 
                *** .. ...*:*     *.::*:***   **.:*  **  **.**   .*  .   . : 
 
HuRNASEN        NFPPPSFNSFQNNPSSFLPSANNSSSPHFRHLPPYPLPKAPSERRSPERLKHYDDHRHRD 235 
ZfRNASEN        LPPPPSFNPAYGQPSGSFKPERSRPPLHY---------KTDSCSRSPERLRHHDDHRHRG 195 
                  ******.  .:**. : . .. .. *:         *: *  ******:*:******. 
 
HuRNASEN        HSHGR-GERHR---SLDRRERGRSPDRRRQDS--RYRSDYDRGRTPSRHRSYERSRERER 289 
ZfRNASEN        HSYSEYGSRHNREFGGEKRDRGCSSERRRSDSPRRCKSDYDRGRVSSRHRS--------R 247 
                **:.. *.**.   . ::*:** *.:***.**  * :*******..*****        * 
 
HuRNASEN        ERHRHRDNRRSPSLERSYKKEYKRSGSRSPSREKKRARWEEEKDRWSDNQSSGKDKNYTS 349 
ZfRNASEN        DRYRHRDDPGSPSSDRHRKHARNRSGSR----ERKRRRVEEDKERRTDGSSSSRERSVNS 303 
                :*:****:  *** :*  *:  :*****    *:** * **:*:* :*..**.:::. .* 
 
HuRNASEN        IKEKEPEETMPDKNEEE--EEELLKPVWIRCTHSENYYSSDPMDQVGDSTVVGTSRLRDL 407 
ZfRNASEN        SRSREAEEITIDRHEEDRGQEELHKPAWIRCTHAENYYSNDPMDQVGDSTVVGTSKLRDL 363 
                 :.:*.**   *::**:  :*** **.******:*****.***************:**** 
 
HuRNASEN        YDKFEEELGSRQEKAKAARPPWEPPKTKLDEDLE-SSSESECESDED-STCSSSSDSEVF 465 
ZfRNASEN        YERFEEELGKRQERAKSIRPKWEPPKTKLDQDQDESSSESECESDGGGSTCSSSSDSEVF 423 
                *::******.***:**: ** *********:* : ********** . ************ 
 
HuRNASEN        DVIAEIKRKKAHPDRLHDELWYNDPGQMNDGPLCKCSAKARRTGIRHSIYPGEEAIKPCR 525 
ZfRNASEN        DVIAEIKRKKAHPDRLHDELWYNDPGQMNDGPLCKCSAKARRTGIRHSIYPGEQPVKQCR 483 
                *****************************************************:.:* ** 
 
HuRNASEN        PMTNNAGRLFHYRITVSPPTNFLTDRPTVIEYDDHEYIFEGFSMFAHAPLTNIPLCKVIR 585 
ZfRNASEN        PMNNNAGKLFHYRITVSPPTNFLTDRPTVIEYDDHEYLFEGFSCFSHTPLTSIPLCRVIR 543 
                **.****:*****************************:***** *:*:***.****:*** 
 
HuRNASEN        FNIDYTIHFIEEMMPENFCVKGLELFSLFLFRDILELYDWNLKGPLFEDSPPCCPRFHFM 645 
ZfRNASEN        FNIDYTIHFIEEMAPENYCVKGLELFSSYLFKDILELYDWNLTDPE-ENSPLGCQRFHFM 602 
                ************* ***:********* :**:**********..*  *:**  * ***** 
 
HuRNASEN        PRFVRFLPDGGKEVLSMHQILLYLLRCSKALVPEEEIANMLQWEELEWQKYAEECKGMIV 705 
ZfRNASEN        PRFVRFLPDGGKEVLSMHQVLLYLLHSSKPLVPEEEIANMLQWEELEWQKYAEECKGMIV 662 
                *******************:*****:.**.****************************** 
 
HuRNASEN        TNPGTKPSSVRIDQLDREQFNPDVITFPIIVHFGIRPAQLSYAGDPQYQKLWKSYVKLRH 765 
ZfRNASEN        TNPGMKPSSVRIDQLDREQFNSSVITFPIIVHFGIRPAQLSYAGDPQYQKLWKSYVKLRH 722 
                **** ****************..************************************* 
 
HuRNASEN        LLANSPKVKQTDKQKLAQREEALQKIRQKNTMRREVTVELSSQGFWKTGIRSDVCQHAMM 825 
ZfRNASEN        LLANSPKVKQIDKQKLMQREEALQKIRQKNTMRREVTVELSSQGFWKTGIRSDVCQHAMM 782 
                ********** ***** ******************************************* 
 
HuRNASEN        LPVLTHHIRYHQCLMHLDKLIGYTFQDRCLLQLAMTHPSHHLNFGMNPDHARNSLSNCGI 885 
ZfRNASEN        LPVLTHHIRYHQCLMHLDKLIGYMFKERCLLQLAMTHPSHHLNFGMNPDHARNSLSNCGI 842 
                *********************** *::********************************* 
 
HuRNASEN        RQPKYGDRKVHHMHMRKKGINTLINIMSRLGQDDPTPSRINHNERLEFLGDAVVEFLTSV 945 
ZfRNASEN        RQPKYGDRKVHHMYMRKKGINTLINIMSRLGQDDPSPSRINHNERLEFLGDAVVEFLTSV 902 
                *************:*********************:************************ 
 
HuRNASEN        HLYYLFPSLEEGGLATYRTAIVQNQHLAMLAKKLELDRFMLYAHGPDLCRESDLRHAMAN 1005 
ZfRNASEN        HLYHLFPSLEEGGLATYRTAIVQNQHLAMLAKKLELDRFMLYAHGPDLCRESDLRHAMAN 962 
                ***:******************************************************** 
 
HuRNASEN        CFEALIGAVYLEGSLEEAKQLFGRLLFNDPDLREVWLNYPLHPLQLQEPNTDRQLIETSP 1065 
ZfRNASEN        CFEALIGAVYLEGGLEEAKDLFGRLLFNTEDMREVWLNYPPHPLQVQEPLTDRQLIESSP 1022 
                *************.*****:********  *:******** ****:*** *******:** 
 
HuRNASEN        VLQKLTEFEEAIGVIFTHVRLLARAFTLRTVGFNHLTLGHNQRMEFLGDSIMQLVATEYL 1125 
ZfRNASEN        VLQKLTNFEDAIGVLFTHVRLLARAFTLRTVGFNHLTLGHNQRMEFLGDSIMQLVATEYL 1082 
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                ******:**:****:********************************************* 
 
HuRNASEN        FIHFPDHHEGHLTLLRSSLVNNRTQAKVAEELGMQEYAITNDKTKRPVALRTKTLADLLE 1185 
ZfRNASEN        FIHFPDHHEGHLTLLRSSLVNNRTQAKVAEELGMQEFAITNDKTKRPVALRTKTLADLLE 1142 
                ************************************:*********************** 
 
HuRNASEN        SFIAALYIDKDLEYVHTFMNVCFFPRLKEFILNQDWNDPKSQLQQCCLTLRTEGKEPDIP 1245 
ZfRNASEN        SFIAALYIDKDLEFVHTFMNVCFFPRLKEFILNQDWNDPKSQLQQCCLTLRTEGKEPDIP 1202 
                *************:********************************************** 
 
HuRNASEN        LYKTLQTVGPSHARTYTVAVYFKGERIGCGKGPSIQQAEMGAAMDALEKYNFPQMAHQKR 1305 
ZfRNASEN        LYKTLQTVGPSHARTYTVAVYFKGERIGCGKGPSIQQAEMGAAMDALEKYNFPQMAHQKR 1262 
                ************************************************************ 
 
HuRNASEN        FIERKYRQELKEMRWEREHQEREPDETEDIKK 1337 
ZfRNASEN        FIERKYRQELKEMRRERERQERDSDEG----- 1289 
                ************** ***:***:.**       
 
Figure 8.10: Comparison of Human (NP_001093882.1) and Zebrafish (predicted from 
cDNA image clone:3815032) Drosha (RNASEN) proteins.  Red indicates small, 
hydrophobic amino acids (A,F,I,L,M,P,V,W). Blue indicates acidic amino acids (D,E). Pink 
indicates basic amino acids (K,R). Green indicates hydroxyl+amine+basic amino acids 
(C,G,H,N,Q,S,T,Y).  Identical amino acids are indicated with a *. : indicates a conservative 
substitution and . indicates a semi-conservative substitution.  Human and zebrafish drosha 
are 77.3% identical and 83.0% similar.  
 
 
 
Domain name 
 
Corresponding 
amino acid (Human) 
 
 
Function 
 
Identity 
 
Similarity 
 
rnc; ribonuclease III 
domain 
 
 
1068 – 1296 
 
Double stranded RNA-
specific endonuclease. 
 
 
97.8% 
 
 
 
99.6% 
 
RIBOc. Ribonuclease 
III C terminal domain.  
 
 
1085 – 1217 
 
Double stranded RNA-
specific endonuclease. 
 
 
98.5% 
 
 
 
100% 
 
DSRM; Double-
stranded RNA 
binding motif.  
 
 
1223 – 1294 
 
Highly specific binding 
of double stranded 
RNA. 
 
100% 
 
100% 
Table 8.3: Comparison of Functional Domains of Drosha. 
 
 
  
Appendices 
207 
 
8.3.4 Exportin 5 
HuXpo5          MAMDQVNALCEQLVKAVTVMMDPNSTQRYRLEALKFCEEFKEKCPICVPCGLRLAEKTQV 60 
ZfXpo5          -MGEQMRALCEELIKAVNVMMEAESSQTYRLEAFKFIEDFKEKSPFCVECGLQLAEKSQT 59 
                   :*:.****:*:***.***:.:*:* *****:** *:****.*:** ***:****:*. 
 
HuXpo5          AIVRHFGLQILEHVVKFRWNGMSRLEKVYLKNSVMELIANGTLNILEEENHIKDALSRIV 120 
ZfXpo5          AVIRHFGLQILEHVVKFRWNNMAPQDKLQLKNCTMGMLSNGTHPILQEECHVKDALSRIV 119 
                *::*****************.*:  :*: ***..* :::***  **:** *:******** 
 
HuXpo5          VEMIKREWPQHWPDMLIELDTLSKQGETQTELVMFILLRLAEDVVTFQTLPPQRRRDIQQ 180 
ZfXpo5          VEMIKREWPQQWPDMLKEMEALTALGDAQTELVMLVLLRLAEDVITFQTLPSQRRRDIQQ 179 
                **********:***** *:::*:  *::******::********:******.******** 
 
HuXpo5          TLTQNMERIFSFLLNTLQENVNKYQQVKTDTSQESKAQANCRVGVAALNTLAGYIDWVSM 240 
ZfXpo5          TLTQNMDSVFTFLLGILQLHVNEYSKMMK---------AHLRVGVATLNTLAGYIDWVSL 230 
                ******: :*:***. ** :**:*.:: .         *: *****:************: 
 
HuXpo5          SHITAENCKLLEILCLLLNEQELQLGAAECLLIAVSRKGKLEDRKPLMVLFGDVAMHYIL 300 
ZfXpo5          SHITSQNCRLLEILCLLLSEPELQLEAAECLLIAISRKGKLEERKPFMVLFDEAAMNYIL 290 
                ****::**:*********.* **** ********:*******:***:****.:.**:*** 
 
HuXpo5          SAAQTADGGGLVEKHYVFLKRLCQVLCALGNQLCALLGADSDVETPSNFGKYLESFLAFT 360 
ZfXpo5          SAAQSS--GGIDERRYTFLKRLCQVLCALGSQVCSLVGSDVEVQVPVNLNKYLEALLAFT 348 
                ****::  **: *::*.*************.*:*:*:*:* :*:.* *:.****::**** 
 
HuXpo5          THPSQFLRSSTQMTWGALFRHEILSRDPLLLAIIPKYLRASMTNLVKMGFPSKTDSPSCE 420 
ZfXpo5          THPSQFLRSSTQMTWGIIFRHEILSKDPVVGQMAIKYLRATRINLVKTGFPSKNDCPGCE 408 
                **************** :*******:**::  :  *****:  **** *****.*.*.** 
 
HuXpo5          YSRFDFDSDEDFNAFFNSSRAQQGEVMRLACRLDPKTSFQMAGEWLKYQLSTFLDAG--- 477 
ZfXpo5          FSRVDFDSDEDFNSSFNSSRAQQGEAVRLTCRIVPFKAFQIARDWMQYQISTPIDAGKTT 468 
                :**.*********: **********.:**:**: * .:**:* :*::**:** :***    
 
HuXpo5          -SVNSCSAVGTGEGSLCSVFSPSFVQWEAMTLFLESVITQMFRTLNREEIPVNDGIELLQ 536 
ZfXpo5          DNCKAVLALGTTEKGLCSPLSPSVVQWEAMTTFTENVFGQLFKILEKEKLPIDEGMALLQ 528 
                 . ::  *:** * .*** :***.******* * *.*: *:*: *::*::*:::*: *** 
 
HuXpo5          MVLNFDTKDPLILSCVLTNVSALFPFVTYRPEFLPQVFSKLFSSVTFETVEESKAPRTRA 596 
ZfXpo5          IAVNFETRDPLILSCVLTIVSTLFPILTHRPHFLPQVLFKIFSAITFELVDERKAPRTRA 588 
                :.:**:*:********** **:***::*:**.*****: *:**::*** *:* ******* 
 
HuXpo5          VRNVRRHACSSIIKMCRDYPQLVLPNFDMLYNHVKQLLSNELLLTQMEKCALMEALVLIS 656 
ZfXpo5          VKNVRRHACSSIIRICRDYSDFMLPCFDLMYEHVKRLFSDELLLTQLEKCALMEALILIS 648 
                *:***********::****.:::** **::*:***:*:*:******:*********:*** 
 
HuXpo5          NQFKNYERQKVFLEELMAPVASIWLSQDMHRVLSDVDAFIAYVGTDQKSCDPGLEDPCGL 716 
ZfXpo5          NQFKDYKKQKAFLEELMAPVTALWLSEEMRSVLWDPATFLTFVGADQEISDSDTDEQMGI 708 
                ****:*::**.*********:::***::*: ** *  :*:::**:**: .*.. ::  *: 
 
HuXpo5          NRARMSFCVYSILGVVKRTCWPTDLEEAKAGGFVVGYTSSGNPIFRNPCTEQILKLLDNL 776 
ZfXpo5          NRSRISLCVHTILGVVKRARWPADADQAKAGGFVVRTASDGTPVYRNPCAEALQALLPNL 768 
                **:*:*:**::*******: **:* ::********  :*.*.*::****:* :  ** ** 
 
HuXpo5          LALIRTHNTLYAPEMLAKMAEPFTKALDMLDAEKSAILGLPQPLLELNDSPVFKTVLERM 836 
ZfXpo5          LALIRTNNSLFLPENITRLSKTFARVYDITDMEKNCVLGISQVVLDSYEAAVYKNFAERM 828 
                ******:*:*: ** ::::::.*::. *: * **..:**:.* :*:  ::.*:*.. *** 
 
HuXpo5          QRFFSTLYENCFHILGKAGPSMQQDFYTVEDLATQLLSSAFVNLNNIPDYRLRPMLRVFV 896 
ZfXpo5          QGFFSSLFENCYHVLGNVGPCLQQDFYGIEGLAEQIVGSAFNHLDSVPDHRLRPLIHILE 888 
                * ***:*:***:*:**:.**.:***** :*.** *::.*** :*:.:**:****:::::  
 
HuXpo5          KPLVLFCPPEHYEALVSPILGPLFTYLHMRLSQKWQVINQRSLLCG--EDEAADENPESQ 954 
ZfXpo5          --------------------------ITMRLNFRWQIINQRASLSAQEEEEAYEENHVTQ 922 
                                          : ***. :**:****: *..  *:** :**  :* 
 
HuXpo5          EMLEEQLVRMLTREVMDLITVCCVSKKGADHSSAPPADGDDEEMMATEVTP-----SAMA 1009 
ZfXpo5          EMVEEQLLRLVTREVMDLLSVTCITRKCPEVNANKEEADGDEEMVSMDSSQGNQVNTPSD 982 
                **:****:*::*******::* *:::* .: .:     ..****:: : :      :.   
 
HuXpo5          ELTDLGKCLMKHEDVCTALLITAFNSLAWKDTLSCQRTTSQLCWPLLKQVLSGTLLADAV 1069 
ZfXpo5          ELSDLGKCLLQSEDIYMTVLTICFNCLSWKDTVNCQRTAGVLCWTLLKQVQGGNLLPEAV 1042 
                **:******:: **:  ::*  .**.*:****:.****:. ***.***** .*.**.:** 
 
HuXpo5          TWLFTSVLKGLQMHGQHDGCMASLVHLAFQIYEALRPRYLEIRAVMEQIPEIQKDSLDQF 1129 
ZfXpo5          TWLFASVLKGLQMHGQHEGCNVALTQLALLIYESLRPRYAELRLIMNQIPDVQADALEQF 1102 
Appendices 
208 
 
                ****:************:** .:*.:**: ***:***** *:* :*:***::* *:*:** 
 
HuXpo5          DCKLLNPSLQKVADKRRKDQFKRLIAGCIGKPLGEQFRKEVHIKNLPSLFKKTKPMLETE 1189 
ZfXpo5          DQKIQ-PGASKLGEKKKKEQFRRLIAGTVGKPLAQQFKKEVHIRNLPSLFKKPKPTKD-L 1160 
                * *:  *. .*:.:*::*:**:***** :****.:**:*****:********.**  :   
 
HuXpo5          VLDNDGGGLATIFEP----- 1204 
ZfXpo5          LENNEDATLISLFTPDHDRC 1180 
                : :*:.. * ::* *      
 
Figure 8.11: Comparison of Human (NP_065801.1) and Zebrafish (XP_001921422.1) 
Exportin 5.  Red indicates small, hydrophobic amino acids (A,F,I,L,M,P,V,W). Blue indicates 
acidic amino acids (D,E). Pink indicates basic amino acids (K,R). Green indicates 
hydroxyl+amine+basic amino acids (C,G,H,N,Q,S,T,Y).  Identical amino acids are indicated 
with a *. : indicates a conservative substitution and . indicates a semi-conservative 
substitution.  Human and zebrafish protein sequences are 58.6% identical and 76.2% 
similar. 
 
 
Domain name 
 
Corresponding 
amino acid 
(Human) 
 
 
Function 
 
Identity 
 
Similarity 
 
CRM1; Importin 
beta-related 
nuclear 
transport 
receptor 
domain 
 
 
56-353 
 
 
mediates the transport of protein 
and RNA macromolecules 
containing nuclear import and 
export signals between the 
nucleus and cytoplasm  
 
 
67.8% 
 
 
82.9% 
 
Xpo1; Exportin 
1-like protein 
domain 
 
109-243 
 
nuclear export receptor that 
interacts with leucine-rich 
nuclear export signal (NES) 
sequences, and Ran-GTP, and 
is involved in translocation of  
proteins and RNA out of the 
nucleus. 
 
 
69.1% 
 
 
80.9% 
 
Table 8.4: Comparison of Functional Domains of Exportin 5. 
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8.4 Targeting the 3‟ UTR 
 
 
Figure 8.12: Open-reading frame miRNA compared to 3’UTR miRNA mediated gene 
knockdown in PAC.2 YFP cells.  Relative YFP levels in PAC.2 YFP cells after transfection 
with vectors containing a control miRNA (black bars), a YFP ORF miRNA (green bars) or 
SV40pA miRNAs (gold and yellow bars).  YFP levels measured using fluorescent flow 
cytometry. Results were analysed by One-way ANOVA. *= p < 0.05, **= p < 0.01, ***= p 
<0.001. 
 
